| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.13e-08 | 37 | 261 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.67e-08 | 38 | 261 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH6 MYO1A ABCA13 ZRANB3 ABCB1 DHX15 ATP2C2 RAD54B ABCC2 DNA2 DNAH6 KIF13B DNAH3 DDX52 SMC4 UBA2 CCT2 KIF20B KIF3A DMC1 RUVBL1 DNAH17 AACS UBA6 MACF1 ATP2B1 ATP2B2 | 4.04e-08 | 614 | 261 | 27 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.59e-07 | 11 | 261 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.17e-07 | 21 | 261 | 6 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.08e-06 | 46 | 261 | 7 | GO:0016893 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | RYR2 ITPR1 SLC9C1 KCNU1 SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 SLC31A2 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 SLC20A2 ATP2B1 ATP2B2 | 3.50e-06 | 465 | 261 | 20 | GO:0046873 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA13 ABCB1 DHX15 ATP2C2 ABCC2 DNA2 DNAH6 KIF13B DNAH3 DDX52 SMC4 CCT2 KIF20B KIF3A DMC1 RUVBL1 MACF1 ATP2B1 ATP2B2 | 6.03e-06 | 441 | 261 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | eukaryotic initiation factor eIF2 binding | 8.75e-06 | 4 | 261 | 3 | GO:0071074 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TNIK ERVK-6 ERVK-7 ERVK-10 PGK1 PGK2 RYK PIK3C2A PIK3CB CLK2 FAM20B TAF1 TAF1L AKT3 SGK1 POLR2A BRSK2 PARP14 POLR3A CDK13 ERVK-8 NT5C2 UBA6 EIF2AK4 BRSK1 MAP2K1 ALPK2 CDK2 EPHA7 | 1.61e-05 | 938 | 261 | 29 | GO:0016772 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.93e-05 | 26 | 261 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.58e-05 | 14 | 261 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CHRNA5 RYR2 NDUFV2 ITPR1 SLC9C1 KCNU1 SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 SLC31A2 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 SLC20A2 ATP2B1 ATP2B2 | 6.57e-05 | 664 | 261 | 22 | GO:0008324 |
| GeneOntologyMolecularFunction | 5'-flap endonuclease activity | 7.43e-05 | 7 | 261 | 3 | GO:0017108 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | RYR2 NDUFV2 ITPR1 SLC9C1 KCNU1 SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 SLC31A2 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 SLC20A2 ATP2B1 ATP2B2 | 8.30e-05 | 627 | 261 | 21 | GO:0022890 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | NUGGC ABCA13 ABCB1 DHX15 ATP2C2 ABCC2 DNA2 DNAH6 KIF13B DNAH3 DDX52 SMC4 CCT2 KIF20B KIF3A GSPT1 DMC1 GTPBP2 RAB34 RUVBL1 EIF5B MACF1 ATP2B1 ATP2B2 | 8.74e-05 | 775 | 261 | 24 | GO:0017111 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC9C1 SCN4A SCN5A SCN8A SCN9A SCN10A SLC3A2 SLC8A1 SLC8A3 SLC20A2 | 8.75e-05 | 171 | 261 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.14e-04 | 37 | 261 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | flap endonuclease activity | 1.18e-04 | 8 | 261 | 3 | GO:0048256 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.62e-04 | 118 | 261 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | RYR2 NDUFV2 ITPR1 SLC9C1 KCNU1 SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 SLC31A2 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 SLC20A2 MFSD8 ATP2B1 ATP2B2 | 1.66e-04 | 758 | 261 | 23 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 1.70e-04 | 2 | 261 | 2 | GO:0099580 | |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 1.70e-04 | 2 | 261 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | long-chain-3-hydroxyacyl-CoA dehydrogenase activity | 1.70e-04 | 2 | 261 | 2 | GO:0016509 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase (NAD(P)H) activity | 1.75e-04 | 9 | 261 | 3 | GO:0047134 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 ERVK-7 ERVK-10 ZRANB3 RAD54B DNA2 AEN DMC1 RUVBL1 ERVK-8 EXO1 GEN1 | 1.83e-04 | 262 | 261 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA6 LIN7C NCK1 NCL MECP2 ITPR1 ATXN1 FMN1 CASKIN1 SCN5A PSMC3IP ABCC2 TRIM16L DMD FMR1 RAPGEF1 KIF20B TRIM16 TGM2 ARRB2 SHCBP1 ATP2B1 ATP2B2 CNOT1 CDK2 | 2.17e-04 | 875 | 261 | 25 | GO:0019904 |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 2.36e-04 | 43 | 261 | 5 | GO:0140828 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 2.48e-04 | 10 | 261 | 3 | GO:0005432 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | NUGGC ABCA13 ABCB1 DHX15 ATP2C2 ABCC2 DNA2 DNAH6 KIF13B DNAH3 DDX52 SMC4 CCT2 KIF20B KIF3A GSPT1 DMC1 GTPBP2 RAB34 RUVBL1 EIF5B MACF1 ATP2B1 ATP2B2 | 2.86e-04 | 839 | 261 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | NUGGC ABCA13 ABCB1 DHX15 ATP2C2 ABCC2 DNA2 DNAH6 KIF13B DNAH3 DDX52 SMC4 CCT2 KIF20B KIF3A GSPT1 DMC1 GTPBP2 RAB34 RUVBL1 EIF5B MACF1 ATP2B1 ATP2B2 | 2.91e-04 | 840 | 261 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | NUGGC ABCA13 ABCB1 DHX15 ATP2C2 ABCC2 DNA2 DNAH6 KIF13B DNAH3 DDX52 SMC4 CCT2 KIF20B KIF3A GSPT1 DMC1 GTPBP2 RAB34 RUVBL1 EIF5B MACF1 ATP2B1 ATP2B2 | 2.91e-04 | 840 | 261 | 24 | GO:0016818 |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.07e-04 | 70 | 261 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CHRNA5 RYR2 NDUFV2 ITPR1 SLC9C1 KCNU1 SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 SLC31A2 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 SLC20A2 MFSD8 ATP2B1 ATP2B2 | 3.16e-04 | 793 | 261 | 23 | GO:0015075 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 3.37e-04 | 11 | 261 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 3.95e-04 | 27 | 261 | 4 | GO:0001091 | |
| GeneOntologyMolecularFunction | endonuclease activity | 4.27e-04 | 136 | 261 | 8 | GO:0004519 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor | 4.45e-04 | 12 | 261 | 3 | GO:0016668 | |
| GeneOntologyMolecularFunction | ligase activity | 4.87e-04 | 174 | 261 | 9 | GO:0016874 | |
| GeneOntologyMolecularFunction | NACHT domain binding | 5.06e-04 | 3 | 261 | 2 | GO:0032089 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 5.06e-04 | 3 | 261 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | fructose-bisphosphate aldolase activity | 5.06e-04 | 3 | 261 | 2 | GO:0004332 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 5.06e-04 | 3 | 261 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 5.73e-04 | 13 | 261 | 3 | GO:0015368 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.78e-04 | 52 | 261 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 7.22e-04 | 14 | 261 | 3 | GO:0016888 | |
| GeneOntologyMolecularFunction | annealing activity | 7.22e-04 | 14 | 261 | 3 | GO:0140666 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA13 SLCO2B1 PEX12 CHRNA5 RYR2 NDUFV2 ABCB1 ITPR1 SLC9C1 KCNU1 SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 SLC31A2 KCNAB2 SLC3A2 TFRC CNNM1 SLC8A1 SLC8A3 SLC20A2 MFSD8 ATP2B1 ATP2B2 | 8.18e-04 | 1180 | 261 | 29 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.52e-04 | 151 | 261 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 ERVK-7 ERVK-10 NSUN2 ZRANB3 DHX15 RAD54B RARS2 DNA2 AEN DDX52 POLR2A POLR3A DMC1 RUVBL1 ERVK-8 EXO1 GEN1 CNOT1 | 8.75e-04 | 645 | 261 | 19 | GO:0140640 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 8.89e-04 | 152 | 261 | 8 | GO:0016779 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 ERVK-7 ERVK-10 ZRANB3 DNA2 AEN ERVK-8 EXO1 GEN1 CNOT1 | 9.62e-04 | 231 | 261 | 10 | GO:0004518 |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 1.00e-03 | 4 | 261 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | TNIK PIK3CB CLK2 TAF1 AKT3 SGK1 BRSK2 CDK13 EIF2AK4 BRSK1 MAP2K1 ALPK2 CDK2 | 1.04e-03 | 363 | 261 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | kinase activity | TNIK PGK1 PGK2 RYK PIK3C2A PIK3CB CLK2 FAM20B TAF1 TAF1L AKT3 SGK1 BRSK2 CDK13 NT5C2 EIF2AK4 BRSK1 MAP2K1 ALPK2 CDK2 EPHA7 | 1.14e-03 | 764 | 261 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.34e-03 | 37 | 261 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.48e-03 | 38 | 261 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.56e-03 | 18 | 261 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | transporter activity | ABCA13 SLCO2B1 PEX12 CHRNA5 RYR2 NDUFV2 ABCB1 ITPR1 SLC9C1 KCNU1 SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A OSBPL8 TMCO3 ABCC2 SLC31A2 KCNAB2 SLC3A2 TFRC CNNM1 SLC8A1 SLC8A3 SLC20A2 MFSD8 ATP2B1 ATP2B2 | 1.56e-03 | 1289 | 261 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | translation initiation factor binding | 1.64e-03 | 39 | 261 | 4 | GO:0031369 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 1.66e-03 | 5 | 261 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.66e-03 | 5 | 261 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 1.66e-03 | 5 | 261 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 MBTPS1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 USP1 CAPN2 USP29 ERVK-8 ADAMTS14 CTSS | 1.66e-03 | 430 | 261 | 14 | GO:0004175 |
| GeneOntologyMolecularFunction | DNA nuclease activity | 1.83e-03 | 67 | 261 | 5 | GO:0004536 | |
| GeneOntologyMolecularFunction | NAD+ binding | 2.13e-03 | 20 | 261 | 3 | GO:0070403 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 2.16e-03 | 42 | 261 | 4 | GO:0140693 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TNIK PIK3CB CLK2 TAF1 TAF1L AKT3 SGK1 BRSK2 CDK13 EIF2AK4 BRSK1 MAP2K1 ALPK2 CDK2 | 2.32e-03 | 446 | 261 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | fructose binding | 2.47e-03 | 6 | 261 | 2 | GO:0070061 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 2.47e-03 | 6 | 261 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | 3-hydroxyacyl-CoA dehydrogenase activity | 2.47e-03 | 6 | 261 | 2 | GO:0003857 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 2.57e-03 | 44 | 261 | 4 | GO:0004520 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TNIK RYK PIK3C2A PIK3CB CLK2 FAM20B TAF1 TAF1L AKT3 SGK1 BRSK2 CDK13 NT5C2 EIF2AK4 BRSK1 MAP2K1 ALPK2 CDK2 EPHA7 | 2.57e-03 | 709 | 261 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.11e-03 | 109 | 261 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.22e-03 | 23 | 261 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.37e-03 | 230 | 261 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | thioredoxin-disulfide reductase (NADPH) activity | 3.42e-03 | 7 | 261 | 2 | GO:0004791 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 3.42e-03 | 7 | 261 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 3.42e-03 | 7 | 261 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 ERVK-7 ERVK-10 NSUN2 DHX15 RAD54B RARS2 DDX52 POLR2A POLR3A ERVK-8 EXO1 CNOT1 | 3.49e-03 | 417 | 261 | 13 | GO:0140098 |
| GeneOntologyMolecularFunction | ADP binding | 3.53e-03 | 48 | 261 | 4 | GO:0043531 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.77e-03 | 79 | 261 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 4.10e-03 | 25 | 261 | 3 | GO:0048027 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA13 SLCO2B1 NDUFV2 ABCB1 SLC9C1 ATP2C2 TMCO3 ABCC2 SLC3A2 SLC8A1 SLC8A3 SLC20A2 ATP2B1 ATP2B2 | 4.22e-03 | 477 | 261 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | IRF2BP1 PEX12 KLHL9 KLHL13 TAF1 HERC2 HERC1 TAF1L TRAF7 RC3H2 RANBP2 RNF169 G2E3 TGM2 NT5C2 | 4.50e-03 | 532 | 261 | 15 | GO:0016755 |
| GeneOntologyMolecularFunction | 3-hydroxyacyl-CoA dehydratase activity | 4.52e-03 | 8 | 261 | 2 | GO:0018812 | |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 ERVK-7 ERVK-10 ZRANB3 PRDM9 RAD54B PSMC3IP RNF169 SYCP3 TFRC DMC1 RUVBL1 H1-2 H1-3 ERVK-8 H1-4 EXO1 GEN1 INO80B | 2.73e-07 | 368 | 262 | 19 | GO:0006310 |
| GeneOntologyBiologicalProcess | action potential | MECP2 CHRNA5 RYR2 SCN4A SCN5A SCN8A SCN9A SCN10A DMD AKAP6 FMR1 KCNAB2 SLC8A1 | 1.89e-06 | 201 | 262 | 13 | GO:0001508 |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse, modulating synaptic transmission | 2.03e-06 | 3 | 262 | 3 | GO:0099577 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse | 2.03e-06 | 3 | 262 | 3 | GO:0140244 | |
| GeneOntologyBiologicalProcess | metal ion transport | RYR2 ITPR1 SLC9C1 SERPINE2 KCNU1 PIK3C2A SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 DMD AKAP6 AKT3 FMR1 SLC31A2 SGK1 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 ARRB2 SLC20A2 ATP2B1 ATP2B2 CDK2 PLCE1 | 4.32e-06 | 1000 | 262 | 31 | GO:0030001 |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 NCOA6 NUGGC MBTPS1 ERVK-7 ERVK-10 HMOX1 ZRANB3 PRDM9 RAD54B TAF1 HERC2 DNA2 USP1 AEN RNF169 FMR1 SGK1 SMC4 SYCP3 DMC1 RUVBL1 BRD7 ERVK-8 EXO1 EIF2AK4 BRSK1 GEN1 INO80B CDK2 | 5.23e-06 | 959 | 262 | 30 | GO:0006974 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 5.61e-06 | 36 | 262 | 6 | GO:0086010 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLCO2B1 CHRNA5 RYR2 ABCB1 ITPR1 SLC9C1 SERPINE2 KCNU1 PIK3C2A SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 DMD AKAP6 AKT3 FMR1 SLC31A2 SGK1 KCNAB2 SLC3A2 TFRC CNNM1 SLC8A1 SLC8A3 ARRB2 SLC20A2 MFSD8 ATP2B1 ATP2B2 CTSS CDK2 PLCE1 | 1.21e-05 | 1374 | 262 | 37 | GO:0006811 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC9C1 SERPINE2 SCN4A SCN5A SCN8A SCN9A SCN10A DMD AKT3 SGK1 SLC3A2 SLC8A1 SLC8A3 SLC20A2 | 1.23e-05 | 275 | 262 | 14 | GO:0006814 |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.49e-05 | 63 | 262 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.50e-05 | 87 | 262 | 8 | GO:0086001 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.66e-05 | 13 | 262 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | ASH1L ARMC2 MECP2 PGK2 SLC9C1 SYNE2 WDR35 DNAH6 KIF13B DNAH3 FMR1 BAG3 AP3B1 KIF20B KIF3A TTLL6 DNAH17 CFAP57 MAP2K1 | 1.94e-05 | 493 | 262 | 19 | GO:0007018 |
| GeneOntologyBiologicalProcess | striated muscle contraction | MYH6 RYR2 SCN4A SCN5A SCN8A SCN9A SCN10A DMD ALDOA AKAP6 SLC8A1 SLC8A3 | 2.29e-05 | 217 | 262 | 12 | GO:0006941 |
| GeneOntologyBiologicalProcess | circulatory system process | MYH6 SLCO2B1 HMOX1 F5 MECP2 RYR2 ABCB1 PIK3C2A SCN4A SCN5A SCN8A SCN9A SCN10A WDR35 ABCC2 DMD AKAP6 SGK1 TFRC SLC8A1 SLC8A3 MAP2K1 ATP2B1 ATP2B2 | 2.34e-05 | 733 | 262 | 24 | GO:0003013 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.69e-05 | 153 | 262 | 10 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 2.95e-05 | 29 | 262 | 5 | GO:1903779 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | RYR2 ITPR1 SLC9C1 SERPINE2 KCNU1 PIK3C2A SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 DMD AKAP6 AKT3 FMR1 SLC31A2 SGK1 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 ARRB2 SLC20A2 ATP2B1 ATP2B2 CTSS CDK2 PLCE1 | 2.97e-05 | 1157 | 262 | 32 | GO:0006812 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.11e-05 | 48 | 262 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | RYR2 ABCB1 ITPR1 ATP2C2 SCN5A DMD AKAP6 AKT3 SGK1 ARRB2 ATP2B1 ATP2B2 CTSS | 3.84e-05 | 266 | 262 | 13 | GO:0043270 |
| GeneOntologyBiologicalProcess | DNA metabolic process | ERVK-6 NUGGC ERVK-7 ERVK-10 ZRANB3 PRDM9 RAD54B PSMC3IP HERC2 DNA2 USP1 AEN RNF169 FMR1 SMC4 SYCP3 CCT2 TFRC DMC1 ARRB2 RUVBL1 BRD7 H1-2 H1-3 ERVK-8 H1-4 EXO1 GEN1 INO80B CDK2 | 5.05e-05 | 1081 | 262 | 30 | GO:0006259 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | TNIK CUL7 MECP2 SERPINE2 ATXN1 ISLR2 FMR1 FXR2 SGK1 TGM2 FXR1 ARRB2 EIF4G2 MACF1 MAP2K1 | 5.12e-05 | 354 | 262 | 15 | GO:0050769 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | RYR2 ABCB1 ITPR1 SERPINE2 PIK3C2A ATP2C2 SCN5A SCN10A DMD AKAP6 AKT3 FMR1 SLC31A2 SGK1 KCNAB2 SLC8A1 ARRB2 ATP2B1 ATP2B2 CTSS | 5.24e-05 | 577 | 262 | 20 | GO:0043269 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 5.67e-05 | 167 | 262 | 10 | GO:0060048 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC9C1 SCN4A SCN5A SCN8A SCN9A SCN10A DMD SLC3A2 SLC8A1 SLC8A3 SLC20A2 | 7.52e-05 | 208 | 262 | 11 | GO:0035725 |
| GeneOntologyBiologicalProcess | regulation of action potential | 7.69e-05 | 81 | 262 | 7 | GO:0098900 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 8.71e-05 | 111 | 262 | 8 | GO:0006942 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 ERVK-7 ERVK-10 ZRANB3 PRDM9 RAD54B HERC2 DNA2 USP1 RNF169 FMR1 SMC4 SYCP3 DMC1 RUVBL1 BRD7 ERVK-8 EXO1 GEN1 INO80B CDK2 | 8.86e-05 | 648 | 262 | 21 | GO:0006281 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 9.28e-05 | 112 | 262 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | ERVK-6 NUGGC ERVK-7 ERVK-10 ZRANB3 DNA2 ERVK-8 EXO1 GEN1 CDK2 | 9.68e-05 | 178 | 262 | 10 | GO:0006261 |
| GeneOntologyBiologicalProcess | RNA localization | ERVK-6 ERVK-21 NSUN2 RANBP2 FMR1 FXR2 CCT2 SHQ1 NOP58 FXR1 RUVBL1 | 1.10e-04 | 217 | 262 | 11 | GO:0006403 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TNIK TANC2 NCK1 CUL7 RYK ITPR1 SERPINE2 P3H1 DMD KIF13B ISLR2 SGK1 BRSK2 RAPGEF1 LZTS1 EIF4G2 MACF1 BRSK1 MAP2K1 EPHA7 | 1.17e-04 | 612 | 262 | 20 | GO:0010975 |
| GeneOntologyBiologicalProcess | heart contraction | MYH6 RYR2 SCN4A SCN5A SCN8A SCN9A SCN10A DMD AKAP6 SLC8A1 SLC8A3 ATP2B1 ATP2B2 | 1.21e-04 | 298 | 262 | 13 | GO:0060047 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.29e-04 | 39 | 262 | 5 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.34e-04 | 62 | 262 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | SELENOT NCOA6 HMOX1 RYR2 ITPR1 SLC9C1 PIK3CB ATP2C2 ABCC2 DMD ALDOA AKAP6 SLC31A2 SGK1 BAG3 BRSK2 AP3B1 TFRC TGM2 SLC8A1 SLC8A3 RAB34 AACS TXNRD3 ATP2B1 ATP2B2 PLCE1 | 1.40e-04 | 981 | 262 | 27 | GO:0019725 |
| GeneOntologyBiologicalProcess | regulation of translation at synapse, modulating synaptic transmission | 1.61e-04 | 9 | 262 | 3 | GO:0099547 | |
| GeneOntologyBiologicalProcess | heart process | MYH6 RYR2 SCN4A SCN5A SCN8A SCN9A SCN10A DMD AKAP6 SLC8A1 SLC8A3 ATP2B1 ATP2B2 | 1.74e-04 | 309 | 262 | 13 | GO:0003015 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | TNIK VPS13C RPS6 NCK1 NCL MECP2 CHRNA5 RYR2 ITPR1 DHX15 SERPINA1 PIK3C2A OSBPL8 TAF1 ALDOB AKAP6 RANBP2 AKT3 SGK1 BRSK2 RAPGEF1 SLC3A2 TRIM16 TGM2 SLC8A1 SLC8A3 ARRB2 AACS HADHA MAP2K1 ATP2B1 CDK2 | 1.75e-04 | 1272 | 262 | 32 | GO:1901698 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | RYR2 ITPR1 SLC9C1 KCNU1 PIK3C2A SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 DMD AKAP6 FMR1 SLC31A2 KCNAB2 SLC3A2 SLC8A1 SLC8A3 SLC20A2 ATP2B1 ATP2B2 CTSS PLCE1 | 1.79e-04 | 942 | 262 | 26 | GO:0098655 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.84e-04 | 93 | 262 | 7 | GO:0086003 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 1.84e-04 | 42 | 262 | 5 | GO:0006734 | |
| GeneOntologyBiologicalProcess | muscle contraction | MYH6 RYR2 PIK3C2A SCN4A SCN5A SCN8A SCN9A SCN10A DMD ALDOA AKAP6 SLC8A1 SLC8A3 MAP2K1 ATP2B1 | 1.98e-04 | 400 | 262 | 15 | GO:0006936 |
| GeneOntologyBiologicalProcess | microtubule-based process | ASH1L CUL7 ARMC2 MECP2 PGK2 SLC9C1 SYNE2 WDR35 DNAH6 KIF13B DNAH3 FMR1 SGK1 BAG3 BRSK2 AP3B1 KIF20B KIF3A PTPA TTLL6 EHHADH DNAH17 MACF1 CFAP57 BRSK1 MAP2K1 GEN1 CDK2 | 2.01e-04 | 1058 | 262 | 28 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | RYR2 ITPR1 SERPINE2 PIK3C2A ATP2C2 SCN5A DMD AKAP6 AKT3 FMR1 SLC31A2 SGK1 KCNAB2 SLC8A1 ARRB2 ATP2B1 ATP2B2 | 2.04e-04 | 493 | 262 | 17 | GO:0010959 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CHRNA5 RYR2 ABCB1 ITPR1 SLC9C1 KCNU1 PIK3C2A SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 DMD AKAP6 FMR1 SLC31A2 KCNAB2 SLC3A2 SLC8A1 SLC8A3 SLC20A2 MFSD8 ATP2B1 ATP2B2 CTSS PLCE1 | 2.07e-04 | 1115 | 262 | 29 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TNIK TANC2 NCK1 CUL7 RYK ITPR1 SH3YL1 SERPINE2 P3H1 SYNE2 DMD KIF13B ISLR2 FMR1 SGK1 BRSK2 RAPGEF1 LZTS1 EIF4G2 MACF1 BRSK1 MAP2K1 PLCE1 EPHA7 | 2.14e-04 | 846 | 262 | 24 | GO:0120035 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.22e-04 | 127 | 262 | 8 | GO:0070252 | |
| GeneOntologyBiologicalProcess | blood circulation | MYH6 HMOX1 F5 MECP2 RYR2 PIK3C2A SCN4A SCN5A SCN8A SCN9A SCN10A WDR35 DMD AKAP6 SGK1 SLC8A1 SLC8A3 MAP2K1 ATP2B1 ATP2B2 | 2.48e-04 | 648 | 262 | 20 | GO:0008015 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | MB HMOX1 MECP2 PGK1 CHRNA5 ZRANB3 RYR2 ABCB1 ITPR1 SERPINE2 ATXN1 PIK3CB CLK2 RAD54B SCN9A SCN10A TAF1 DMD USP1 AEN SGK1 CAPN2 BAG3 TFRC SLC8A1 SLC8A3 ARRB2 EIF2AK4 BRSK1 MAP2K1 ATP2B2 CTSS CDK2 | 2.70e-04 | 1361 | 262 | 33 | GO:0009628 |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | RYR2 SCN4A SCN5A SCN10A DMD AKAP6 SLC8A1 SLC8A3 MAP2K1 ATP2B1 | 2.71e-04 | 202 | 262 | 10 | GO:0006937 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TNIK TANC2 NCK1 CUL7 RYK ITPR1 SH3YL1 SERPINE2 P3H1 SYNE2 DMD KIF13B ISLR2 FMR1 SGK1 BRSK2 RAPGEF1 LZTS1 EIF4G2 MACF1 BRSK1 MAP2K1 PLCE1 EPHA7 | 2.86e-04 | 863 | 262 | 24 | GO:0031344 |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.89e-04 | 100 | 262 | 7 | GO:0061337 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SELENOT NCOA6 HMOX1 RYR2 ITPR1 SLC9C1 PIK3CB ATP2C2 ABCC2 DMD AKAP6 SLC31A2 SGK1 BRSK2 AP3B1 TFRC TGM2 SLC8A1 SLC8A3 RAB34 AACS ATP2B1 ATP2B2 PLCE1 | 3.01e-04 | 866 | 262 | 24 | GO:0055082 |
| GeneOntologyBiologicalProcess | heme catabolic process | 3.10e-04 | 11 | 262 | 3 | GO:0042167 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term neuronal synaptic plasticity | 3.10e-04 | 11 | 262 | 3 | GO:0048170 | |
| GeneOntologyBiologicalProcess | pigment catabolic process | 3.10e-04 | 11 | 262 | 3 | GO:0046149 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | RYR2 ITPR1 SLC9C1 KCNU1 PIK3C2A SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 DMD AKAP6 FMR1 SLC31A2 KCNAB2 SLC3A2 SLC8A1 SLC8A3 SLC20A2 ATP2B1 ATP2B2 PLCE1 | 3.12e-04 | 922 | 262 | 25 | GO:0098662 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | TNIK CUL7 MECP2 SERPINE2 ATXN1 ISLR2 FMR1 FXR2 SGK1 TGM2 FXR1 ARRB2 EIF4G2 MACF1 MAP2K1 | 3.16e-04 | 418 | 262 | 15 | GO:0051962 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | TNIK CUL7 MECP2 RYK SERPINE2 ATXN1 ISLR2 FMR1 FXR2 SGK1 TGM2 FXR1 ARRB2 EIF4G2 MACF1 MAP2K1 EPHA7 | 3.38e-04 | 515 | 262 | 17 | GO:0050767 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | HMOX1 RYR2 ITPR1 PIK3CB ATP2C2 ABCC2 DMD AKAP6 SLC31A2 SGK1 AP3B1 TFRC CNNM1 TGM2 SLC8A1 SLC8A3 ATP2B1 ATP2B2 PLCE1 | 4.02e-04 | 622 | 262 | 19 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | HMOX1 RYR2 ITPR1 SLC9C1 PIK3CB ATP2C2 ABCC2 DMD AKAP6 SLC31A2 SGK1 AP3B1 TFRC TGM2 SLC8A1 SLC8A3 ATP2B1 ATP2B2 PLCE1 | 4.02e-04 | 622 | 262 | 19 | GO:0006873 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 4.10e-04 | 12 | 262 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 4.10e-04 | 12 | 262 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 4.72e-04 | 142 | 262 | 8 | GO:0006090 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in establishment of planar polarity | 4.78e-04 | 3 | 262 | 2 | GO:0090176 | |
| GeneOntologyBiologicalProcess | thyroid hormone transport | 5.27e-04 | 13 | 262 | 3 | GO:0070327 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 5.27e-04 | 13 | 262 | 3 | GO:0006787 | |
| GeneOntologyBiologicalProcess | regulation of translation at synapse | 5.27e-04 | 13 | 262 | 3 | GO:0140243 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 5.44e-04 | 111 | 262 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 5.55e-04 | 53 | 262 | 5 | GO:0071320 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | RYR2 ITPR1 SLC9C1 KCNU1 PIK3C2A SCN4A ATP2C2 SCN5A SCN8A SCN9A SCN10A TMCO3 ABCC2 DMD AKAP6 FMR1 SLC31A2 KCNAB2 SLC3A2 SLC8A1 SLC8A3 SLC20A2 MFSD8 ATP2B1 ATP2B2 PLCE1 | 5.75e-04 | 1017 | 262 | 26 | GO:0098660 |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle contraction | 6.11e-04 | 31 | 262 | 4 | GO:0014829 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 6.11e-04 | 31 | 262 | 4 | GO:0061615 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 6.34e-04 | 225 | 262 | 10 | GO:0030705 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 6.65e-04 | 14 | 262 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 6.73e-04 | 115 | 262 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | DNA replication | ERVK-6 NUGGC ERVK-7 ERVK-10 ZRANB3 DNA2 RUVBL1 ERVK-8 EXO1 GEN1 INO80B CDK2 | 6.83e-04 | 312 | 262 | 12 | GO:0006260 |
| GeneOntologyBiologicalProcess | positive regulation of translation | 7.09e-04 | 151 | 262 | 8 | GO:0045727 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.50e-04 | 85 | 262 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.50e-04 | 85 | 262 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 7.78e-04 | 57 | 262 | 5 | GO:0050974 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 7.79e-04 | 33 | 262 | 4 | GO:0010880 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 8.07e-04 | 192 | 262 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase RNA localization to Cajal body | 8.23e-04 | 15 | 262 | 3 | GO:1904874 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 8.23e-04 | 15 | 262 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | MECP2 CHRNA5 RYR2 ATXN1 SCN4A SCN5A SCN8A SCN9A SCN10A DMD AKAP6 FMR1 PCLO KCNAB2 SLC8A1 SLC8A3 ARRB2 | 8.48e-04 | 559 | 262 | 17 | GO:0042391 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | HMOX1 RYR2 ITPR1 SLC9C1 PIK3CB ATP2C2 DMD AKAP6 SLC31A2 SGK1 AP3B1 TFRC TGM2 SLC8A1 SLC8A3 ATP2B1 ATP2B2 PLCE1 | 8.64e-04 | 611 | 262 | 18 | GO:0030003 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | HMOX1 RYR2 ITPR1 SLC9C1 PIK3CB ATP2C2 ABCC2 DMD AKAP6 SLC31A2 SGK1 AP3B1 TFRC CNNM1 TGM2 SLC8A1 SLC8A3 ATP2B1 ATP2B2 PLCE1 | 8.86e-04 | 717 | 262 | 20 | GO:0050801 |
| GeneOntologyBiologicalProcess | membrane depolarization | 9.09e-04 | 121 | 262 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 9.09e-04 | 121 | 262 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | calcium ion export | 9.48e-04 | 4 | 262 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | replication fork reversal | 9.48e-04 | 4 | 262 | 2 | GO:0071932 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 9.56e-04 | 89 | 262 | 6 | GO:0055117 | |
| GeneOntologyBiologicalProcess | syncytium formation | 9.56e-04 | 89 | 262 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | neuron projection development | TNIK TANC2 NCK1 CUL7 MECP2 RYK ITPR1 SERPINE2 MRTFB P3H1 ALCAM DMD HERC1 KIF13B ISLR2 FMR1 SGK1 BRSK2 RAPGEF1 KIF20B KIF3A LZTS1 EIF4G2 UBA6 MACF1 EIF2AK4 BRSK1 MAP2K1 ATP2B2 EPHA7 | 9.57e-04 | 1285 | 262 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of blood circulation | MYH6 RYR2 SCN5A SCN10A WDR35 DMD AKAP6 SLC8A1 SLC8A3 MAP2K1 ATP2B1 ATP2B2 | 9.99e-04 | 326 | 262 | 12 | GO:1903522 |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.07e-03 | 91 | 262 | 6 | GO:0006446 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration involved in sprouting angiogenesis | 1.09e-03 | 36 | 262 | 4 | GO:0090050 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | TNIK CUL7 MECP2 RYK SERPINE2 ATXN1 ISLR2 FMR1 FXR2 SGK1 TYMP TGM2 FXR1 ARRB2 EIF4G2 MACF1 MAP2K1 EPHA7 | 1.12e-03 | 625 | 262 | 18 | GO:0051960 |
| GeneOntologyCellularComponent | postsynaptic density | TNIK TANC2 LIN7C SPTBN1 RPS13 RYK ITPR1 SCN8A DMD FMR1 PCLO KCNAB2 SLC8A1 SLC8A3 LZTS1 EIF4G2 MACF1 MAP2K1 ATP2B2 EPHA7 | 1.25e-06 | 451 | 263 | 20 | GO:0014069 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.66e-06 | 17 | 263 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | postsynapse | RPL21 TNIK TANC2 LIN7C SPTBN1 PSMA7 RPS13 MECP2 CHRNA5 RYK ITPR1 CASKIN1 SCN8A DMD FMR1 FXR2 PCLO CAPN2 KCNAB2 KIF3A TFRC SLC8A1 SLC8A3 FXR1 ARRB2 LZTS1 EIF4G2 MACF1 MAP2K1 ATP2B1 ATP2B2 EPHA7 | 1.83e-06 | 1018 | 263 | 32 | GO:0098794 |
| GeneOntologyCellularComponent | asymmetric synapse | TNIK TANC2 LIN7C SPTBN1 RPS13 RYK ITPR1 SCN8A DMD FMR1 PCLO KCNAB2 SLC8A1 SLC8A3 LZTS1 EIF4G2 MACF1 MAP2K1 ATP2B2 EPHA7 | 2.92e-06 | 477 | 263 | 20 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | TNIK TANC2 LIN7C SPTBN1 RPS13 RYK ITPR1 SCN8A DMD FMR1 PCLO KCNAB2 SLC8A1 SLC8A3 LZTS1 EIF4G2 MACF1 MAP2K1 ATP2B2 EPHA7 | 6.45e-06 | 503 | 263 | 20 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TNIK TANC2 LIN7C SPTBN1 RPS13 RYK ITPR1 SCN8A DMD FMR1 PCLO KCNAB2 SLC8A1 SLC8A3 LZTS1 EIF4G2 MACF1 MAP2K1 ATP2B2 EPHA7 | 1.14e-05 | 523 | 263 | 20 | GO:0098984 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | TNIK RPS6 HMOX1 CUL7 ITPR1 ATP2C2 SCN5A DMD ALDOB VTI1B AKAP6 TRAF7 RANBP2 FMR1 SGK1 PCLO CAPN2 USP29 BRSK2 RAPGEF1 KIF20B TFRC TGM2 SLC8A3 FXR1 RAB34 TRAPPC12 MAP2K1 | 2.01e-05 | 934 | 263 | 28 | GO:0048471 |
| GeneOntologyCellularComponent | sodium channel complex | 2.81e-05 | 29 | 263 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | Z disc | 1.29e-04 | 151 | 263 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | axon | TANC2 MYO1A SPTBN1 SACS SCN4A SCN5A SCN8A SCN9A SCN10A ALCAM DMD KIF13B FMR1 PCLO BRSK2 KCNAB2 AP3B1 KIF20B KIF3A SLC8A1 SLC8A3 FXR1 EIF4G2 BRSK1 MAP2K1 | 1.61e-04 | 891 | 263 | 25 | GO:0030424 |
| GeneOntologyCellularComponent | I band | 2.62e-04 | 166 | 263 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | ribbon synapse | 6.67e-04 | 32 | 263 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | cell body | MYO1A RPS6 CHRNA5 ITPR1 SERPINE2 SCN8A ALCAM DMD VTI1B FMR1 PCLO CAPN2 CCT2 KIF3A SLC3A2 ARG1 CNNM1 SLC8A1 SLC8A3 LZTS1 MAP2K1 ATP2B1 ATP2B2 EPHA7 | 7.13e-04 | 929 | 263 | 24 | GO:0044297 |
| GeneOntologyCellularComponent | myofibril | MYH6 SPTBN1 RYR2 SYNE2 SCN5A SCN8A DMD ALDOA BAG3 SLC8A1 FXR1 | 7.19e-04 | 273 | 263 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | platelet alpha granule | 1.14e-03 | 93 | 263 | 6 | GO:0031091 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH6 SPTBN1 RYR2 SYNE2 SCN5A SCN8A DMD ALDOA BAG3 SLC8A1 FXR1 | 1.17e-03 | 290 | 263 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | 1.27e-03 | 249 | 263 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.55e-03 | 67 | 263 | 5 | GO:0031093 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TNIK TANC2 LIN7C SPTBN1 MECP2 RYK CASKIN1 SCN8A SCN10A FMR1 FXR2 PCLO KCNAB2 KIF3A FXR1 ARRB2 LZTS1 MAP2K1 ATP2B1 ATP2B2 EPHA7 | 1.63e-03 | 817 | 263 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 MYO1A RPS6 CHRNA5 ITPR1 SERPINE2 SACS SCN8A ALCAM DMD VTI1B FMR1 FXR2 PCLO CAPN2 KIF3A SLC3A2 ARG1 CNNM1 SLC8A1 SLC8A3 FXR1 ARRB2 LZTS1 MAP2K1 ATP2B1 ATP2B2 EPHA7 | 1.75e-03 | 1228 | 263 | 28 | GO:0036477 |
| GeneOntologyCellularComponent | presynapse | TNIK LIN7C VPS45 RPS6 CHRNA5 RYK ITPR1 SCN8A SCN10A DMD VTI1B FMR1 FXR2 PCLO KCNAB2 SLC8A1 SLC8A3 FXR1 BRSK1 MCTP2 ATP2B1 ATP2B2 | 1.95e-03 | 886 | 263 | 22 | GO:0098793 |
| GeneOntologyCellularComponent | postsynaptic membrane | LIN7C CHRNA5 RYK SCN8A DMD FMR1 KCNAB2 SLC8A1 SLC8A3 ARRB2 LZTS1 ATP2B2 EPHA7 | 1.96e-03 | 405 | 263 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH6 MYO1A SPTBN1 GDPD2 RYR2 FMN1 SYNE2 SCN5A SCN8A DMD ALDOA DNAH6 KIF13B DNAH3 BAG3 KCNAB2 CCT2 KIF20B KIF3A SLC8A1 SLC8A3 FXR1 TTLL6 EHHADH DNAH17 MACF1 MAP2K1 | 1.98e-03 | 1179 | 263 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | neuronal cell body | MYO1A CHRNA5 ITPR1 SERPINE2 SCN8A ALCAM DMD VTI1B FMR1 PCLO CAPN2 KIF3A SLC3A2 ARG1 CNNM1 SLC8A1 SLC8A3 MAP2K1 ATP2B1 ATP2B2 EPHA7 | 2.11e-03 | 835 | 263 | 21 | GO:0043025 |
| GeneOntologyCellularComponent | ribosome | 2.13e-03 | 267 | 263 | 10 | GO:0005840 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH6 MYO1A SPTBN1 GDPD2 RYR2 FMN1 SYNE2 SCN5A SCN8A DMD ALDOA DNAH6 KIF13B DNAH3 BAG3 KCNAB2 CCT2 KIF20B KIF3A SLC8A1 SLC8A3 FXR1 TTLL6 EHHADH DNAH17 MACF1 MAP2K1 | 2.18e-03 | 1187 | 263 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.25e-03 | 269 | 263 | 10 | GO:0036464 | |
| MousePheno | disorganized myocardium | 2.04e-05 | 40 | 200 | 6 | MP:0002190 | |
| MousePheno | abnormal myocardium layer morphology | NCOA6 MYH6 SPTBN1 MB HMOX1 RYR2 MRTFB SCN5A SCN8A DMD BAG3 KIF3A TGM2 SLC8A1 FXR1 CDK13 MFSD8 HADHA | 2.82e-05 | 414 | 200 | 18 | MP:0005329 |
| MousePheno | abnormal heart layer morphology | NCOA6 MYH6 SPTBN1 MB HMOX1 RYR2 MRTFB SCN5A SCN8A DMD BAG3 KIF3A TGM2 SLC8A1 FXR1 CDK13 MFSD8 HADHA | 3.63e-05 | 422 | 200 | 18 | MP:0010545 |
| MousePheno | increased muscle fatigability | 6.47e-05 | 16 | 200 | 4 | MP:0003646 | |
| MousePheno | irregular heartbeat | 6.77e-05 | 71 | 200 | 7 | MP:0001636 | |
| MousePheno | ventricular fibrillation | 9.68e-05 | 7 | 200 | 3 | MP:0006110 | |
| Domain | Na_channel_asu | 1.11e-07 | 10 | 256 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 1.11e-07 | 10 | 256 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 1.11e-07 | 10 | 256 | 5 | PF06512 | |
| Domain | Agenet-like_dom | 2.55e-06 | 3 | 256 | 3 | IPR008395 | |
| Domain | FXMRP1_C_core | 2.55e-06 | 3 | 256 | 3 | PF12235 | |
| Domain | Agenet | 2.55e-06 | 3 | 256 | 3 | PF05641 | |
| Domain | AGENET_LIKE | 2.55e-06 | 3 | 256 | 3 | PS51641 | |
| Domain | FXMRP1_C_core | 2.55e-06 | 3 | 256 | 3 | IPR022034 | |
| Domain | - | DECR1 KCNU1 HSD17B3 FMO5 HSDL2 MTHFD1L UBA2 PTGR1 EHHADH UBA6 HADHA | 2.22e-05 | 169 | 256 | 11 | 3.40.50.720 |
| Domain | Ion_trans_dom | 2.75e-05 | 114 | 256 | 9 | IPR005821 | |
| Domain | Ion_trans | 2.75e-05 | 114 | 256 | 9 | PF00520 | |
| Domain | NAD(P)-bd_dom | DECR1 KCNU1 HSD17B3 FMO5 HSDL2 MTHFD1L UBA2 PTGR1 EHHADH UBA6 HADHA | 2.76e-05 | 173 | 256 | 11 | IPR016040 |
| Domain | P-loop_NTPase | TANC2 NUGGC MYH6 MYO1A ABCA13 ZRANB3 ABCB1 DHX15 SAMD9L SULT1C2 RAD54B ABCC2 DNA2 DNAH6 KIF13B DNAH3 MTHFD1L DDX52 SMC4 KIF20B KIF3A GSPT1 DMC1 GTPBP2 RAB34 RUVBL1 EIF5B | 4.30e-05 | 848 | 256 | 27 | IPR027417 |
| Domain | Na_trans_cytopl | 4.94e-05 | 6 | 256 | 3 | IPR024583 | |
| Domain | Na_trans_cytopl | 4.94e-05 | 6 | 256 | 3 | PF11933 | |
| Domain | SPEC | 6.92e-05 | 32 | 256 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.92e-05 | 32 | 256 | 5 | IPR018159 | |
| Domain | Histone_H5 | 1.35e-04 | 8 | 256 | 3 | IPR005819 | |
| Domain | Bromodomain | 1.61e-04 | 38 | 256 | 5 | PF00439 | |
| Domain | FXR_C1 | 1.87e-04 | 2 | 256 | 2 | IPR032172 | |
| Domain | Caskin_C | 1.87e-04 | 2 | 256 | 2 | IPR032117 | |
| Domain | DUF3591 | 1.87e-04 | 2 | 256 | 2 | PF12157 | |
| Domain | PGK | 1.87e-04 | 2 | 256 | 2 | PF00162 | |
| Domain | Phosphoglycerate_kinase_CS | 1.87e-04 | 2 | 256 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 1.87e-04 | 2 | 256 | 2 | IPR015901 | |
| Domain | Caskin-tail | 1.87e-04 | 2 | 256 | 2 | PF16632 | |
| Domain | TAF1_animal | 1.87e-04 | 2 | 256 | 2 | IPR011177 | |
| Domain | TFIID_sub1_DUF3591 | 1.87e-04 | 2 | 256 | 2 | IPR022591 | |
| Domain | PGLYCERATE_KINASE | 1.87e-04 | 2 | 256 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 1.87e-04 | 2 | 256 | 2 | IPR015824 | |
| Domain | TBP-binding | 1.87e-04 | 2 | 256 | 2 | PF09247 | |
| Domain | - | 1.87e-04 | 2 | 256 | 2 | 3.40.50.1270 | |
| Domain | - | 1.87e-04 | 2 | 256 | 2 | 3.40.50.1260 | |
| Domain | FXR_C1 | 1.87e-04 | 2 | 256 | 2 | PF16096 | |
| Domain | TAF_II_230-bd | 1.87e-04 | 2 | 256 | 2 | IPR009067 | |
| Domain | - | 1.87e-04 | 2 | 256 | 2 | 1.10.1100.10 | |
| Domain | BROMODOMAIN_2 | 2.33e-04 | 41 | 256 | 5 | PS50014 | |
| Domain | IQ_motif_EF-hand-BS | 2.38e-04 | 90 | 256 | 7 | IPR000048 | |
| Domain | Spectrin | 2.49e-04 | 23 | 256 | 4 | PF00435 | |
| Domain | ACTININ_2 | 2.49e-04 | 23 | 256 | 4 | PS00020 | |
| Domain | ACTININ_1 | 2.49e-04 | 23 | 256 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.49e-04 | 23 | 256 | 4 | IPR001589 | |
| Domain | Bromodomain | 2.62e-04 | 42 | 256 | 5 | IPR001487 | |
| Domain | - | 2.62e-04 | 42 | 256 | 5 | 1.20.920.10 | |
| Domain | BROMO | 2.62e-04 | 42 | 256 | 5 | SM00297 | |
| Domain | IQ | 2.91e-04 | 93 | 256 | 7 | PS50096 | |
| Domain | IQ | 4.25e-04 | 71 | 256 | 6 | PF00612 | |
| Domain | RNA_pol_Rpb1_2 | 5.56e-04 | 3 | 256 | 2 | PF00623 | |
| Domain | RNA_pol_Rpb1_1 | 5.56e-04 | 3 | 256 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 5.56e-04 | 3 | 256 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 5.56e-04 | 3 | 256 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 5.56e-04 | 3 | 256 | 2 | PF05000 | |
| Domain | CPH_domain | 5.56e-04 | 3 | 256 | 2 | IPR021097 | |
| Domain | Na_Ca_Ex | 5.56e-04 | 3 | 256 | 2 | IPR004836 | |
| Domain | RNA_pol_Rpb1_4 | 5.56e-04 | 3 | 256 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 5.56e-04 | 3 | 256 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 5.56e-04 | 3 | 256 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 5.56e-04 | 3 | 256 | 2 | IPR007066 | |
| Domain | Na_Ca_Ex_C-exten | 5.56e-04 | 3 | 256 | 2 | IPR032452 | |
| Domain | Glycolytic | 5.56e-04 | 3 | 256 | 2 | PF00274 | |
| Domain | Aldolase_I_AS | 5.56e-04 | 3 | 256 | 2 | IPR029768 | |
| Domain | ALDOLASE_CLASS_I | 5.56e-04 | 3 | 256 | 2 | PS00158 | |
| Domain | Cul7 | 5.56e-04 | 3 | 256 | 2 | PF11515 | |
| Domain | FBA_I | 5.56e-04 | 3 | 256 | 2 | IPR000741 | |
| Domain | RNA_pol_asu | 5.56e-04 | 3 | 256 | 2 | IPR000722 | |
| Domain | RNA_pol_N | 5.56e-04 | 3 | 256 | 2 | IPR006592 | |
| Domain | Phosphoglycerate_kinase | 5.56e-04 | 3 | 256 | 2 | IPR001576 | |
| Domain | RPOLA_N | 5.56e-04 | 3 | 256 | 2 | SM00663 | |
| Domain | Na_Ca_ex_C | 5.56e-04 | 3 | 256 | 2 | PF16494 | |
| Domain | Spectrin_repeat | 6.25e-04 | 29 | 256 | 4 | IPR002017 | |
| Domain | H15 | 6.58e-04 | 13 | 256 | 3 | SM00526 | |
| Domain | Linker_histone | 6.58e-04 | 13 | 256 | 3 | PF00538 | |
| Domain | H15 | 6.58e-04 | 13 | 256 | 3 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 8.28e-04 | 14 | 256 | 3 | IPR005818 | |
| Domain | AAA+_ATPase | 8.46e-04 | 144 | 256 | 8 | IPR003593 | |
| Domain | AAA | 8.46e-04 | 144 | 256 | 8 | SM00382 | |
| Domain | IQ | 8.60e-04 | 81 | 256 | 6 | SM00015 | |
| Domain | Serpin_CS | 9.17e-04 | 32 | 256 | 4 | IPR023795 | |
| Domain | - | 1.09e-03 | 57 | 256 | 5 | 1.20.120.350 | |
| Domain | Channel_four-helix_dom | 1.09e-03 | 57 | 256 | 5 | IPR027359 | |
| Domain | HhH2 | 1.10e-03 | 4 | 256 | 2 | IPR008918 | |
| Domain | - | 1.10e-03 | 4 | 256 | 2 | 1.10.3240.10 | |
| Domain | 3HCDH | 1.10e-03 | 4 | 256 | 2 | PF00725 | |
| Domain | 5-3_exonuclease_C | 1.10e-03 | 4 | 256 | 2 | IPR020045 | |
| Domain | 3-OHacyl-CoA_DH_NAD-bd | 1.10e-03 | 4 | 256 | 2 | IPR006176 | |
| Domain | 3-OHacyl-CoA_DH_CS | 1.10e-03 | 4 | 256 | 2 | IPR006180 | |
| Domain | XPGN | 1.10e-03 | 4 | 256 | 2 | SM00485 | |
| Domain | XPGI | 1.10e-03 | 4 | 256 | 2 | SM00484 | |
| Domain | XPG_I | 1.10e-03 | 4 | 256 | 2 | PF00867 | |
| Domain | ATP_Ca_trans_C | 1.10e-03 | 4 | 256 | 2 | IPR022141 | |
| Domain | XPG-I_dom | 1.10e-03 | 4 | 256 | 2 | IPR006086 | |
| Domain | XPG/Rad2 | 1.10e-03 | 4 | 256 | 2 | IPR006084 | |
| Domain | ATP_Ca_trans_C | 1.10e-03 | 4 | 256 | 2 | PF12424 | |
| Domain | 3HC_DH_C | 1.10e-03 | 4 | 256 | 2 | IPR006108 | |
| Domain | 3HCDH | 1.10e-03 | 4 | 256 | 2 | PS00067 | |
| Domain | 3HCDH_N | 1.10e-03 | 4 | 256 | 2 | PF02737 | |
| Domain | XPG_1 | 1.10e-03 | 4 | 256 | 2 | PS00841 | |
| Domain | XPG_2 | 1.10e-03 | 4 | 256 | 2 | PS00842 | |
| Domain | P-type_ATPase_IIB | 1.10e-03 | 4 | 256 | 2 | IPR006408 | |
| Domain | HhH2 | 1.10e-03 | 4 | 256 | 2 | SM00279 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | RYR2 ITPR1 SCN4A SCN5A SCN8A SCN9A SCN10A SLC8A1 SLC8A3 ATP2B1 ATP2B2 | 2.26e-06 | 130 | 199 | 11 | M27454 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.03e-06 | 31 | 199 | 6 | M877 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | MYH6 RYR2 ITPR1 SCN4A SCN5A SCN8A SCN9A SCN10A DMD SLC8A1 SLC8A3 ATP2B1 ATP2B2 | 6.17e-06 | 203 | 199 | 13 | M5485 |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.75e-05 | 12 | 199 | 4 | M27326 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 2.75e-05 | 26 | 199 | 5 | M13748 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 2.75e-05 | 26 | 199 | 5 | MM15392 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.34e-05 | 27 | 199 | 5 | MM15053 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.45e-05 | 14 | 199 | 4 | MM15052 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 3.78e-05 | 45 | 199 | 6 | M39474 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.02e-05 | 28 | 199 | 5 | M924 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 6.72e-05 | 31 | 199 | 5 | M39476 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 7.79e-05 | 51 | 199 | 6 | MM15928 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 7.87e-05 | 32 | 199 | 5 | M27455 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.08e-04 | 54 | 199 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.08e-04 | 54 | 199 | 6 | MM15202 | |
| Pathway | REACTOME_HEMOSTASIS | VPS45 F5 ITPR1 SERPINA1 SERPINE2 PIK3CB ALDOA VTI1B KIF13B JMJD1C KIF20B KIF3A SLC3A2 SLC8A1 SLC8A3 GTPBP2 ARRB2 EHHADH ATP2B1 ATP2B2 | 1.70e-04 | 571 | 199 | 20 | MM14472 |
| Pathway | PID_AURORA_B_PATHWAY | 2.08e-04 | 39 | 199 | 5 | M14 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.19e-04 | 9 | 199 | 3 | M45020 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 2.99e-04 | 91 | 199 | 7 | M48079 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.16e-04 | 121 | 199 | 8 | M872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 3.86e-04 | 25 | 199 | 4 | M47623 | |
| Pubmed | RPL21 MYH6 MYO1A SLCO2B1 RPS6 SPTBN1 MB PSMA7 PABPC4 ASH1L NCL MECP2 PSMA8 PGK1 PGK2 RYR2 NDUFV2 ABCB1 SACS SYNE2 SCN4A SCN9A DLAT ALCAM ABCC2 DMD USP1 DNAH6 KIF13B RANBP2 MACC1 DDX52 PCLO SMC4 CCT2 GSPT1 SLC3A2 TFRC TRIM16 FXR1 CDK13 H1-2 H1-3 H1-4 EIF5B MACF1 EIF2AK4 HADHA ATP2B1 ATP2B2 | 2.04e-19 | 1442 | 265 | 50 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL21 RPS6 SPTBN1 PSMA7 RPS13 NCL NSUN2 PGK1 GMPS DHX15 DECR1 PIK3C2A MKI67 DLAT UTP20 HERC2 ALDOA TIMM44 RANBP2 TCF20 MTHFD1L DDX52 POLR2A CAPN2 BAG3 ADNP2 SMC4 CCT2 KIF20B GSPT1 POLR3A SLC3A2 TFRC ARG1 TGM2 NOP58 FXR1 ARRB2 RAB34 RUVBL1 SHCBP1 H1-2 EIF4G2 EIF5B PDCD11 MACF1 HADHA ATP2B1 | 4.79e-19 | 1353 | 265 | 48 | 29467282 |
| Pubmed | RPL21 RPS6 SPTBN1 PABPC4 NCL CUL7 NSUN2 PGK1 GMPS DHX15 SYNE2 MKI67 OSBPL8 DLAT UTP20 HERC2 RANBP2 FMR1 TCF20 FXR2 MTHFD1L DDX52 POLR2A SMC4 CCT2 NOP58 FXR1 H1-3 H1-4 EIF5B PDCD11 MACF1 HADHA CNOT1 | 1.36e-18 | 653 | 265 | 34 | 22586326 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL21 LIN7C RPS6 SPTBN1 PSMA7 NCL HMOX1 NSUN2 PGK1 GMPS DHX15 NAA25 MRTFB PIK3C2A SYNE2 ALCAM ALDOA ALDH6A1 RANBP2 MTHFD1L CAPN2 BAG3 SMC4 CCT2 GSPT1 SLC3A2 GSS TFRC ARG1 TGM2 NOP58 FXR1 RAB34 RUVBL1 PTGR1 H1-2 EIF4G2 EIF5 UBA6 EIF5B PDCD11 HADHA PC CNOT1 CDK2 | 1.16e-16 | 1367 | 265 | 45 | 32687490 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL21 VPS13C RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL NSUN2 PGK1 DHX15 MKI67 DLAT UTP20 TDRD6 ALDOA TIMM44 RANBP2 FMR1 HSDL2 MTHFD1L DDX52 PCLO POLR2A SMC4 CCT2 AP3B1 GSPT1 POLR3A SLC3A2 TFRC NOP58 FXR1 RUVBL1 H1-2 EIF4G2 EIF5 UBA6 EIF5B PDCD11 HADHA PC ATP2B1 CNOT1 CDK2 | 5.32e-16 | 1425 | 265 | 45 | 30948266 |
| Pubmed | RPL21 TANC2 MYH6 VPS45 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL MECP2 PGK1 NDUFV2 DHX15 SACS CASKIN1 OSBPL8 DLAT PLCL1 DMD ALDOA DNAH6 ASRGL1 FMR1 PCLO BRSK2 KCNAB2 CCT2 AP3B1 KIF3A SLC3A2 FXR1 LZTS1 MRPL48 EIF4G2 H1-3 MACF1 HADHA BRSK1 PC MAP2K1 ATP2B1 ATP2B2 CNOT1 | 3.04e-15 | 1431 | 265 | 44 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL21 IRF2BP1 RPS6 PABPC4 RPS13 NCL CUL7 NSUN2 F5 PGK1 ABCB1 DHX15 SACS SYNE2 MKI67 UTP20 HERC2 RANBP2 TCF20 DDX52 POLR2A SMC4 CCT2 SLC3A2 TFRC ARG1 NOP58 FXR1 RUVBL1 H1-4 UBA6 EIF5B PDCD11 MACF1 HADHA ATP2B1 CNOT1 | 4.69e-15 | 1024 | 265 | 37 | 24711643 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL NSUN2 PGK1 GMPS DHX15 DECR1 SYNE2 OSBPL8 DLAT ALDOA TIMM44 RANBP2 HSDL2 FXR2 MTHFD1L POLR2A CAPN2 BAG3 SMC4 CCT2 AP3B1 GSPT1 SLC3A2 TFRC NOP58 FXR1 ARRB2 RUVBL1 CDK13 H1-2 EIF4G2 UBA6 EIF5B MACF1 HADHA PC CDK2 | 9.83e-15 | 1415 | 265 | 43 | 28515276 |
| Pubmed | RPL21 TNIK TANC2 VPS45 RPS6 SPTBN1 RPS13 NCL PGK1 RYR2 NDUFV2 ITPR1 GMPS DECR1 SERPINE2 CASKIN1 OSBPL8 DLAT ALDOA TIMM44 ALDH6A1 RANBP2 ASRGL1 FMR1 FXR2 PCLO CAPN2 BRSK2 KCNAB2 SLC3A2 RUVBL1 H1-2 EIF4G2 H1-4 MACF1 HADHA PC CNOT1 | 2.38e-14 | 1139 | 265 | 38 | 36417873 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPS6 SPTBN1 PSMA7 ASH1L NCL NSUN2 PGK1 DHX15 SCN8A ALDOA PCLO POLR2A CCT2 AP3B1 SLC3A2 TFRC NBAS TGM2 NOP58 PTPA RUVBL1 H1-2 H1-3 H1-4 NT5C2 EIF5B MACF1 HADHA BRSK1 PC CNOT1 | 1.88e-13 | 807 | 265 | 31 | 30575818 |
| Pubmed | RPL21 NCOA6 LIN7C RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 PGK1 GMPS DHX15 PIK3C2A MKI67 DLAT ALDOA RANBP2 FMR1 FXR2 DDX52 POLR2A BAG3 SMC4 CCT2 AP3B1 KIF3A GSPT1 NOP58 FXR1 RUVBL1 H1-2 EIF4G2 H1-3 H1-4 EIF5B HADHA RASSF8 MAP2K1 | 3.86e-13 | 1247 | 265 | 38 | 27684187 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | TNIK NCOA6 MYH6 RPS6 SPTBN1 RPS13 NCL NDUFV2 ITPR1 DHX15 TDRD6 ALDOA SGK1 PCLO CAPN2 KCNAB2 CCT2 GSPT1 SLC3A2 EHHADH H1-2 H1-3 EIF5 H1-4 PC MAP2K1 ATP2B2 | 4.26e-13 | 621 | 265 | 27 | 22794259 |
| Pubmed | RPL21 CTNNAL1 RPS6 SPTBN1 PABPC4 RPS13 NCK1 GMPS DHX15 OSBPL8 TIMM44 RANBP2 SMC4 CCT2 AP3B1 JMJD1C SLC3A2 TFRC RUVBL1 EIF4G2 EIF5 H1-4 UBA6 EIF5B MACF1 HADHA ATP2B1 CNOT1 | 1.50e-12 | 708 | 265 | 28 | 39231216 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL21 RPS6 PABPC4 RPS13 NCL NSUN2 PSMA8 GMPS DHX15 DECR1 CLK2 MKI67 OSBPL8 TIMM44 RANBP2 HSDL2 FXR2 MTHFD1L DDX52 SMC4 UBA2 CCT2 AP3B1 GSPT1 TFRC TGM2 NOP58 FXR1 RUVBL1 H1-2 H1-3 H1-4 EIF5B PDCD11 HADHA PC MAP2K1 CDK2 | 2.05e-12 | 1318 | 265 | 38 | 30463901 |
| Pubmed | RPL21 RPS6 SPTBN1 RPS13 NCL NSUN2 PGK1 GMPS MKI67 TIMM44 RANBP2 MTHFD1L ZG16B UBA2 CCT2 SLC3A2 ARG1 NOP58 RUVBL1 H1-2 EIF4G2 H1-4 PDCD11 CFAP57 PC CNOT1 | 5.61e-12 | 641 | 265 | 26 | 36057605 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPL21 RPS6 PSMA7 PABPC4 RPS13 NCL NSUN2 GMPS DHX15 KLHL9 KLHL13 RARS2 ALDOA DNA2 TIMM44 USP1 RANBP2 HSDL2 MTHFD1L POLR2A SMC4 CCT2 GSPT1 POLR3A SLC3A2 TFRC NOP58 FXR1 RUVBL1 H1-2 H1-3 H1-4 EXO1 HADHA CNOT1 CDK2 | 1.00e-11 | 1257 | 265 | 36 | 37317656 |
| Pubmed | RPS6 SPTBN1 PABPC4 RPS13 PGK1 DHX15 ALDOA FXR2 CCT2 TYMP SLC3A2 CCDC7 TFRC ARG1 TGM2 FXR1 H1-2 MACF1 HADHA | 1.07e-11 | 327 | 265 | 19 | 31409639 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPL21 RPS6 PABPC4 RPS13 NCL PSMA8 PGK1 GMPS DHX15 MKI67 DLAT ALDOA ALDH6A1 FMR1 FXR2 DDX52 POLR2A CCT2 SLC3A2 TFRC NOP58 FXR1 RUVBL1 EHHADH H1-2 H1-4 HADHA | 1.07e-11 | 714 | 265 | 27 | 28302793 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 ITPR1 DHX15 MKI67 UTP20 ALDOA FMR1 FXR2 DDX52 ZG16B SMC4 CCT2 SLC3A2 ARG1 NOP58 FXR1 CDK13 H1-2 H1-3 H1-4 EIF5B PDCD11 HADHA PC MCTP2 | 1.21e-11 | 949 | 265 | 31 | 36574265 |
| Pubmed | RPL21 SELENOT TNIK SPTBN1 PSMA7 RPS13 NCL NDUFV2 ITPR1 PIK3C2A SACS CASKIN2 P3H1 SYNE2 OSBPL8 DLAT HERC2 DNA2 TIMM44 HSDL2 DNAJC25 MTHFD1L BAG3 AP3B1 SLC3A2 TFRC NBAS NOP58 MRPL48 EIF4G2 UBA6 EIF5B CDK5RAP1 PDCD11 MACF1 HADHA MAP2K1 ATP2B1 EPHA7 | 1.77e-11 | 1487 | 265 | 39 | 33957083 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 NCL GMPS DHX15 KLHL9 SCN5A DLAT ALDOA RANBP2 BAG3 SMC4 GSPT1 SLC3A2 FXR1 H1-3 H1-4 EIF5B HADHA | 2.23e-11 | 477 | 265 | 22 | 31300519 |
| Pubmed | RPL21 SPTBN1 RPS13 GMPS DHX15 DLAT ALDOA TIMM44 RANBP2 DDX52 POLR2A SMC4 CCT2 AP3B1 GSPT1 SLC3A2 TFRC NOP58 FXR1 RUVBL1 EIF4G2 EIF5B PDCD11 HADHA CNOT1 | 3.05e-11 | 638 | 265 | 25 | 33239621 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RPL21 SPTBN1 PABPC4 RPS13 NCL NSUN2 DHX15 UTP20 RARS2 ZC3H7B ALDOA RC3H2 FMR1 FXR2 DDX52 POLR2A NOP58 FXR1 CDK13 H1-2 EIF4G2 H1-3 EIF5 H1-4 EIF5B PDCD11 MACF1 CNOT1 | 3.22e-11 | 807 | 265 | 28 | 22681889 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | RPS6 PSMA7 PABPC4 F5 MECP2 RYR2 SYNE2 TDRD6 DMD KIF13B FXR2 BAG3 CDK13 MACF1 ATP2B1 | 3.83e-11 | 197 | 265 | 15 | 20811636 |
| Pubmed | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL NSUN2 PGK1 NDUFV2 GMPS DHX15 DECR1 ALDOA CCT2 SLC3A2 TFRC TGM2 NOP58 EIF4G2 H1-3 EIF5 EIF5B MACF1 HADHA CNOT1 | 4.83e-11 | 707 | 265 | 26 | 19738201 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL21 LIN7C RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL NSUN2 PGK1 GMPS DHX15 DLAT ALDOA RANBP2 FXR2 BAG3 SMC4 UBA2 CCT2 AP3B1 GSPT1 GSS TFRC NOP58 FXR1 RUVBL1 H1-2 EIF5 EIF5B MACF1 HADHA CNOT1 | 7.38e-11 | 1149 | 265 | 33 | 35446349 |
| Pubmed | NCOA6 IRF2BP1 ARHGAP15 PSMA7 PABPC4 NSUN2 MECP2 PGK1 GMPS DHX15 MKI67 ALDOA RANBP2 TCF20 KCNAB2 SMC4 UBA2 CCT2 JMJD1C GSPT1 SLC3A2 ARID3B CCDC7 NOP58 CDK13 H1-2 EIF4G2 EIF5 EIF5B HADHA CNOT1 CDK2 | 1.14e-10 | 1103 | 265 | 32 | 34189442 | |
| Pubmed | LIN7C VPS13C RPS6 PABPC4 RPS13 NCL NSUN2 PGK1 GMPS DHX15 CASKIN1 MKI67 DLAT ALDOA DNAH3 MTHFD1L BAG3 SMC4 CCT2 SLC3A2 ARG1 NOP58 FXR1 RUVBL1 H1-2 HADHA CDK2 | 1.48e-10 | 803 | 265 | 27 | 36517590 | |
| Pubmed | PABPC4 NCL NSUN2 DHX15 MKI67 UTP20 DMD FXR2 BAG3 JMJD1C SLC3A2 TFRC FXR1 EIF4G2 H1-3 CDK5RAP1 HADHA | 1.78e-10 | 298 | 265 | 17 | 30737378 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | NCOA6 ASH1L RYR2 MRTFB SYNE2 RANBP2 TCF20 CCT2 JMJD1C RUVBL1 EIF4G2 CNOT1 | 2.03e-10 | 123 | 265 | 12 | 26912792 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL21 PABPC4 RPS13 NCL CUL7 NSUN2 DECR1 MKI67 DLAT UTP20 HERC2 ZC3H7B FMR1 FXR2 DDX52 KIF20B ARID3B NOP58 FXR1 RUVBL1 CDK13 H1-4 EXO1 PDCD11 MACF1 CNOT1 | 2.23e-10 | 759 | 265 | 26 | 35915203 |
| Pubmed | RPS13 NCL NSUN2 MECP2 GMPS DHX15 MKI67 FMR1 FXR2 POLR2A SMC4 CCT2 ARID3B FXR1 ARRB2 H1-2 H1-3 H1-4 EIF5B HADHA | 2.51e-10 | 441 | 265 | 20 | 31239290 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | NCL PGK1 PGK2 GMPS DHX15 ATXN1 DLAT RANBP2 MTHFD1L BAG3 CCT2 AP3B1 JMJD1C GSPT1 SLC3A2 TFRC NOP58 FXR1 EHHADH CDK13 HADHA MAP2K1 CNOT1 CDK2 | 4.05e-10 | 665 | 265 | 24 | 30457570 |
| Pubmed | IRF2BP1 VPS45 SPTBN1 PSMA7 PABPC4 NSUN2 ITPR1 DHX15 DECR1 PIK3C2A SYNE2 MKI67 OSBPL8 RARS2 ALDOA TIMM44 VTI1B RANBP2 AKT3 FXR2 MTHFD1L SMC4 CCT2 GSPT1 POLR3A SLC3A2 TFRC NBAS NOP58 EIF4G2 EIF5B PDCD11 HADHA ATP2B1 CNOT1 CDK2 | 4.25e-10 | 1440 | 265 | 36 | 30833792 | |
| Pubmed | RPL21 TNIK SPTBN1 PABPC4 NCL NSUN2 MECP2 PSMA8 PGK1 DHX15 DECR1 PIK3C2A MKI67 OSBPL8 DLAT HERC2 ALDOA TIMM44 RC3H2 FMR1 FXR2 DDX52 AP3B1 TGM2 NOP58 FXR1 RUVBL1 EHHADH CDK13 BRD7 PDCD11 EIF2AK4 HADHA PC CNOT1 | 4.41e-10 | 1371 | 265 | 35 | 36244648 | |
| Pubmed | RPS6 PABPC4 RPS13 NCL PGK1 DHX15 MKI67 ALDOA RANBP2 FMR1 FXR2 CCT2 SLC3A2 TFRC FXR1 H1-2 H1-3 H1-4 PDCD11 ATP2B1 | 5.85e-10 | 463 | 265 | 20 | 34901782 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL21 RPS6 RPS13 NCL NSUN2 RYK DHX15 MKI67 DLAT UTP20 AEN RANBP2 RNF169 TCF20 MTHFD1L DDX52 POLR2A BAG3 CCT2 JMJD1C KIF20B SLC3A2 TFRC NOP58 RUVBL1 H1-2 PDCD11 HADHA PC | 7.12e-10 | 989 | 265 | 29 | 36424410 |
| Pubmed | RPL21 RPS6 PABPC4 RPS13 NCL PGK1 DHX15 MRTFB MKI67 ALDOA RANBP2 UBA2 CCT2 RUVBL1 H1-2 EIF5 PC | 8.49e-10 | 330 | 265 | 17 | 32529326 | |
| Pubmed | RPL21 RPS6 SPTBN1 RPS13 NCL NSUN2 DHX15 DECR1 DLAT DMD ALDOA HSDL2 SMC4 CCT2 KIF20B KIF3A SLC3A2 NOP58 RUVBL1 H1-2 EIF4G2 H1-3 EIF5B HADHA CNOT1 ALPK2 | 8.58e-10 | 809 | 265 | 26 | 32129710 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RPL21 TANC2 SPTBN1 F5 PGK1 ITPR1 SERPINE2 FMN1 CASKIN1 SCN8A SCN9A HERC2 RANBP2 FMR1 HSDL2 POLR2A KIF3A FXR1 EIF5 EIF5B | 9.10e-10 | 475 | 265 | 20 | 31040226 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | VPS13C PSMA7 NCL CUL7 ARMCX2 NDUFV2 ITPR1 DECR1 PIK3C2A SYNE2 OSBPL8 DLAT RARS2 HERC2 HERC1 TIMM44 FMR1 HSDL2 FXR2 MTHFD1L PCLO CCT2 POLR3A NBAS NOP58 FXR1 ARRB2 CDK13 MRPL48 BRD7 H1-3 H1-4 CDK5RAP1 PDCD11 HADHA GEN1 | 1.18e-09 | 1496 | 265 | 36 | 32877691 |
| Pubmed | RPL21 RPS6 SPTBN1 PABPC4 NCL ABCB1 DLAT ALCAM ALDOA RANBP2 MTHFD1L SMC4 SLC3A2 TFRC NOP58 RUVBL1 H1-2 PDCD11 PC CNOT1 | 1.26e-09 | 484 | 265 | 20 | 31995728 | |
| Pubmed | NCL NSUN2 ITPR1 RUSC2 CASKIN2 RAD54B ZC3H7B DNA2 RC3H2 FMR1 AP3B1 JMJD1C POLR3A TGM2 GTPBP2 CDK13 SHCBP1 H1-3 AACS H1-4 CDK5RAP1 EIF2AK4 PLCE1 | 1.39e-09 | 650 | 265 | 23 | 38777146 | |
| Pubmed | SPTBN1 NSUN2 F5 DHX15 DECR1 PIK3C2A P3H1 MKI67 RANBP2 FMR1 FXR2 TFRC TGM2 NOP58 FXR1 ARRB2 RUVBL1 H1-2 H1-3 H1-4 EIF5B MACF1 HADHA | 1.86e-09 | 660 | 265 | 23 | 32780723 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL NSUN2 GMPS DHX15 SERPINE2 P3H1 HERC1 ALDOA POLR2A CAPN2 BAG3 SMC4 UBA2 CCT2 AP3B1 TYMP GSPT1 GSS TRIM16 TGM2 RUVBL1 H1-2 EIF5 H1-4 NT5C2 UBA6 EIF5B MACF1 CNOT1 | 2.07e-09 | 1455 | 265 | 35 | 22863883 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | RPL21 SPTBN1 RPS13 NSUN2 PGK1 GMPS SERPINA1 OSBPL8 ALDOA RANBP2 MTHFD1L BAG3 GSPT1 SLC3A2 NOP58 EIF4G2 EIF5 UBA6 EIF5B HADHA PC MAP2K1 | 2.07e-09 | 607 | 265 | 22 | 39147351 |
| Pubmed | RPL21 LIN7C RPS6 PABPC4 RPS13 NCL NSUN2 DHX15 DECR1 P3H1 FMR1 FXR2 MTHFD1L POLR2A NOP58 FXR1 RUVBL1 H1-2 EIF4G2 UBA6 EIF5B HADHA | 2.63e-09 | 615 | 265 | 22 | 31048545 | |
| Pubmed | CTNNAL1 SPTBN1 CUL7 ITPR1 GMPS CASKIN2 P3H1 SYNE2 MKI67 HERC2 DMD HERC1 HSD17B3 USP1 RANBP2 RNF169 HSDL2 POLR2A BAG3 CCT2 AP3B1 SLC3A2 CNNM1 PTPA EIF2AK4 HADHA PC ATP2B1 CNOT1 | 2.69e-09 | 1049 | 265 | 29 | 27880917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 F5 MECP2 PGK1 DHX15 DECR1 MKI67 UTP20 ALDOA FMR1 FXR2 DDX52 SMC4 CCT2 KIF20B SLC3A2 ARG1 TGM2 NOP58 FXR1 RUVBL1 H1-3 EIF5 EIF5B PDCD11 HADHA | 2.83e-09 | 1257 | 265 | 32 | 36526897 |
| Pubmed | 3.04e-09 | 9 | 265 | 5 | 16382098 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | RPL21 TANC2 LIN7C RPS6 SPTBN1 PABPC4 RPS13 NCL RUSC2 DHX15 MKI67 RNF169 DDX52 POLR2A RUVBL1 H1-2 PDCD11 | 3.28e-09 | 361 | 265 | 17 | 30344098 |
| Pubmed | 3.30e-09 | 4 | 265 | 4 | 10567518 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 3.30e-09 | 4 | 265 | 4 | 10469592 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 DHX15 PIK3C2A DMD DNAH3 KIF3A ARRB2 CDK13 H1-2 EIF2AK4 | 3.60e-09 | 317 | 265 | 16 | 17620599 |
| Pubmed | IRF2BP1 PSMA7 NCL NSUN2 PGK1 GMPS DHX15 MKI67 TAF1 RANBP2 RNF169 TCF20 POLR2A CAPN2 SMC4 UBA2 CCT2 POLR3A TFRC NOP58 PTPA PTGR1 CDK13 H1-2 EIF4G2 UBA6 EIF5B CDK2 | 5.29e-09 | 1014 | 265 | 28 | 32416067 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 PABPC4 NCL MECP2 NDUFV2 DHX15 MKI67 TAF1 ALDOA TAF1L RANBP2 RNF169 TCF20 POLR2A JMJD1C KIF20B ARID3B NOP58 RUVBL1 BRD7 H1-2 EIF4G2 EIF5 EIF5B PDCD11 PC INO80B | 6.04e-09 | 954 | 265 | 27 | 36373674 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RPL21 TNIK UTP20 ZC3H7B TIMM44 KIF13B RANBP2 MTHFD1L DDX52 POLR2A SMC4 UBA2 AP3B1 POLR3A NBAS NOP58 FXR1 RUVBL1 EIF5 PDCD11 HADHA PC CNOT1 | 6.23e-09 | 704 | 265 | 23 | 29955894 |
| Pubmed | RPL21 RPS6 RPS13 NCL F5 PGK1 ITPR1 PIK3C2A P3H1 MKI67 OSBPL8 HERC2 ALDOA RANBP2 FMR1 HSDL2 FXR2 MTHFD1L DDX52 PARP14 AP3B1 POLR3A SLC3A2 NBAS NOP58 FXR1 EIF4G2 MCTP2 ATP2B1 CNOT1 | 7.53e-09 | 1168 | 265 | 30 | 19946888 | |
| Pubmed | RPL21 RPS6 PABPC4 RPS13 NCL NSUN2 DHX15 MKI67 UTP20 RANBP2 FMR1 FXR2 BAG3 FXR1 RUVBL1 CDK13 H1-2 H1-3 H1-4 EIF5B HADHA PC | 8.23e-09 | 655 | 265 | 22 | 35819319 | |
| Pubmed | RPL21 RPS6 PSMA7 PABPC4 RPS13 NCL HMOX1 NSUN2 ABCB1 DHX15 OSBPL8 ALDOA TIMM44 FXR2 BAG3 SMC4 CCT2 SLC3A2 NOP58 FXR1 RUVBL1 EIF4G2 EIF5B PDCD11 HADHA ATP2B1 CDK2 | 8.73e-09 | 971 | 265 | 27 | 33306668 | |
| Pubmed | RPS6 SPTBN1 ARMCX2 DHX15 PIK3C2A ATXN1 SYNE2 TAF1 ALDOA USP1 AKAP6 RANBP2 FMR1 JMJD1C ZNF181 KIF3A EIF4G2 MACF1 PLCE1 | 1.16e-08 | 497 | 265 | 19 | 23414517 | |
| Pubmed | RPL21 CTNNAL1 C5orf22 RPS6 PSMA7 PABPC4 RPS13 NCL NSUN2 PSMA8 GMPS DHX15 DLAT ALDOA RANBP2 HSDL2 MTHFD1L DDX52 POLR2A CCT2 POLR3A SLC3A2 FXR1 RUVBL1 SHCBP1 H1-2 EIF4G2 H1-4 EIF5B HADHA PC CDK2 | 1.18e-08 | 1335 | 265 | 32 | 29229926 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SPTBN1 PABPC4 TAF1 RANBP2 TCF20 FXR2 DDX52 SMC4 CCT2 AP3B1 NOP58 RUVBL1 BRD7 H1-2 PDCD11 HADHA CNOT1 | 1.20e-08 | 394 | 265 | 17 | 27248496 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.64e-08 | 5 | 265 | 4 | 12629516 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | RPL21 RPS6 PSMA7 RPS13 NSUN2 GMPS DHX15 FMR1 FXR2 MTHFD1L BAG3 CCT2 SLC3A2 TFRC NOP58 FXR1 RUVBL1 H1-2 HADHA PC | 1.70e-08 | 565 | 265 | 20 | 33567341 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | RPL21 RPS6 RPS13 NSUN2 DHX15 SMC4 CCT2 RUVBL1 H1-2 H1-3 PDCD11 HADHA CNOT1 | 1.79e-08 | 221 | 265 | 13 | 29991511 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL MECP2 DHX15 MKI67 HERC2 ALDOA RANBP2 FMR1 FXR2 TGM2 NOP58 FXR1 RUVBL1 H1-2 H1-4 HADHA | 1.86e-08 | 626 | 265 | 21 | 33644029 |
| Pubmed | 1.88e-08 | 12 | 265 | 5 | 14557543 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | IRF2BP1 MECP2 MKI67 DLAT UTP20 ALDOA DNAH3 FMR1 FXR2 MTHFD1L PARP14 KIF20B ARID3B NOP58 CDK13 SHCBP1 BRD7 | 2.15e-08 | 410 | 265 | 17 | 26949251 |
| Pubmed | IRF2BP1 VPS13C SPTBN1 NCL NSUN2 ITPR1 GMPS DHX15 SYNE2 MKI67 TMCO3 DMD RC3H2 FMR1 HSDL2 MTHFD1L POLR2A SMC4 TRIM16 RAB34 RUVBL1 TTLL6 H1-3 | 2.21e-08 | 754 | 265 | 23 | 35906200 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | PABPC4 NCL NSUN2 DHX15 CLK2 DLAT TAF1 HERC2 TAF1L UBA2 ARID3B NOP58 H1-3 EIF5B | 2.37e-08 | 269 | 265 | 14 | 29511261 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 PGK1 DHX15 OSBPL8 TDRD6 ALDOA FXR2 CCT2 SLC3A2 TFRC H1-3 EIF5 EIF5B HADHA | 2.61e-08 | 580 | 265 | 20 | 35676659 |
| Pubmed | PABPC4 ARMCX2 MECP2 CLK2 DNA2 RC3H2 RANBP2 CRYBG2 FMR1 SMC4 PARP14 ARID3B NOP58 FXR1 CDK13 BRD7 H1-3 CNOT1 | 2.67e-08 | 469 | 265 | 18 | 27634302 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | RPL21 RPS6 PABPC4 NCL NSUN2 PGK1 DHX15 OSBPL8 TIMM44 RANBP2 NOP58 H1-2 HADHA PC | 2.72e-08 | 272 | 265 | 14 | 25315684 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | RPL21 SPTBN1 PSMA7 NSUN2 PSMA8 DLAT HERC1 ALDOA MTHFD1L SMC4 KIF20B TFRC NOP58 | 3.03e-08 | 231 | 265 | 13 | 36597993 |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | NUGGC PABPC4 RPS13 PGK1 CASKIN2 ZC3H7B ALDOA TCF20 FXR2 POLR2A BAG3 KCNAB2 TFRC TGM2 FXR1 | 3.97e-08 | 327 | 265 | 15 | 15592455 |
| Pubmed | RPL21 RPS6 NCL MKI67 DLAT UTP20 ALDOA RANBP2 DDX52 CCT2 NOP58 RUVBL1 CDK13 H1-2 H1-4 EIF5B PDCD11 HADHA | 4.16e-08 | 483 | 265 | 18 | 36912080 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL PGK1 PGK2 ALDOA DNAH6 DNAH3 SMC4 UBA2 CCT2 AP3B1 POLR3A RUVBL1 H1-2 H1-3 EIF5 H1-4 MACF1 ATP2B1 | 4.31e-08 | 847 | 265 | 24 | 35235311 |
| Pubmed | RPL21 RPS6 RPS13 NCL NSUN2 MECP2 PGK1 CLK2 ZC3H7B ALDOA KIF13B RC3H2 FXR2 POLR2A KIF3A NOP58 FXR1 RUVBL1 CDK13 EIF5 H1-4 EIF5B | 4.72e-08 | 723 | 265 | 22 | 34133714 | |
| Pubmed | 4.88e-08 | 6 | 265 | 4 | 11438699 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | RPL21 RPS6 SPTBN1 PSMA7 RPS13 NCL F5 NDUFV2 ABCB1 DHX15 OSBPL8 DDX52 SLC3A2 TFRC NOP58 RUVBL1 H1-2 H1-3 H1-4 HADHA | 5.07e-08 | 604 | 265 | 20 | 37616343 |
| Pubmed | PIK3C2A RANBP2 POLR2A SMC4 SLC3A2 TFRC EIF5B PDCD11 MAP2K1 ATP2B1 ATP2B2 CNOT1 | 5.73e-08 | 202 | 265 | 12 | 24639526 | |
| Pubmed | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL PGK1 GMPS DHX15 MKI67 ALDOA CCT2 KIF20B TFRC RUVBL1 EIF5B CNOT1 | 5.84e-08 | 494 | 265 | 18 | 26831064 | |
| Pubmed | RPL21 RPS6 SPTBN1 RPS13 NCL DHX15 DECR1 MKI67 FMR1 TFRC ARG1 NOP58 RUVBL1 | 6.04e-08 | 245 | 265 | 13 | 21182205 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL DHX15 RC3H2 FXR2 DDX52 BAG3 CCT2 NOP58 FXR1 CDK13 EIF4G2 H1-4 EIF5B PDCD11 HADHA CNOT1 | 7.17e-08 | 678 | 265 | 21 | 30209976 |
| Pubmed | NCL NSUN2 DHX15 P3H1 DLAT FXR2 MTHFD1L UBA2 CCT2 AP3B1 GSPT1 SLC3A2 TFRC H1-2 EIF4G2 H1-3 H1-4 | 8.49e-08 | 451 | 265 | 17 | 36168627 | |
| Pubmed | 8.57e-08 | 101 | 265 | 9 | 26949739 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | RPS6 SPTBN1 PSMA7 RPS13 NCL NSUN2 PSMA8 PGK1 DHX15 MRTFB USP1 SMC4 JMJD1C SLC3A2 NOP58 FXR1 EIF4G2 EXO1 PC CDK2 | 8.58e-08 | 624 | 265 | 20 | 33729478 |
| Pubmed | 1.17e-07 | 138 | 265 | 10 | 30320910 | ||
| Pubmed | RPL21 RPS6 PABPC4 RPS13 NCL DHX15 MKI67 FMR1 HSDL2 POLR2A AP3B1 SLC3A2 FXR1 | 1.20e-07 | 260 | 265 | 13 | 36199071 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | RPL21 IRF2BP1 RPS6 NCL ARMCX2 PGK1 DLAT UTP20 BAG3 PARP14 H1-2 EIF4G2 H1-4 | 1.32e-07 | 262 | 265 | 13 | 36880596 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | RPL21 MORC1 RPS6 SPTBN1 PABPC4 RPS13 NCL DHX15 VTI1B SLC3A2 TFRC RUVBL1 H1-2 H1-3 H1-4 HADHA PC | 1.44e-07 | 468 | 265 | 17 | 36042349 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RPL21 CTNNAL1 C5orf22 LIN7C NCK1 NCL GMPS SERPINA1 OSBPL8 DMD RANBP2 FXR2 MTHFD1L CAPN2 BAG3 SMC4 UBA2 AP3B1 SLC3A2 TFRC FXR1 RAB34 SHCBP1 ATP2B1 CDK2 | 1.47e-07 | 974 | 265 | 25 | 28675297 |
| Pubmed | MYH6 PSMA7 PABPC4 RPS13 NCL PSMA8 PGK1 GMPS DHX15 MKI67 DMD ALDOA RANBP2 CCT2 SLC3A2 ARG1 TGM2 H1-2 EIF4G2 H1-3 H1-4 MACF1 HADHA | 1.67e-07 | 844 | 265 | 23 | 25963833 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | PABPC4 NSUN2 MKI67 ZC3H7B FMR1 FXR2 BAG3 SMC4 SYCP3 NOP58 FXR1 EIF4G2 MACF1 CNOT1 | 1.67e-07 | 315 | 265 | 14 | 26777405 |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | RPL21 RPS6 PABPC4 RPS13 NCL GMPS P3H1 ALDOA SMC4 CCT2 SLC3A2 FXR1 RUVBL1 H1-3 HADHA CDK2 | 1.67e-07 | 418 | 265 | 16 | 32552912 |
| Pubmed | RPL21 ABCA13 SPTBN1 RPS13 NCL PGK1 ITPR1 DHX15 SERPINA1 MKI67 ALDOA RANBP2 FMR1 POLR2A SMC4 ARG1 NOP58 RUVBL1 H1-2 H1-4 | 1.73e-07 | 652 | 265 | 20 | 31180492 | |
| Pubmed | RPS6 RPS13 NCL DLAT DMD ALDOA FMR1 JMJD1C MRPL48 H1-2 H1-4 EIF5B HADHA PC | 1.80e-07 | 317 | 265 | 14 | 30997501 | |
| Pubmed | RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation. | 1.95e-07 | 18 | 265 | 5 | 27558965 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RPL21 PABPC4 DHX15 PIK3C2A MKI67 RC3H2 RANBP2 FMR1 FXR2 AP3B1 GSPT1 NOP58 FXR1 RAB34 RUVBL1 EIF5 EIF5B MACF1 HADHA GEN1 CNOT1 | 2.13e-07 | 724 | 265 | 21 | 36232890 |
| Interaction | SIRT7 interactions | RPL21 RPS6 SPTBN1 PABPC4 NCL CUL7 NSUN2 PGK1 GMPS DHX15 SYNE2 MKI67 OSBPL8 DLAT UTP20 HERC2 RANBP2 FMR1 TCF20 FXR2 MTHFD1L DDX52 POLR2A SMC4 CCT2 NOP58 FXR1 H1-3 H1-4 EIF5B PDCD11 MACF1 HADHA CNOT1 | 9.21e-11 | 744 | 255 | 34 | int:SIRT7 |
| Interaction | CAPZB interactions | RPL21 LIN7C RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL CUL7 NSUN2 MECP2 ITPR1 DHX15 DECR1 PIK3C2A ATXN1 MKI67 OSBPL8 DLAT ALDOA RC3H2 AKT3 RNF169 HSDL2 MTHFD1L BAG3 UBA2 CCT2 AP3B1 GSPT1 TFRC RUVBL1 SHCBP1 H1-2 EIF5 HADHA CNOT1 CDK2 | 4.77e-09 | 1049 | 255 | 38 | int:CAPZB |
| Interaction | KCTD13 interactions | RPL21 TANC2 MYH6 VPS45 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL MECP2 PGK1 NDUFV2 DHX15 SACS CASKIN1 OSBPL8 DLAT PLCL1 DMD ALDOA DNAH6 ASRGL1 FMR1 PCLO CAPN2 BRSK2 KCNAB2 CCT2 AP3B1 KIF3A SLC3A2 FXR1 LZTS1 MRPL48 EIF4G2 MACF1 HADHA BRSK1 PC MAP2K1 ATP2B1 ATP2B2 CNOT1 CDK2 | 5.42e-09 | 1394 | 255 | 45 | int:KCTD13 |
| Interaction | PINK1 interactions | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 NCL HMOX1 GMPS DHX15 KLHL9 SCN5A DLAT ALDOA RANBP2 NLRX1 BAG3 SMC4 TYMP GSPT1 SLC3A2 TRIM16 TGM2 FXR1 H1-3 H1-4 EIF5B HADHA PC SERPINA9 | 1.13e-08 | 679 | 255 | 29 | int:PINK1 |
| Interaction | EFTUD2 interactions | RPL21 TNIK RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL CUL7 NSUN2 MECP2 GMPS DHX15 DECR1 ATXN1 SYNE2 DLAT ALDOA TIMM44 RANBP2 HSDL2 FXR2 MTHFD1L POLR2A CAPN2 BAG3 SMC4 CCT2 AP3B1 GSPT1 SLC3A2 NOP58 FXR1 ARRB2 RUVBL1 CDK13 BRD7 H1-2 EIF4G2 NT5C2 EIF5B MACF1 HADHA PC CDK2 | 1.74e-08 | 1449 | 255 | 45 | int:EFTUD2 |
| Interaction | PPP1CC interactions | RPL21 TNIK TANC2 LIN7C RPS6 SPTBN1 PABPC4 RPS13 NCL CUL7 MECP2 RYR2 RUSC2 DHX15 ATXN1 MKI67 HSD17B3 RC3H2 RNF169 DDX52 POLR2A CCT2 POLR3A RUVBL1 BRD7 H1-2 PDCD11 EIF2AK4 RASSF8 CDK2 | 1.89e-08 | 738 | 255 | 30 | int:PPP1CC |
| Interaction | AGR2 interactions | IRF2BP1 RPS6 SPTBN1 PSMA7 ASH1L NCL NSUN2 PGK1 DHX15 SCN8A ALDOA PCLO POLR2A CCT2 AP3B1 SLC3A2 TFRC NBAS TGM2 NOP58 PTPA RUVBL1 PTGR1 BRD7 H1-2 H1-3 H1-4 NT5C2 EIF5B MACF1 HADHA BRSK1 PC CNOT1 | 3.01e-08 | 934 | 255 | 34 | int:AGR2 |
| Interaction | RBM39 interactions | RPL21 NCOA6 RPS6 PABPC4 RPS13 NCL CUL7 MECP2 PSMA8 PGK1 GMPS DHX15 ATXN1 CLK2 MKI67 DLAT HERC2 ALDOA ALDH6A1 RC3H2 FMR1 FXR2 DDX52 POLR2A CCT2 SLC3A2 TFRC NOP58 FXR1 RUVBL1 EHHADH BRD7 H1-2 H1-4 HADHA INO80B | 4.25e-08 | 1042 | 255 | 36 | int:RBM39 |
| Interaction | PIH1D1 interactions | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL NSUN2 PGK1 GMPS DHX15 OSBPL8 ALDOA RANBP2 HSDL2 MTHFD1L POLR2A SMC4 CCT2 GSPT1 POLR3A SLC3A2 NOP58 RUVBL1 H1-2 UBA6 EIF5B HADHA CDK2 | 5.61e-08 | 731 | 255 | 29 | int:PIH1D1 |
| Interaction | KCNA3 interactions | RPL21 CTNNAL1 ABCA13 RPS6 SPTBN1 PABPC4 RPS13 NCK1 GMPS DHX15 OSBPL8 ALDOA TIMM44 RANBP2 KCNAB2 SMC4 CCT2 AP3B1 JMJD1C SLC3A2 TFRC RUVBL1 EIF4G2 EIF5 H1-4 UBA6 EIF5B MACF1 EIF2AK4 HADHA ATP2B1 CNOT1 | 6.48e-08 | 871 | 255 | 32 | int:KCNA3 |
| Interaction | SYNGAP1 interactions | RPL21 TNIK TANC2 ARHGAP15 VPS45 SPTBN1 NCL MECP2 SYNE2 PLCL1 ALDH6A1 ASRGL1 FMR1 KCNAB2 RUVBL1 H1-2 H1-4 MAP2K1 | 8.09e-08 | 307 | 255 | 18 | int:SYNGAP1 |
| Interaction | HTT interactions | TNIK NCOA6 MYH6 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL NDUFV2 ITPR1 DHX15 DLAT TDRD6 ALDOA SGK1 PCLO POLR2A CAPN2 BAG3 KCNAB2 CCT2 GSPT1 SLC3A2 TGM2 RUVBL1 H1-2 EIF5 H1-4 HADHA PC MAP2K1 ATP2B2 | 1.43e-07 | 949 | 255 | 33 | int:HTT |
| Interaction | HDAC2 interactions | TNIK MBTPS1 PABPC4 NCL CUL7 NSUN2 MECP2 DHX15 MKI67 UTP20 HERC2 DMD FMR1 TCF20 FXR2 BAG3 SMC4 PARP14 JMJD1C POLR3A SLC3A2 TFRC FXR1 ARRB2 RUVBL1 TMEM132D EIF4G2 H1-3 CDK5RAP1 HADHA MAP2K1 | 1.83e-07 | 865 | 255 | 31 | int:HDAC2 |
| Interaction | ACE2 interactions | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 PGK1 GMPS DECR1 MKI67 DLAT ALCAM ALDOA TIMM44 RANBP2 MTHFD1L ZG16B UBA2 CCT2 SLC3A2 TFRC ARG1 TGM2 NOP58 GTPBP2 ARRB2 RUVBL1 H1-2 EIF4G2 H1-4 PDCD11 HADHA CFAP57 PC CNOT1 | 1.85e-07 | 1106 | 255 | 36 | int:ACE2 |
| Interaction | TRIM28 interactions | RPL21 TNIK RPS6 PABPC4 NCL CUL7 MECP2 DHX15 PIK3C2A ATXN1 MKI67 UTP20 ZC3H7B TIMM44 KIF13B RC3H2 RANBP2 FMR1 MTHFD1L DDX52 POLR2A SMC4 UBA2 E2F3 CCT2 AP3B1 ZNF181 GSPT1 POLR3A TFRC NBAS NOP58 FXR1 ARRB2 RUVBL1 BRD7 H1-3 EIF5 PDCD11 HADHA PC CNOT1 CDK2 | 2.21e-07 | 1474 | 255 | 43 | int:TRIM28 |
| Interaction | LOXL2 interactions | RPS6 SPTBN1 PABPC4 RPS13 PGK1 DHX15 ALDOA FXR2 CCT2 TYMP SLC3A2 CCDC7 TFRC ARG1 TGM2 FXR1 H1-2 MACF1 HADHA EPHA7 | 3.03e-07 | 410 | 255 | 20 | int:LOXL2 |
| Interaction | BIRC3 interactions | RPL21 MBTPS1 RPS6 SPTBN1 PSMA7 RPS13 NCL PGK1 DHX15 MKI67 DLAT UTP20 TDRD6 ALDOA TIMM44 RANBP2 HSDL2 MTHFD1L DDX52 POLR2A SMC4 CCT2 AP3B1 GSPT1 SLC3A2 TFRC NOP58 FXR1 RUVBL1 H1-2 EIF4G2 EIF5 UBA6 EIF5B PDCD11 HADHA PC ATP2B1 CNOT1 CDK2 | 3.09e-07 | 1334 | 255 | 40 | int:BIRC3 |
| Interaction | KIF23 interactions | RPL21 MYO1A ABCA13 RPS6 SPTBN1 PABPC4 RPS13 NCL DHX15 MKI67 DLAT DMD TIMM44 KIF13B FMR1 FXR2 PCLO BAG3 SMC4 KIF20B SLC3A2 NOP58 FXR1 RUVBL1 TTLL6 SHCBP1 EIF4G2 H1-4 EIF5B PDCD11 MACF1 HADHA GEN1 INO80B | 3.13e-07 | 1031 | 255 | 34 | int:KIF23 |
| Interaction | NCL interactions | RPL21 RPS6 PABPC4 RPS13 NCL CUL7 NSUN2 MECP2 RYR2 RUSC2 DHX15 ATXN1 SCN9A HERC2 FGFBP1 RC3H2 FMR1 DNAJC25 POLR2A BAG3 FXR1 ARRB2 BRD7 H1-2 H1-3 H1-4 EIF5B PDCD11 EIF2AK4 | 3.54e-07 | 798 | 255 | 29 | int:NCL |
| Interaction | CEBPA interactions | NCOA6 IRF2BP1 ARHGAP15 SPTBN1 PSMA7 PABPC4 NSUN2 MECP2 PGK1 GMPS DHX15 MKI67 ALDOA RANBP2 TCF20 POLR2A CAPN2 KCNAB2 SMC4 UBA2 CCT2 JMJD1C GSPT1 SLC3A2 ARID3B CCDC7 NOP58 RAB34 CDK13 H1-2 EIF4G2 EIF5 EIF5B PDCD11 MACF1 HADHA CNOT1 CDK2 | 4.11e-07 | 1245 | 255 | 38 | int:CEBPA |
| Interaction | AURKB interactions | RPL21 MYO1A RPS6 PABPC4 RPS13 CUL7 NSUN2 DHX15 KLHL9 KLHL13 MKI67 TAF1 HERC2 RC3H2 RANBP2 FMR1 BAG3 CCT2 KIF3A POLR3A SLC3A2 NOP58 PTPA FXR1 RUVBL1 H1-4 MACF1 CNOT1 | 4.47e-07 | 761 | 255 | 28 | int:AURKB |
| Interaction | CDK7 interactions | RPL21 MORC1 RPS6 SPTBN1 RPS13 NCL MECP2 DHX15 MKI67 TAF1 VTI1B DDX52 POLR2A CCT2 SLC3A2 ARRB2 H1-2 H1-3 H1-4 HADHA PC CDK2 | 4.60e-07 | 501 | 255 | 22 | int:CDK7 |
| Interaction | RPS20 interactions | RPL21 RPS6 PABPC4 RPS13 NCL MECP2 PGK1 ALDOA RC3H2 FMR1 FXR2 POLR2A GSPT1 FXR1 USP40 H1-2 EIF4G2 EIF5 H1-4 UBA6 CNOT1 CDK2 | 6.84e-07 | 513 | 255 | 22 | int:RPS20 |
| Interaction | CCDC8 interactions | PABPC4 NCL CUL7 NSUN2 F5 SACS MKI67 UTP20 HERC2 RANBP2 POLR2A SMC4 CCT2 SLC3A2 ARG1 NOP58 FXR1 RUVBL1 H1-4 UBA6 PDCD11 MACF1 HADHA ATP2B1 CNOT1 | 1.02e-06 | 656 | 255 | 25 | int:CCDC8 |
| Interaction | NOP56 interactions | RPL21 TNIK RPS6 RPS13 NCL CUL7 MECP2 DHX15 DECR1 ATXN1 MKI67 UTP20 FGFBP1 RC3H2 DNAJC25 DDX52 NOP58 FXR1 ARRB2 BRD7 H1-3 H1-4 PDCD11 | 1.08e-06 | 570 | 255 | 23 | int:NOP56 |
| Interaction | NR2C2 interactions | RPL21 TANC2 RPS6 PABPC4 RPS13 NCL NSUN2 PSMA8 GMPS DHX15 DECR1 CLK2 MKI67 OSBPL8 TIMM44 RC3H2 RANBP2 HSDL2 FXR2 MTHFD1L DDX52 SMC4 UBA2 CCT2 AP3B1 GSPT1 TFRC TGM2 NOP58 FXR1 RUVBL1 H1-2 H1-3 H1-4 EIF5B PDCD11 HADHA PC MAP2K1 CDK2 | 1.11e-06 | 1403 | 255 | 40 | int:NR2C2 |
| Interaction | NPM1 interactions | RPL21 RPS6 PABPC4 RPS13 NCL CUL7 NSUN2 MECP2 RYK DHX15 DECR1 ATXN1 CASKIN1 SYNE2 MKI67 RC3H2 FMR1 FXR2 DNAJC25 MTHFD1L DDX52 BRSK2 CCT2 ZNF181 PTPA FXR1 ARRB2 BRD7 H1-2 EIF4G2 H1-3 H1-4 PDCD11 PC INO80B CDK2 | 1.31e-06 | 1201 | 255 | 36 | int:NPM1 |
| Interaction | FMR1 interactions | TNIK RPS6 SPTBN1 NCK1 NCL CASKIN1 MKI67 HERC2 ZC3H7B RC3H2 RANBP2 FMR1 TCF20 FXR2 BAG3 FXR1 BRD7 NT5C2 UBA6 MACF1 BRSK1 CNOT1 | 1.41e-06 | 536 | 255 | 22 | int:FMR1 |
| Interaction | KPNB1 interactions | RPS6 NCL CUL7 MECP2 RUSC2 ATXN1 USP1 RANBP2 FMR1 KIF20B NOP58 FXR1 ARRB2 RUVBL1 BRD7 H1-2 H1-4 NT5C2 EXO1 HADHA MAP2K1 CDK2 | 1.80e-06 | 544 | 255 | 22 | int:KPNB1 |
| Interaction | RPL6 interactions | RPL21 RPS6 PABPC4 RPS13 NCK1 NCL CUL7 MECP2 ATXN1 FMR1 DNAJC25 SMC4 GSPT1 NOP58 ARRB2 BRD7 H1-2 H1-3 EIF5 H1-4 MACF1 HADHA INO80B CDK2 | 2.07e-06 | 637 | 255 | 24 | int:RPL6 |
| Interaction | RRS1 interactions | RPS6 RPS13 NCL CUL7 MECP2 ATXN1 MKI67 FGFBP1 RC3H2 RANBP2 TFRC NOP58 BRD7 H1-2 H1-3 H1-4 PDCD11 | 2.09e-06 | 345 | 255 | 17 | int:RRS1 |
| Interaction | EED interactions | RPL21 VPS45 VPS13C RPS6 SPTBN1 RPS13 NCL CUL7 NSUN2 PGK1 GMPS DHX15 NAA25 PIK3C2A CLK2 UTP20 HERC2 RANBP2 FXR2 MTHFD1L DDX52 POLR2A CAPN2 SMC4 UBA2 CCT2 AP3B1 KIF20B NOP58 FXR1 RUVBL1 H1-2 H1-4 UBA6 EIF5B PDCD11 MACF1 HADHA MAP2K1 CNOT1 | 2.32e-06 | 1445 | 255 | 40 | int:EED |
| Interaction | HSF1 interactions | NCOA6 IRF2BP1 RPS6 PABPC4 NCL NSUN2 PGK1 GMPS DHX15 SYNE2 TAF1 ALDOA RC3H2 RANBP2 POLR2A BAG3 KCNAB2 SMC4 TRIM16 RUVBL1 H1-2 EIF5B BRSK1 | 3.28e-06 | 609 | 255 | 23 | int:HSF1 |
| Interaction | YAP1 interactions | RPL21 NCOA6 LIN7C MYO1A RPS6 SPTBN1 RPS13 NCK1 NCL PGK1 DHX15 MRTFB DLAT TAF1 ALDOA TCF20 POLR2A BAG3 SMC4 UBA2 CCT2 JMJD1C SLC3A2 ARID3B TGM2 FXR1 RUVBL1 H1-4 HADHA RASSF8 PC MAP2K1 CNOT1 | 3.40e-06 | 1095 | 255 | 33 | int:YAP1 |
| Interaction | RPLP0 interactions | RPL21 RPS6 PABPC4 RPS13 NCK1 NCL CUL7 MECP2 PIK3C2A RC3H2 RANBP2 FMR1 FXR2 DNAJC25 GSPT1 ARRB2 CDK13 BRD7 H1-2 H1-4 EIF5B PDCD11 INO80B CDK2 | 3.81e-06 | 660 | 255 | 24 | int:RPLP0 |
| Interaction | KIF20A interactions | RPL21 MYO1A RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 ITPR1 DHX15 SAMD9L PIK3C2A SYNE2 MKI67 HERC2 HERC1 RANBP2 FMR1 HSDL2 FXR2 PCLO BAG3 NOP58 FXR1 RUVBL1 LZTS1 H1-2 H1-3 H1-4 TXNRD3 MACF1 HADHA | 4.00e-06 | 1052 | 255 | 32 | int:KIF20A |
| Interaction | GTPBP4 interactions | TNIK RPS6 NCL CUL7 NSUN2 MECP2 ATXN1 PIK3CB MKI67 FGFBP1 RC3H2 UBA2 JMJD1C NOP58 FXR1 BRD7 EIF4G2 H1-4 PDCD11 | 4.03e-06 | 443 | 255 | 19 | int:GTPBP4 |
| Interaction | C9orf72 interactions | RPL21 RPS6 PSMA7 PABPC4 RPS13 NCL NSUN2 GMPS DHX15 KLHL9 KLHL13 RARS2 ALDOA DNA2 TIMM44 USP1 RANBP2 HSDL2 DNAJC25 MTHFD1L POLR2A SMC4 CCT2 GSPT1 POLR3A SLC3A2 TFRC NOP58 FXR1 RUVBL1 H1-2 H1-3 H1-4 EXO1 HADHA CNOT1 CDK2 | 4.32e-06 | 1319 | 255 | 37 | int:C9orf72 |
| Interaction | ATG16L1 interactions | TANC2 ARHGAP15 VPS45 VPS13C NCL RYR2 ITPR1 RUSC2 DECR1 PIK3C2A CLK2 OSBPL8 HERC1 VTI1B TRAF7 RANBP2 FMR1 POLR2A SMC4 CCT2 PARP14 KIF3A TFRC TRIM16 NBAS FXR1 ARRB2 RUVBL1 TTLL6 SHCBP1 MRPL48 EIF4G2 EIF5 NT5C2 | 4.43e-06 | 1161 | 255 | 34 | int:ATG16L1 |
| Interaction | CSNK2A1 interactions | RPL21 RPS6 SPTBN1 PABPC4 NCL CUL7 F5 MECP2 PGK1 DHX15 ATXN1 CLK2 OSBPL8 TAF1 FMR1 FXR2 POLR2A CCT2 POLR3A NOP58 PTPA FXR1 ARRB2 RUVBL1 EIF4G2 EIF5 EIF5B MACF1 ATP2B1 CDK2 | 4.47e-06 | 956 | 255 | 30 | int:CSNK2A1 |
| Interaction | TNIP1 interactions | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 PGK2 ITPR1 DHX15 MKI67 UTP20 DMD ALDOA FMR1 FXR2 DDX52 ZG16B SMC4 CCT2 SLC3A2 ARG1 NOP58 FXR1 ARRB2 EHHADH CDK13 H1-2 H1-3 H1-4 EIF5B PDCD11 HADHA PC MCTP2 | 4.71e-06 | 1217 | 255 | 35 | int:TNIP1 |
| Interaction | H1-0 interactions | NCK1 ATXN1 MKI67 FGFBP1 RC3H2 DDX52 JMJD1C BRD7 H1-2 H1-3 H1-4 MAP2K1 CDK2 PLCE1 | 5.17e-06 | 256 | 255 | 14 | int:H1-0 |
| Interaction | ARRB2 interactions | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 DHX15 PIK3C2A SYNE2 RANBP2 AP3B1 PTPA ARRB2 CDK13 H1-2 EIF2AK4 MAP2K1 ALPK2 | 5.73e-06 | 454 | 255 | 19 | int:ARRB2 |
| Interaction | LGALS9 interactions | RPL21 RPS6 SPTBN1 PABPC4 NCL ABCB1 DLAT ALCAM ABCC2 ALDOA RANBP2 MTHFD1L SMC4 SLC3A2 TFRC NOP58 RUVBL1 H1-2 PDCD11 PC ATP2B1 CNOT1 | 6.28e-06 | 588 | 255 | 22 | int:LGALS9 |
| Interaction | HERC2 interactions | TNIK SPTBN1 PABPC4 NCL DHX15 CLK2 SYNE2 TAF1 HERC2 HERC1 TAF1L FMR1 HSDL2 ZG16B FXR1 RAB34 EIF5B MACF1 CNOT1 EPHA7 | 6.93e-06 | 503 | 255 | 20 | int:HERC2 |
| Interaction | FBL interactions | RPS6 PABPC4 RPS13 NCL CUL7 NSUN2 MECP2 PGK1 DHX15 ATXN1 MKI67 UTP20 RC3H2 FMR1 FXR2 DDX52 NOP58 ARRB2 RUVBL1 EIF5B PDCD11 MAP2K1 CDK2 | 7.23e-06 | 639 | 255 | 23 | int:FBL |
| Interaction | TERF2 interactions | RPS6 PABPC4 NCL MECP2 RYR2 SYNE2 MKI67 TDRD6 DMD KIF13B FXR2 BAG3 CDK13 BRD7 MACF1 ATP2B1 | 7.51e-06 | 340 | 255 | 16 | int:TERF2 |
| Interaction | NAT10 interactions | TNIK RPS6 NCL CUL7 MECP2 ATXN1 UTP20 HERC2 FGFBP1 NOP58 FXR1 BRD7 H1-2 H1-4 MAP2K1 | 7.65e-06 | 302 | 255 | 15 | int:NAT10 |
| Interaction | FBXO32 interactions | MYH6 C5orf22 RPS13 GMPS DECR1 UTP20 ALDOA TIMM44 MTHFD1L POLR2A SMC4 CCT2 AP3B1 PC ATP2B1 CNOT1 CDK2 | 9.30e-06 | 386 | 255 | 17 | int:FBXO32 |
| Interaction | HDAC4 interactions | RPL21 TANC2 SPTBN1 CUL7 NSUN2 PGK1 ITPR1 SERPINE2 ATXN1 FMN1 CASKIN1 SCN8A SCN9A HERC2 KIF13B RANBP2 FMR1 POLR2A AP3B1 KIF3A PTPA FXR1 H1-2 EIF5 EIF5B | 9.36e-06 | 744 | 255 | 25 | int:HDAC4 |
| Interaction | SOX2 interactions | NCOA6 IRF2BP1 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL HMOX1 CUL7 MECP2 PSMA8 PGK1 DHX15 SERPINA1 ATXN1 ABCC2 RANBP2 TCF20 DDX52 CAPN2 BAG3 CCT2 TYMP JMJD1C ARID3B NOP58 RUVBL1 LZTS1 SHCBP1 BRD7 EIF5B PDCD11 MACF1 HADHA BRSK1 CNOT1 EPHA7 | 9.66e-06 | 1422 | 255 | 38 | int:SOX2 |
| Interaction | NOP58 interactions | RPS6 RPS13 CUL7 MECP2 DHX15 ATXN1 MKI67 UTP20 RC3H2 UBA2 NOP58 RUVBL1 BRD7 EIF5B MAP2K1 | 1.01e-05 | 309 | 255 | 15 | int:NOP58 |
| Interaction | CUL7 interactions | RPL21 RPS6 PABPC4 RPS13 NCL CUL7 PGK1 ABCB1 DHX15 SYNE2 MKI67 RANBP2 POLR2A CCT2 SLC3A2 TFRC NOP58 GTPBP2 FXR1 RUVBL1 USP40 H1-4 EIF5B PDCD11 MACF1 HADHA EPHA7 | 1.01e-05 | 845 | 255 | 27 | int:CUL7 |
| Interaction | RPF2 interactions | RPS6 NCL CUL7 MECP2 DHX15 MKI67 FGFBP1 RC3H2 BRD7 H1-2 H1-4 PDCD11 CTSS | 1.04e-05 | 236 | 255 | 13 | int:RPF2 |
| Interaction | FN1 interactions | RPL21 RPS6 SPTBN1 PSMA7 PABPC4 RPS13 NCL PGK1 NDUFV2 GMPS DHX15 DECR1 SERPINA1 ALDOA SERPINA7 CCT2 SLC3A2 TFRC TGM2 NOP58 EIF4G2 H1-3 EIF5 EIF5B MACF1 HADHA CNOT1 | 1.07e-05 | 848 | 255 | 27 | int:FN1 |
| Interaction | RPS3A interactions | RPL21 RPS6 SPTBN1 PABPC4 ASH1L RPS13 NCL CUL7 MECP2 RC3H2 FMR1 GSPT1 NOP58 ARRB2 RUVBL1 BRD7 USP40 H1-2 EIF5 H1-4 PC INO80B CDK2 | 1.08e-05 | 655 | 255 | 23 | int:RPS3A |
| Interaction | EIF4G1 interactions | RPS6 PABPC4 RPS13 CUL7 MECP2 ATXN1 MKI67 HERC2 ZC3H7B RC3H2 FMR1 FXR2 GSPT1 TGM2 FXR1 BRD7 EIF4G2 EIF5 | 1.11e-05 | 433 | 255 | 18 | int:EIF4G1 |
| Interaction | SERBP1 interactions | RPS6 PABPC4 NCL NSUN2 GMPS ATXN1 P3H1 DLAT ZC3H7B RC3H2 FMR1 FXR2 DDX52 PCLO UBA2 CCT2 GSPT1 POLR3A SLC3A2 SHQ1 TFRC PTPA FXR1 ARRB2 CDK13 BRD7 H1-2 EIF4G2 H1-3 EIF5 H1-4 UBA6 HADHA MAP2K1 ATP2B1 CNOT1 INO80B CDK2 | 1.13e-05 | 1432 | 255 | 38 | int:SERBP1 |
| Interaction | OBSL1 interactions | IRF2BP1 RPS6 PSMA7 NCL CUL7 DHX15 SLC9C1 SYNE2 MKI67 DLAT UTP20 HERC2 ZC3H7B ALDOA RANBP2 TCF20 FXR2 DDX52 PCLO POLR2A CCT2 NOP58 RUVBL1 H1-4 EIF5B PDCD11 MACF1 ALPK2 | 1.16e-05 | 902 | 255 | 28 | int:OBSL1 |
| Interaction | DKC1 interactions | RPS6 CUL7 MECP2 DHX15 HERC2 FGFBP1 RC3H2 FMR1 SHQ1 NOP58 ARRB2 RUVBL1 BRD7 H1-2 H1-3 H1-4 EIF5B | 1.17e-05 | 393 | 255 | 17 | int:DKC1 |
| Interaction | STIP1 interactions | RPL21 SPTBN1 RPS13 CUL7 PGK1 GMPS DHX15 ATXN1 DLAT ALDOA TIMM44 RANBP2 FMR1 DDX52 POLR2A ZG16B SMC4 CCT2 AP3B1 GSPT1 SLC3A2 TFRC NOP58 FXR1 RUVBL1 EIF4G2 EIF5B PDCD11 HADHA CNOT1 | 1.21e-05 | 1006 | 255 | 30 | int:STIP1 |
| Interaction | CEBPB interactions | RPL21 IRF2BP1 RPS6 PSMA7 PABPC4 RPS13 NCL NSUN2 PGK1 GMPS DHX15 SERPINA1 KLHL9 MKI67 ALDOA TIMM44 RANBP2 TCF20 POLR2A SMC4 UBA2 CCT2 KIF20B POLR3A SLC3A2 TFRC ARG1 NOP58 RUVBL1 CDK13 H1-2 H1-3 EIF5 H1-4 EIF5B EIF2AK4 HADHA MAP2K1 | 1.34e-05 | 1443 | 255 | 38 | int:CEBPB |
| Interaction | SNCA interactions | TNIK ARHGAP15 VPS13C SPTBN1 NCL GMPS SACS ATXN1 P3H1 SYNE2 OSBPL8 FMR1 FXR2 PCLO POLR2A BRSK2 AP3B1 KIF3A FXR1 RUVBL1 CDK13 H1-2 EIF5B MACF1 | 1.48e-05 | 716 | 255 | 24 | int:SNCA |
| Interaction | NUP43 interactions | NCOA6 ASH1L CUL7 MECP2 RYR2 MRTFB SYNE2 MKI67 UTP20 RANBP2 TCF20 HSDL2 CCT2 JMJD1C NOP58 RUVBL1 TRAPPC12 H1-2 EIF4G2 H1-4 PDCD11 CNOT1 | 1.62e-05 | 625 | 255 | 22 | int:NUP43 |
| Interaction | PRC1 interactions | RPL21 RPS6 SPTBN1 PABPC4 RPS13 NCL NSUN2 MECP2 DHX15 MKI67 UTP20 HERC1 RANBP2 FMR1 FXR2 DDX52 POLR2A SMC4 CCT2 NOP58 FXR1 RUVBL1 H1-2 H1-3 H1-4 EIF5B PDCD11 HADHA CDK2 | 1.72e-05 | 973 | 255 | 29 | int:PRC1 |
| Interaction | RPA4 interactions | RPL21 RPS6 SPTBN1 PSMA7 RPS13 NCL PGK1 SERPINA1 MKI67 ALDOA RANBP2 FXR2 CCT2 FXR1 RUVBL1 CDK13 H1-2 H1-4 | 1.97e-05 | 452 | 255 | 18 | int:RPA4 |
| Interaction | PTEN interactions | RPL21 VPS45 RPS6 SPTBN1 RPS13 ARMC2 PGK1 DHX15 P3H1 MKI67 SCN10A USP1 SERPINA7 RANBP2 HSDL2 POLR2A KCNAB2 SMC4 CCT2 CCDC7 TGM2 NOP58 PTPA EIF5 PDCD11 HADHA PC ATP2B1 | 1.99e-05 | 929 | 255 | 28 | int:PTEN |
| Interaction | NDN interactions | RPL21 RPS6 PABPC4 RPS13 NCL PGK1 DHX15 MRTFB MKI67 ALDOA RANBP2 FXR2 UBA2 CCT2 RUVBL1 H1-2 EIF5 PC | 2.03e-05 | 453 | 255 | 18 | int:NDN |
| Interaction | EEF2 interactions | RPL21 RPS6 PSMA7 RPS13 NCL MECP2 PGK1 RC3H2 FMR1 FXR2 CCT2 TYMP GSPT1 FXR1 ARRB2 CDK13 BRD7 MACF1 HADHA CNOT1 CDK2 | 2.05e-05 | 588 | 255 | 21 | int:EEF2 |
| Interaction | NUPR1 interactions | SPTBN1 NSUN2 F5 DHX15 DECR1 PIK3C2A P3H1 MKI67 RANBP2 FMR1 FXR2 TFRC TGM2 NOP58 FXR1 ARRB2 RUVBL1 H1-2 H1-3 H1-4 EIF5B MACF1 HADHA | 2.09e-05 | 683 | 255 | 23 | int:NUPR1 |
| Interaction | DHX57 interactions | RPS6 SPTBN1 RPS13 MECP2 FGFBP1 RC3H2 FMR1 FXR2 FXR1 BRD7 H1-2 H1-3 H1-4 | 2.09e-05 | 252 | 255 | 13 | int:DHX57 |
| Interaction | HECTD1 interactions | RPL21 PABPC4 RPS13 NCL CUL7 NSUN2 DECR1 MKI67 DLAT UTP20 TAF1 HERC2 ZC3H7B FMR1 FXR2 DDX52 SMC4 KIF20B POLR3A ARID3B NOP58 FXR1 RUVBL1 CDK13 H1-4 EXO1 PDCD11 MACF1 CNOT1 | 2.12e-05 | 984 | 255 | 29 | int:HECTD1 |
| Interaction | PURA interactions | TNIK RPS6 MECP2 MKI67 FGFBP1 RC3H2 FMR1 TGM2 FXR1 BRD7 H1-2 H1-3 H1-4 CDK2 | 2.20e-05 | 291 | 255 | 14 | int:PURA |
| Interaction | SREK1 interactions | RPS6 SPTBN1 PABPC4 NCL MECP2 HERC2 FGFBP1 RC3H2 H1-2 H1-4 INO80B | 2.25e-05 | 183 | 255 | 11 | int:SREK1 |
| Interaction | FKBP5 interactions | NSUN2 PIK3C2A SACS RAD54B DLAT DNA2 AKT3 SGK1 DDX52 BAG3 ZG16B RUVBL1 CDK13 CDK5RAP1 PDCD11 MAP2K1 PLCE1 | 2.29e-05 | 414 | 255 | 17 | int:FKBP5 |
| Interaction | CECR2 interactions | 2.37e-05 | 46 | 255 | 6 | int:CECR2 | |
| Interaction | SYNE2 interactions | TNIK ARHGAP15 SPTBN1 CUL7 ATXN1 SYNE2 HERC2 DMD TIMM44 DNAJC25 TFRC ARRB2 | 2.41e-05 | 219 | 255 | 12 | int:SYNE2 |
| Interaction | RAPSN interactions | 2.42e-05 | 28 | 255 | 5 | int:RAPSN | |
| Interaction | MYEF2 interactions | 2.45e-05 | 152 | 255 | 10 | int:MYEF2 | |
| Interaction | PARP1 interactions | MORC1 NCOA6 NCK1 NCL CUL7 MECP2 PGK1 RYK GMPS SACS MKI67 DLAT UTP20 ZC3H7B USP1 RNF169 ASRGL1 DDX52 POLR2A CAPN2 BAG3 SMC4 UBA2 E2F3 SLC3A2 ARID3B NOP58 CDK13 BRD7 H1-2 EIF4G2 H1-3 PDCD11 HADHA CDK2 | 2.50e-05 | 1316 | 255 | 35 | int:PARP1 |
| Interaction | DDX18 interactions | RPS6 NCL CUL7 MECP2 DHX15 ATXN1 UTP20 FGFBP1 RC3H2 DDX52 NOP58 EHHADH BRD7 H1-4 MAP2K1 | 2.50e-05 | 334 | 255 | 15 | int:DDX18 |
| Interaction | WWP2 interactions | RPL21 LIN7C RPS6 PABPC4 RPS13 NCL NSUN2 DHX15 DECR1 P3H1 SCN5A FMR1 FXR2 MTHFD1L POLR2A CCT2 NOP58 FXR1 RUVBL1 H1-2 EIF4G2 UBA6 EIF5B CDK5RAP1 HADHA PC | 2.55e-05 | 840 | 255 | 26 | int:WWP2 |
| Interaction | OPTN interactions | MYH6 NCL ARMCX2 SYNE2 MKI67 OSBPL8 AKAP6 MTHFD1L ZNF181 TFRC TRIM16 H1-2 CDK5RAP1 PDCD11 HADHA MAP2K1 CDK2 | 2.91e-05 | 422 | 255 | 17 | int:OPTN |
| Interaction | SCN11A interactions | 3.06e-05 | 15 | 255 | 4 | int:SCN11A | |
| Interaction | BRIX1 interactions | RPS6 PABPC4 RPS13 NCL CUL7 MECP2 ATXN1 MKI67 FGFBP1 RC3H2 UBA2 H1-2 H1-4 PDCD11 | 3.07e-05 | 300 | 255 | 14 | int:BRIX1 |
| Interaction | NOP9 interactions | 3.08e-05 | 125 | 255 | 9 | int:NOP9 | |
| Interaction | METTL14 interactions | RPL21 RPS6 SPTBN1 PSMA7 RPS13 NCL NSUN2 PSMA8 DLAT HERC1 ALDOA MTHFD1L SMC4 CCT2 KIF20B SLC3A2 TFRC ARG1 NOP58 H1-2 | 3.09e-05 | 558 | 255 | 20 | int:METTL14 |
| Interaction | LGR4 interactions | CNPY4 PIK3C2A RANBP2 POLR2A SMC4 RAPGEF1 SLC3A2 TFRC EIF5B PDCD11 ATP2B1 ATP2B2 CNOT1 | 3.14e-05 | 262 | 255 | 13 | int:LGR4 |
| Interaction | WDR76 interactions | SPTBN1 PABPC4 MKI67 TAF1 RANBP2 DDX52 POLR2A SMC4 CCT2 AP3B1 NOP58 FXR1 BRD7 H1-2 HADHA CNOT1 | 3.24e-05 | 383 | 255 | 16 | int:WDR76 |
| Interaction | UTP23 interactions | 3.34e-05 | 191 | 255 | 11 | int:UTP23 | |
| Interaction | RNF168 interactions | 3.47e-05 | 98 | 255 | 8 | int:RNF168 | |
| Interaction | FZR1 interactions | RPL21 RPS6 PSMA7 PABPC4 RPS13 NCL HMOX1 NSUN2 ABCB1 DHX15 OSBPL8 PSMC3IP ALDOA TIMM44 USP1 FMR1 FXR2 BAG3 BRSK2 SMC4 E2F3 CCT2 SLC3A2 NOP58 FXR1 RUVBL1 EIF4G2 EIF5B PDCD11 HADHA ATP2B1 CDK2 | 3.48e-05 | 1172 | 255 | 32 | int:FZR1 |
| Interaction | YWHAQ interactions | RPL21 TANC2 NCOA6 PABPC4 NCL CUL7 PGK1 RUSC2 SERPINA1 PIK3C2A ATXN1 PIK3CB CLK2 KIF13B SGK1 BAG3 TGM2 SLC8A1 SLC8A3 ARRB2 SHCBP1 H1-2 H1-3 EIF5 EXO1 MACF1 HADHA RASSF8 PC MAP2K1 CDK2 | 3.49e-05 | 1118 | 255 | 31 | int:YWHAQ |
| Interaction | CIT interactions | RPL21 TNIK RPS6 SPTBN1 PABPC4 ASH1L RPS13 NCL CUL7 NSUN2 DHX15 PIK3CB SYNE2 MKI67 UTP20 HERC1 RANBP2 TCF20 FXR2 PCLO POLR2A SMC4 CCT2 SLC3A2 TFRC NBAS NOP58 FXR1 RUVBL1 H1-2 EIF4G2 H1-3 H1-4 EIF5B PDCD11 MACF1 HADHA | 3.49e-05 | 1450 | 255 | 37 | int:CIT |
| Interaction | ATG5 interactions | VPS45 VPS13C PSMA7 PGK1 DHX15 PIK3C2A SACS ATXN1 ALDOA FMR1 MTHFD1L CAPN2 CCT2 ARRB2 EIF2AK4 | 3.52e-05 | 344 | 255 | 15 | int:ATG5 |
| Interaction | MAPT interactions | TNIK RPS6 NCL NSUN2 PGK1 SERPINE2 DLAT ALDOA ALDH6A1 FMR1 SGK1 CAPN2 BAG3 BRSK2 KCNAB2 CCT2 GSPT1 SLC3A2 TFRC ARG1 PTPA FXR1 RUVBL1 EIF4G2 NT5C2 EIF5B HADHA BRSK1 MAP2K1 ATP2B1 CDK2 | 3.54e-05 | 1119 | 255 | 31 | int:MAPT |
| Interaction | CTNNA1 interactions | TNIK SPTBN1 CUL7 RYK FMN1 HERC2 DMD HSD17B3 ALDOB FXR1 ARRB2 MACF1 RASSF8 MAP2K1 EPHA7 | 3.89e-05 | 347 | 255 | 15 | int:CTNNA1 |
| Interaction | GRWD1 interactions | RPL21 RPS6 RPS13 NCL NSUN2 DHX15 RC3H2 SMC4 CCT2 RUVBL1 BRD7 H1-2 H1-3 PDCD11 HADHA CNOT1 | 4.03e-05 | 390 | 255 | 16 | int:GRWD1 |
| Interaction | PINX1 interactions | 4.20e-05 | 130 | 255 | 9 | int:PINX1 | |
| Interaction | RNF2 interactions | RPL21 NCOA6 PABPC4 RPS13 NCL ABCB1 MKI67 KIF13B RANBP2 FXR2 DDX52 PCLO POLR2A SMC4 TFRC NOP58 RUVBL1 TMEM132D CDK13 SHCBP1 MRPL48 H1-2 H1-3 H1-4 PDCD11 ATP2B1 | 4.26e-05 | 866 | 255 | 26 | int:RNF2 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 9.52e-09 | 9 | 174 | 5 | 1203 | |
| GeneFamily | ATPases Ca2+ transporting | 7.05e-05 | 9 | 174 | 3 | 1209 | |
| GeneFamily | Serpin peptidase inhibitors | 4.27e-04 | 37 | 174 | 4 | 739 | |
| GeneFamily | Dyneins, axonemal | 5.39e-04 | 17 | 174 | 3 | 536 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | MYO1A RPS6 NCK1 NCL PGK1 CHRNA5 NDUFV2 GMPS DHX15 MKI67 PSMC3IP DLAT UTP20 DNA2 USP1 TCF20 DDX52 ADNP2 SMC4 UBA2 CCT2 KIF20B GSPT1 TFRC RUVBL1 EXO1 EIF5B CNOT1 | 1.90e-09 | 761 | 255 | 28 | M11961 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCK1 MECP2 RYK ITPR1 GMPS DHX15 PIK3C2A SACS ATXN1 SYNE2 OSBPL8 UTP20 ALCAM DMD RANBP2 E2F3 AP3B1 KIF20B NBAS FXR1 CDK13 SLC20A2 NT5C2 MACF1 MAP2K1 ATP2B1 PLCE1 | 9.07e-08 | 856 | 255 | 27 | M4500 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | RPS6 PSMA7 RPS13 NCL ALDOA SMC4 SLC3A2 TFRC H1-3 EIF5 H1-4 EIF5B | 7.90e-07 | 203 | 255 | 12 | MM3795 |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | TNIK ARHGAP15 MB PSMA8 SYNE2 SCN4A RAD54B CAPN2 ARID3B LZTS1 ATP2B1 | 9.99e-07 | 171 | 255 | 11 | M8820 |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL | PSMA7 PGK1 NDUFV2 GMPS DECR1 SERPINA1 MKI67 ALCAM ALDOA USP1 MACC1 ASRGL1 SLC31A2 SMC4 KIF20B SLC3A2 TGM2 RAB34 PTGR1 SHCBP1 H1-2 H1-3 H1-4 HADHA ATP2B1 CTSS MCEMP1 | 1.00e-06 | 968 | 255 | 27 | M41693 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | ASH1L SERPINA1 SERPINE2 SYNE2 ALDH6A1 MACC1 PARP14 TGM2 PTGR1 NT5C2 MACF1 | 1.75e-06 | 181 | 255 | 11 | M39225 |
| Coexpression | LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB | RPL21 VPS13C RPS6 PSMA7 RPS13 NCL PGK1 SERPINA1 ALDOA CAPN2 GSPT1 TGM2 EIF4G2 EIF5 HADHA | 2.21e-06 | 353 | 255 | 15 | M39229 |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | NCOA6 MBTPS1 RPS6 PABPC4 ARMCX2 PGK1 SCN5A TIMM44 SLC31A2 DDX52 DNAH17 | 4.16e-06 | 198 | 255 | 11 | M3242 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NCL ZRANB3 ABCB1 SERPINE2 MKI67 PSMC3IP DNA2 USP1 AEN RC3H2 POLR2A SMC4 KIF20B SHQ1 NOP58 PTGR1 SHCBP1 EXO1 CDK2 | 4.42e-06 | 578 | 255 | 19 | M2368 |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | RPS6 PSMA7 PABPC4 PGK1 DHX15 USP1 UBA2 CCT2 GSPT1 EIF4G2 CDK2 | 4.59e-06 | 200 | 255 | 11 | M5926 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | LIN7C PSMA7 NCK1 PGK1 RYK NDUFV2 DHX15 DECR1 SERPINE2 ATXN1 PIK3CB USP1 ALDH6A1 VTI1B RANBP2 SMC4 UBA2 CCT2 AP3B1 GSPT1 GSS TFRC TRIM16 NBAS TGM2 RUVBL1 BRD7 EIF4G2 EIF5 HADHA MAP2K1 CDK2 | 6.58e-06 | 1399 | 255 | 32 | M535 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NCL ZRANB3 ABCB1 SERPINE2 MKI67 PSMC3IP DNA2 USP1 AEN RC3H2 POLR2A SMC4 KIF20B SHQ1 NOP58 PTGR1 SHCBP1 EXO1 CDK2 | 7.01e-06 | 597 | 255 | 19 | MM1309 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | SP140L OSBPL8 RARS2 USP1 RC3H2 MTHFD1L DDX52 SMC4 G2E3 CCT2 KIF20B TFRC TGM2 GTPBP2 FXR1 EIF4G2 EIF5 UBA6 EIF5B ATP2B1 CNOT1 | 8.88e-06 | 721 | 255 | 21 | M10237 |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | LIN7C RPS6 PABPC4 HMOX1 PGK1 SERPINA1 ATP2C2 SGK1 CAPN2 GSPT1 TFRC TGM2 EIF4G2 | 9.20e-06 | 302 | 255 | 13 | MM16604 |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | NCL GMPS DHX15 SERPINE2 MKI67 PSMC3IP DMD USP1 FGFBP1 SYCP3 G2E3 CCT2 AP3B1 NOP58 RUVBL1 SHCBP1 EIF5 EXO1 | 9.52e-06 | 555 | 255 | 18 | M2343 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | SELENOT PGK1 ZRANB3 DHX15 KLHL13 RAD54B MKI67 PSMC3IP DLAT DNA2 USP1 KIF13B AEN ASRGL1 SMC4 UBA2 G2E3 CCT2 KIF20B SLC3A2 RUVBL1 CDK13 MRPL48 BRD7 EXO1 EIF5B MAP2K1 GEN1 CNOT1 CDK2 | 9.53e-06 | 1290 | 255 | 30 | M80 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | PGK1 ZRANB3 FMN1 RAD54B MKI67 DNA2 USP1 SMC4 KIF20B NOP58 SHCBP1 NT5C2 EXO1 GEN1 CDK2 | 1.06e-05 | 402 | 255 | 15 | MM454 |
| Coexpression | LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB | RPL21 RPS6 PSMA7 RPS13 NCL PGK1 SERPINA1 ALDOA CAPN2 TGM2 EIF4G2 EIF5 | 1.98e-05 | 278 | 255 | 12 | M39227 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | C5orf22 CHRNA5 GMPS P3H1 MKI67 PSMC3IP USP1 MTHFD1L SMC4 KIF20B GSPT1 TFRC NOP58 FXR1 SHCBP1 EIF4G2 UBA6 EIF5B GEN1 | 2.01e-05 | 644 | 255 | 19 | M10501 |
| Coexpression | IBRAHIM_NRF2_UP | SLCO2B1 NCL HMOX1 NSUN2 ABCB1 RUSC2 SERPINE2 TRIM16L FXR2 BAG3 SLC3A2 TFRC TRIM16 FXR1 BRD7 EIF4G2 EIF5 | 2.09e-05 | 533 | 255 | 17 | M42510 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | NCOA6 ARHGAP15 VPS45 SPTBN1 ABCB1 DECR1 SACS ATXN1 SYNE2 SCN9A OSBPL8 ALCAM USP1 AKT3 FMR1 HSDL2 UBA2 CCT2 GSPT1 SHQ1 CDK13 MRPL48 AACS NT5C2 EIF5B CDK5RAP1 MACF1 CNOT1 | 2.27e-05 | 1215 | 255 | 28 | M41122 |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN | 2.33e-05 | 156 | 255 | 9 | M6865 | |
| Coexpression | NABA_ECM_REGULATORS | CPAMD8 SPAM1 SERPINA1 SERPINE2 P3H1 FAM20B SERPINA7 TGM2 ADAMTS14 SERPINA9 CTSS | 2.35e-05 | 238 | 255 | 11 | M3468 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SELENOT ARHGAP15 VPS13C PSMA7 ASH1L RPS13 MECP2 PGK1 ABCB1 ITPR1 SAMD9L SACS ATXN1 OSBPL8 HERC1 USP1 RANBP2 FMR1 CAPN2 KCNAB2 UBA2 RAPGEF1 PARP14 JMJD1C ARRB2 CDK13 EIF4G2 EIF5 MACF1 MAP2K1 CNOT1 CTSS | 2.37e-05 | 1492 | 255 | 32 | M40023 |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN | PABPC4 NCL DECR1 PIK3C2A DLAT CAPN2 GSPT1 TFRC RUVBL1 SHCBP1 | 2.39e-05 | 196 | 255 | 10 | M3183 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | TANC2 SPTBN1 ATXN1 HERC1 ALDOB KIF13B RANBP2 AKT3 MACC1 JMJD1C SLC8A1 | 2.54e-05 | 240 | 255 | 11 | M39236 |
| Coexpression | HALLMARK_UV_RESPONSE_UP | 2.58e-05 | 158 | 255 | 9 | M5941 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | CTNNAL1 PABPC4 GMPS CLK2 SYNE2 MKI67 PSMC3IP DLAT DNA2 TIMM44 USP1 TRAF7 ASRGL1 DDX52 SMC4 E2F3 G2E3 AP3B1 KIF20B GSPT1 GSS PTPA RUVBL1 SHCBP1 MRPL48 BRD7 EXO1 CDK5RAP1 GEN1 CDK2 | 2.70e-05 | 1363 | 255 | 30 | M45782 |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 2.84e-05 | 200 | 255 | 10 | M3893 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP | 2.84e-05 | 200 | 255 | 10 | M4497 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | SPTBN1 PSMA7 SH3YL1 DECR1 PIK3C2A SACS SYNE2 RAD54B HERC2 SGK1 CAPN2 TYMP JMJD1C GSPT1 GSS PTPA LZTS1 AACS MACF1 ATP2B1 CTSS | 3.42e-05 | 790 | 255 | 21 | M12490 |
| Coexpression | HSIAO_LIVER_SPECIFIC_GENES | F5 DECR1 SERPINA1 ABCC2 ALDOB ALDH6A1 SDS SERPINA7 FMO5 ARG1 PTGR1 | 3.56e-05 | 249 | 255 | 11 | M13283 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | SPTBN1 GMPS ATXN1 PIK3CB FAM20B MKI67 OSBPL8 AKT3 SHCBP1 MACF1 CNOT1 | 3.69e-05 | 250 | 255 | 11 | M11318 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ZRANB3 GMPS CASKIN1 RAD54B SCN8A MKI67 DNA2 BRSK2 SMC4 UBA2 G2E3 KIF20B SLC8A1 NOP58 SHCBP1 NT5C2 EXO1 GEN1 CDK2 | 4.21e-05 | 680 | 255 | 19 | MM456 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | PSMA7 NCL PGK1 GMPS DHX15 NAA25 PIK3C2A SACS RAD54B MKI67 PSMC3IP DMD DNA2 TMEM200C AEN RANBP2 AKT3 MTHFD1L DDX52 ADNP2 SMC4 UBA2 E2F3 CCT2 KIF20B TFRC NOP58 FXR1 EXO1 EIF2AK4 | 4.84e-05 | 1407 | 255 | 30 | M14427 |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | MYO1A SERPINA1 PLAAT2 MS4A8 ABCC2 ALDOB CRYBG2 SGK1 SLC3A2 H1-2 ATP2B1 | 5.09e-05 | 259 | 255 | 11 | M40029 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | C5orf22 SPTBN1 PABPC4 GMPS NAA25 KCNU1 AEN ASRGL1 RAPGEF1 GSPT1 TFRC PDCD11 PC ATP2B1 | 5.18e-05 | 408 | 255 | 14 | M11891 |
| Coexpression | WANG_LMO4_TARGETS_DN | SPTBN1 PIK3CB DMD RC3H2 MACC1 BAG3 AP3B1 SLC3A2 FXR1 H1-2 UBA6 EIF5B RASSF8 | 5.90e-05 | 361 | 255 | 13 | M12674 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | C5orf22 SPTBN1 PABPC4 GMPS NAA25 KCNU1 AEN ASRGL1 RAPGEF1 GSPT1 TFRC PDCD11 PC ATP2B1 | 6.22e-05 | 415 | 255 | 14 | MM1028 |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | SPAM1 F5 NDUFV2 DECR1 ALDOB ALDH6A1 SDS FXR2 ARG1 PTGR1 EHHADH | 6.46e-05 | 266 | 255 | 11 | M1286 |
| Coexpression | LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB | RPL21 VPS13C RPS6 PSMA7 RPS13 NCL PGK1 SERPINA1 ALDOA TGM2 EIF4G2 | 6.91e-05 | 268 | 255 | 11 | M39228 |
| Coexpression | MATZUK_SPERMATOCYTE | 7.30e-05 | 72 | 255 | 6 | M1831 | |
| Coexpression | MATZUK_SPERMATOCYTE | 7.89e-05 | 73 | 255 | 6 | MM1234 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | SELENOT TNIK ABCA13 NCK1 HMOX1 MECP2 SERPINE2 SAMD9L SP140L PIK3CB PLAAT2 FGFBP1 TCF20 SLC31A2 SGK1 KCNAB2 PARP14 TYMP TGM2 EIF5 NT5C2 ADAMTS14 MAP2K1 EPHA7 | 7.93e-05 | 1033 | 255 | 24 | M4196 |
| Coexpression | LEE_BMP2_TARGETS_DN | NSUN2 PGK1 GMPS NAA25 SACS PSMC3IP DLAT UTP20 DNA2 USP1 AEN MTHFD1L UBA2 E2F3 GSPT1 SHQ1 TFRC NOP58 RUVBL1 EXO1 PDCD11 MCTP2 | 8.18e-05 | 904 | 255 | 22 | M2325 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CTNNAL1 VPS13C NCL ITPR1 SULT1C2 SACS SYNE2 RAD54B MKI67 OSBPL8 USP1 ASRGL1 SMC4 AP3B1 KIF20B KIF3A FXR1 EIF5B | 8.43e-05 | 656 | 255 | 18 | M18979 |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | CTNNAL1 NCL DHX15 SGK1 BAG3 UBA2 CCT2 JMJD1C GSPT1 SLC3A2 EIF4G2 EIF5 EIF5B | 9.88e-05 | 380 | 255 | 13 | M41703 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | LIN7C PGK1 RYK GMPS DHX15 SERPINE2 RAD54B MKI67 PSMC3IP DLAT ALDOA TIMM44 SMC4 GSS SHQ1 AACS EIF5B HADHA | 1.08e-04 | 669 | 255 | 18 | M18635 |
| Coexpression | LEE_BMP2_TARGETS_DN | NSUN2 PGK1 GMPS NAA25 SACS PSMC3IP DLAT UTP20 DNA2 USP1 AEN MTHFD1L UBA2 E2F3 GSPT1 SHQ1 TFRC NOP58 RUVBL1 EXO1 PDCD11 MCTP2 | 1.09e-04 | 922 | 255 | 22 | MM1068 |
| Coexpression | GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP | 1.17e-04 | 192 | 255 | 9 | M4677 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | TNIK RYK NDUFV2 KLHL9 PIK3C2A ATXN1 PLCL1 RANBP2 ADNP2 SMC4 G2E3 JMJD1C ARID3B NOP58 BRD7 H1-2 MCTP2 ATP2B1 | 1.32e-04 | 680 | 255 | 18 | M41089 |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN | 1.37e-04 | 196 | 255 | 9 | M8024 | |
| Coexpression | NABA_ECM_REGULATORS | SPAM1 SERPINA1 SERPINE2 P3H1 FAM20B SERPINA7 TGM2 ADAMTS14 SERPINA9 CTSS | 1.39e-04 | 242 | 255 | 10 | MM17062 |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 1.47e-04 | 198 | 255 | 9 | M8379 | |
| Coexpression | GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN | 1.47e-04 | 198 | 255 | 9 | M7708 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN | 1.53e-04 | 199 | 255 | 9 | M3921 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 1.53e-04 | 199 | 255 | 9 | M6839 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.59e-04 | 200 | 255 | 9 | M9563 | |
| Coexpression | GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 1.59e-04 | 200 | 255 | 9 | M9767 | |
| Coexpression | GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN | 1.59e-04 | 200 | 255 | 9 | M7791 | |
| Coexpression | GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN | 1.59e-04 | 200 | 255 | 9 | M5137 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 1.59e-04 | 200 | 255 | 9 | M9277 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | TNIK LIX1L ARMCX2 ABCB1 ITPR1 C3orf33 NAA25 SCN8A AKAP6 ISLR2 ASRGL1 TYMP KIF3A NOP58 USP40 CNOT1 | 1.75e-04 | 574 | 255 | 16 | M8215 |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | MBTPS1 RPS6 CNPY4 RPS13 NDUFV2 KLHL9 SYNE2 RAD54B TMCO3 DNA2 ASRGL1 BAG3 SMC4 CCT2 DRAM2 KIF20B KIF3A TFRC EHHADH SHCBP1 EXO1 GEN1 CNOT1 | 1.81e-04 | 1023 | 255 | 23 | M17122 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | VPS13C SPTBN1 PABPC4 MRTFB RAD54B FAM20B MKI67 OSBPL8 PSMC3IP ALCAM HERC2 USP1 ASRGL1 SMC4 G2E3 KIF20B CCDC7 MACF1 RASSF8 GEN1 PLCE1 | 1.87e-04 | 892 | 255 | 21 | M18120 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | TNIK HMOX1 C3orf33 SAMD9L SP140L SCN9A WDR35 MACC1 TCF20 SLC31A2 SGK1 BAG3 UBA2 DRAM2 PARP14 TGM2 H1-2 H1-4 ADAMTS14 | 2.05e-04 | 768 | 255 | 19 | M6444 |
| Coexpression | KARLSSON_TGFB1_TARGETS_UP | 2.07e-04 | 123 | 255 | 7 | M2080 | |
| Coexpression | FISCHER_DREAM_TARGETS | ZRANB3 DHX15 RAD54B MKI67 PSMC3IP DNA2 USP1 AEN SMC4 G2E3 KIF20B SLC3A2 NOP58 GTPBP2 ARRB2 SHCBP1 H1-2 H1-3 EXO1 GEN1 CNOT1 CDK2 | 2.19e-04 | 969 | 255 | 22 | M149 |
| Coexpression | MOOTHA_GLUCONEOGENESIS | 2.24e-04 | 31 | 255 | 4 | M13448 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | RPL21 NCOA6 MYO1A RPS6 NCK1 NCL PGK1 CLK2 MKI67 PSMC3IP TAF1 DNA2 USP1 TCF20 DDX52 SMC4 UBA2 AP3B1 KIF20B GSS RUVBL1 CDK13 H1-4 NT5C2 EIF5B RASSF8 CNOT1 CTSS | 2.36e-04 | 1394 | 255 | 28 | M9585 |
| Coexpression | KARLSSON_TGFB1_TARGETS_UP | 2.52e-04 | 127 | 255 | 7 | MM1289 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING | RPL21 RPS6 RPS13 NCL PGK1 SP140L ALDOA TGM2 H1-4 EIF5B MACF1 ATP2B1 MCEMP1 | 2.57e-04 | 419 | 255 | 13 | MM3768 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | TNIK LIX1L ARMCX2 ABCB1 ITPR1 C3orf33 NAA25 SCN8A AKAP6 ISLR2 ASRGL1 TYMP KIF3A NOP58 USP40 CNOT1 | 2.87e-04 | 600 | 255 | 16 | MM1025 |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 2.96e-04 | 60 | 255 | 5 | M1515 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | SELENOT NSUN2 PGK1 CHRNA5 NAA25 SERPINE2 KLHL13 RAD54B ALDOA E2F3 G2E3 CCT2 TFRC NOP58 RUVBL1 EIF5 EIF5B ATP2B1 GEN1 | 3.01e-04 | 792 | 255 | 19 | M12113 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NCOA6 SPTBN1 TAF1 TAF1L RC3H2 TCF20 ADNP2 GSPT1 SLC8A1 PTGR1 H1-2 H1-4 CDK2 EPHA7 | 3.06e-04 | 484 | 255 | 14 | MM999 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | NCK1 ITPR1 SERPINE2 SACS ATXN1 MKI67 UTP20 ADNP2 AP3B1 NBAS NT5C2 MACF1 | 3.12e-04 | 372 | 255 | 12 | M19261 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | NCOA6 VPS45 VPS13C MECP2 RYK MRTFB ATXN1 OSBPL8 HERC2 USP1 FMR1 HSDL2 MACF1 | 3.22e-04 | 429 | 255 | 13 | M29 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | MYH6 SPAM1 MYO1A HMOX1 MECP2 ITPR1 SERPINA1 SULT1C2 ATXN1 SCN9A DLAT HSD17B3 ALDOB DNAH6 SDS KCNAB2 GSS BPIFA2 SLC8A1 SLC8A3 ARRB2 USP40 EIF5B HADHA ATP2B2 CTSS | 3.40e-04 | 1281 | 255 | 26 | M1884 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | ARMCX2 PGK1 ABCB1 SH3YL1 SULT1C2 PIK3C2A ABCC2 ALDOB ALDH6A1 VTI1B FMR1 KIF3A SLC3A2 EHHADH PC | 3.71e-04 | 553 | 255 | 15 | M1475 |
| Coexpression | LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA | RPL21 RPS6 SPTBN1 PSMA7 RPS13 PGK1 ALDOA RANBP2 CAPN2 PTGR1 HADHA | 3.79e-04 | 326 | 255 | 11 | M39238 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 | 3.84e-04 | 179 | 255 | 8 | MM534 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP | NCOA6 C5orf22 HMOX1 ITPR1 UBA2 TFRC ARRB2 MRPL48 H1-2 EXO1 CDK2 | 3.99e-04 | 328 | 255 | 11 | M854 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 3.99e-04 | 137 | 255 | 7 | M39241 | |
| Coexpression | SEMENZA_HIF1_TARGETS | 4.03e-04 | 36 | 255 | 4 | M12299 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 4.14e-04 | 181 | 255 | 8 | M2969 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | RPL21 RPS6 SPTBN1 PSMA7 NCL CLK2 UBA2 CCT2 BRD7 EIF4G2 EIF5B PC | 4.14e-04 | 384 | 255 | 12 | M1865 |
| Coexpression | ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR | 4.44e-04 | 100 | 255 | 6 | M39212 | |
| Coexpression | EIF4E_DN | 4.44e-04 | 100 | 255 | 6 | M2790 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | CTNNAL1 HMOX1 SERPINE2 ATXN1 SYNE2 HSDL2 SGK1 BAG3 CCT2 NOP58 FXR1 EIF5 MACF1 | 4.46e-04 | 444 | 255 | 13 | M41713 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | CHRNA5 SERPINE2 SACS RAD54B MKI67 PSMC3IP DNA2 AEN MTHFD1L SGK1 PCLO ARID3B TFRC SHCBP1 EXO1 | 4.81e-04 | 567 | 255 | 15 | M45692 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | CTNNAL1 GMPS SYNE2 RAD54B MKI67 PSMC3IP DNA2 USP1 ASRGL1 FMR1 E2F3 G2E3 KIF20B GSS SHCBP1 EXO1 CDK2 | 4.93e-04 | 694 | 255 | 17 | M45767 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 5.14e-04 | 187 | 255 | 8 | M6807 | |
| Coexpression | RUIZ_TNC_TARGETS_DN | 5.17e-04 | 143 | 255 | 7 | M19048 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | SELENOT PSMA7 PGK1 NDUFV2 ABCB1 ITPR1 SH3YL1 SACS ATXN1 DLAT HERC2 DMD HERC1 RANBP2 PCLO KCNAB2 CCT2 TFRC CNNM1 LZTS1 EIF5 MAP2K1 ATP2B1 ATP2B2 EPHA7 | 5.36e-04 | 1248 | 255 | 25 | M17728 |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN | 5.48e-04 | 104 | 255 | 6 | M41147 | |
| Coexpression | SPIRA_SMOKERS_LUNG_CANCER_UP | 5.51e-04 | 39 | 255 | 4 | M7880 | |
| Coexpression | LU_EZH2_TARGETS_DN | NSUN2 CHRNA5 CLK2 DLAT ALDH6A1 ASRGL1 DDX52 SHQ1 DMC1 EIF4G2 ATP2B1 ALPK2 | 5.94e-04 | 400 | 255 | 12 | M2140 |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 6.06e-04 | 70 | 255 | 5 | M40002 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 6.07e-04 | 40 | 255 | 4 | MM17488 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | VPS13C NCL GMPS PSMC3IP USP1 RANBP2 DDX52 PCLO SMC4 KIF20B GSPT1 FXR1 BRD7 EIF4G2 EIF5 UBA6 EXO1 EIF5B GEN1 CNOT1 | 5.50e-06 | 532 | 250 | 20 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | GDPD2 NCL GMPS PIK3C2A FMN1 RANBP2 FMO5 SMC4 KIF20B GSPT1 NOP58 FXR1 BRD7 UBA6 EXO1 EIF5B GEN1 CNOT1 | 1.24e-05 | 469 | 250 | 18 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | FAM185A LIN7C PABPC4 GDPD2 NCL PGK1 ZRANB3 RUSC2 DHX15 CLK2 RAD54B PSMC3IP UTP20 ALDOA USP1 ASRGL1 FXR2 DNAJC25 MTHFD1L BRSK2 SMC4 G2E3 KIF20B GSPT1 ARID3B TFRC NOP58 ARRB2 SLC20A2 BRD7 H1-4 UBA6 EXO1 EIF5B EPHA7 | 1.29e-05 | 1371 | 250 | 35 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA6 FAM185A LIN7C GDPD2 NCL NSUN2 NAA25 PIK3CB CLK2 SYNE2 MKI67 UTP20 DMD RANBP2 FMR1 PCLO SMC4 AP3B1 KIF20B KIF3A ARID3B NOP58 ARRB2 NT5C2 EXO1 ATP2B1 GEN1 ATP2B2 | 1.67e-05 | 989 | 250 | 28 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | NCOA6 NCL CLK2 SYNE2 MKI67 RANBP2 FMR1 SMC4 AP3B1 KIF20B KIF3A NOP58 EXO1 GEN1 | 2.08e-05 | 311 | 250 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | TANC2 LIN7C ASH1L RYR2 PIK3C2A ALCAM HERC2 AKT3 ASRGL1 SMC4 G2E3 AP3B1 GSPT1 TFRC RASSF8 ATP2B1 | 2.11e-05 | 397 | 250 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | MORC1 FAM185A C5orf22 PSMA8 ZRANB3 NAA25 PIK3CB KLHL13 RAD54B UTP20 TAF1 DNA2 FMR1 FXR2 SYCP3 KIF20B ARID3B SHQ1 TFRC DMC1 ARRB2 RUVBL1 EXO1 PDCD11 | 2.73e-05 | 799 | 250 | 24 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NCOA6 NCL ZRANB3 GMPS SERPINA1 PRDM9 CLK2 SYNE2 RAD54B SCN8A MKI67 PSMC3IP UTP20 DMD DNA2 USP1 DNAJC25 SMC4 E2F3 G2E3 KIF20B GSPT1 ARID3B NOP58 BRD7 EIF4G2 EIF5 UBA6 EXO1 EIF5B MACF1 GEN1 | 3.33e-05 | 1257 | 250 | 32 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | MORC1 FAM185A C5orf22 ZRANB3 NAA25 PIK3CB RAD54B UTP20 DNA2 KIF20B ARID3B SHQ1 TFRC ARRB2 RUVBL1 EXO1 PDCD11 | 3.80e-05 | 463 | 250 | 17 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | VPS45 VPS13C C3orf33 PRDM9 ATXN1 SYNE2 ALCAM DMD USP1 ALDH6A1 RANBP2 HSDL2 PCLO SMC4 KIF20B USP40 EIF5 NT5C2 EXO1 EIF5B | 1.02e-04 | 654 | 250 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | RPS13 NCL PGK1 ZRANB3 DHX15 NAA25 SCN8A PSMC3IP ALDOA DNA2 USP1 CRYBG2 MTHFD1L BRSK2 SMC4 E2F3 G2E3 KIF20B ARID3B TFRC NOP58 PTPA SLC20A2 EIF5 UBA6 EXO1 EIF5B PDCD11 GEN1 | 1.16e-04 | 1164 | 250 | 29 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NCOA6 CNPY4 ASH1L NCL MECP2 NAA25 MRTFB CLK2 SYNE2 RAD54B MKI67 DMD ALDH6A1 RANBP2 TCF20 PCLO SMC4 AP3B1 KIF20B KIF3A NT5C2 EXO1 GEN1 | 1.37e-04 | 831 | 250 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.60e-04 | 204 | 250 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500 | SELENOT FAM185A NCL MRTFB FMN1 OSBPL8 UTP20 FXR2 MTHFD1L ARID3B TFRC H1-2 H1-3 EIF5 H1-4 ATP2B1 | 2.15e-04 | 484 | 250 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NCOA6 SLCO2B1 NCL ZRANB3 GMPS SERPINA1 PRDM9 CLK2 SYNE2 RAD54B SCN8A MKI67 PSMC3IP UTP20 DMD DNA2 USP1 DNAJC25 SMC4 E2F3 G2E3 KIF20B GSPT1 ARID3B NOP58 BRD7 EIF4G2 EIF5 UBA6 EXO1 EIF5B MACF1 GEN1 | 2.36e-04 | 1459 | 250 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | SELENOT FAM185A NCK1 NCL ZRANB3 MRTFB FMN1 SYNE2 OSBPL8 UTP20 TAF1 FXR2 MTHFD1L AP3B1 ARID3B SHQ1 TFRC ARRB2 H1-2 H1-3 EIF5 H1-4 MACF1 EIF2AK4 ATP2B1 | 2.58e-04 | 983 | 250 | 25 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | CTNNAL1 RPS13 GDPD2 NCL PGK1 ZRANB3 DHX15 NAA25 SCN8A PSMC3IP ALDOA DNA2 USP1 CRYBG2 MTHFD1L BRSK2 SMC4 E2F3 G2E3 KIF20B ARID3B TFRC NOP58 PTPA SLC20A2 EIF5 UBA6 EXO1 EIF5B PDCD11 GEN1 | 2.75e-04 | 1347 | 250 | 31 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 2.85e-04 | 142 | 250 | 8 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#4 | 2.99e-04 | 50 | 250 | 5 | ratio_EB_vs_SC_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.07e-04 | 28 | 250 | 4 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.28e-04 | 110 | 250 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.40e-04 | 79 | 250 | 6 | gudmap_kidney_adult_Mesangium_Meis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | MORC1 SPTBN1 ASH1L PSMA8 RYR2 GMPS PRDM9 SACS SYNE2 HERC1 RC3H2 FMR1 SMC4 SYCP3 G2E3 JMJD1C KIF3A DMC1 USP40 UBA6 EXO1 | 3.63e-04 | 776 | 250 | 21 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 3.64e-04 | 80 | 250 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.73e-04 | 186 | 250 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | RPS13 GDPD2 NCL PGK1 ZRANB3 KLHL13 RAD54B PSMC3IP UTP20 DMD ALDOA CRYBG2 ASRGL1 MTHFD1L BRSK2 SMC4 G2E3 GSPT1 ARID3B TFRC ARG1 NOP58 RUVBL1 H1-4 UBA6 EXO1 | 4.49e-04 | 1080 | 250 | 26 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.52e-04 | 116 | 250 | 7 | gudmap_developingGonad_e18.5_testes_1000_k5 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | ZRANB3 RAD54B MKI67 DNA2 USP1 SMC4 E2F3 G2E3 KIF20B TFRC NOP58 SHCBP1 EXO1 GEN1 | 4.55e-04 | 417 | 250 | 14 | GSM399403_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.70e-04 | 192 | 250 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 HMOX1 SERPINA1 FMN1 ALCAM SLC31A2 SGK1 TYMP TFRC SLC8A1 ARRB2 CTSS MCEMP1 | 1.74e-10 | 200 | 257 | 13 | 2d2835f97e0ff4f99d384f18e10876575f6bdefd |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 HMOX1 SERPINA1 ALCAM SDS SLC31A2 SGK1 TYMP TFRC SLC8A1 ARRB2 CTSS MCEMP1 | 1.74e-10 | 200 | 257 | 13 | 09bac15df511687ff336c1e7a67d980c6c281f79 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH6 VPS13C RYR2 DMD AKAP6 KIF13B RANBP2 JMJD1C SLC8A1 H1-4 MACF1 HADHA | 5.12e-10 | 176 | 257 | 12 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SLCO2B1 HMOX1 SERPINA1 SLC31A2 SGK1 KCNAB2 RAPGEF1 TYMP TFRC SLC8A1 ARRB2 CTSS | 2.09e-09 | 199 | 257 | 12 | 22001aa733273e784051b7f750e07d99aaf7a225 |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 HMOX1 SERPINA1 FMN1 ALCAM SLC31A2 SGK1 TYMP TFRC SLC8A1 ARRB2 CTSS | 2.21e-09 | 200 | 257 | 12 | ea039de8bd8b325845ce361f84e600c6dad922ed |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | CTNNAL1 SLCO2B1 SPTBN1 SAMD9L PIK3C2A CASKIN2 SYNE2 SCN9A ALCAM PARP14 TGM2 MACF1 | 2.21e-09 | 200 | 257 | 12 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 HMOX1 SERPINA1 ALCAM SDS SLC31A2 SGK1 TYMP TFRC SLC8A1 ARRB2 CTSS | 2.21e-09 | 200 | 257 | 12 | eac46978e2b3d38cf42b44f7b0350d0489d036b3 |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | VPS13C NCL SYNE2 CAPN2 PARP14 CDK13 H1-2 H1-3 EIF5 H1-4 MACF1 CNOT1 | 2.21e-09 | 200 | 257 | 12 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | TNIK MYH6 RYR2 SCN5A PLCL1 AKAP6 HSDL2 SLC8A1 TRIQK HADHA ALPK2 | 1.43e-08 | 189 | 257 | 11 | 9c1debd65c13d63fd4f3158917d621b44b714c26 |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | ARHGAP15 SLCO2B1 HMOX1 FMN1 SDS RAPGEF1 TYMP TFRC ARRB2 MAP2K1 CTSS | 1.87e-08 | 194 | 257 | 11 | ac26e5c71d5069622de72fa25a9c920887ac2c19 |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | ARHGAP15 VPS13C ASH1L NCL SAMD9L SYNE2 H1-2 EIF4G2 H1-3 H1-4 MACF1 | 2.31e-08 | 198 | 257 | 11 | 4c93ee921d56132d80832d8e94563f32ccf13bbc |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 SERPINA1 ALCAM SDS SGK1 TYMP TFRC SLC8A1 ARRB2 CTSS MCEMP1 | 2.43e-08 | 199 | 257 | 11 | 8a7bccf76fdf0b46854750a0a6a5eade0e14e515 |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | SLCO2B1 PABPC4 FMN1 ALCAM SDS SGK1 RAPGEF1 TFRC SLC8A1 MAP2K1 CTSS | 2.43e-08 | 199 | 257 | 11 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | VPS13C ASH1L NCL SAMD9L SYNE2 PARP14 JMJD1C CDK13 BRD7 H1-4 MACF1 | 2.56e-08 | 200 | 257 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 SERPINA1 ALCAM SDS SGK1 TYMP TFRC SLC8A1 ARRB2 CTSS MCEMP1 | 2.56e-08 | 200 | 257 | 11 | c30da72c3581d384b76c95f5989e32a36d783ef3 |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | SLCO2B1 LIX1L ABCB1 SERPINA1 SULT1C2 ALDOB TYMP ATP2B2 CTSS ALPK2 | 7.77e-08 | 175 | 257 | 10 | 8a37b2811f39bb9baa537e8755a29d559eb8185a |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | ARHGAP15 ASH1L ATXN1 SYNE2 HERC1 RANBP2 AKT3 JMJD1C TFRC MACF1 | 1.07e-07 | 181 | 257 | 10 | f2315414e714ac86211546a935660c4be6e85f1b |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | TNIK ABCA13 SERPINA1 SERPINE2 SYNE2 PLCL1 MACC1 CNNM1 ALPK2 EPHA7 | 1.24e-07 | 184 | 257 | 10 | 51ed1ebfdef45149541917c66cbacad87072e51f |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | CTNNAL1 CHRNA5 MKI67 PSMC3IP UTP20 DMC1 SHCBP1 TXNRD3 EXO1 CDK2 | 1.60e-07 | 189 | 257 | 10 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 1.68e-07 | 190 | 257 | 10 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | MBTPS1 VPS13C ALCAM DNA2 KIF13B PARP14 TFRC NBAS MACF1 MCTP2 | 1.76e-07 | 191 | 257 | 10 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | TNIK ASH1L SYNE2 PLCL1 HERC1 RANBP2 POLR2A JMJD1C TFRC MACF1 | 1.85e-07 | 192 | 257 | 10 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-07 | 192 | 257 | 10 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.94e-07 | 193 | 257 | 10 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | SLCO2B1 PABPC4 FMN1 SDS KIF13B SGK1 RAPGEF1 TFRC SLC8A1 MAP2K1 | 2.03e-07 | 194 | 257 | 10 | 7d682408e9a6239a4e47befc9376e760cc3d133a |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | ARHGAP15 SLCO2B1 HMOX1 KCNU1 FMN1 SDS RAPGEF1 TYMP SLC8A1 ARRB2 | 2.03e-07 | 194 | 257 | 10 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | SLCO2B1 HMOX1 FMN1 ALCAM RAPGEF1 TYMP TFRC SLC8A1 ARRB2 CTSS | 2.13e-07 | 195 | 257 | 10 | c172c5599379c29123340621a36bfb1fc90c2115 |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | ARHGAP15 SLCO2B1 HMOX1 FMN1 SCN9A TYMP TFRC ARRB2 MAP2K1 CTSS | 2.13e-07 | 195 | 257 | 10 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | SLCO2B1 SERPINA1 FMN1 RAPGEF1 TFRC SLC8A1 MAP2K1 ATP2B1 CTSS MCEMP1 | 2.13e-07 | 195 | 257 | 10 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.13e-07 | 195 | 257 | 10 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TANC2 SLCO2B1 PSMA7 PABPC4 SERPINA1 SAMD9L SLC31A2 TFRC CTSS MCEMP1 | 2.13e-07 | 195 | 257 | 10 | ec218ae03ebf8588996e86d6d9a8ea3cf71affaa |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 2.24e-07 | 196 | 257 | 10 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | ARHGAP15 SLCO2B1 FMN1 ALCAM KCNAB2 TYMP TFRC SLC8A1 ARRB2 CTSS | 2.24e-07 | 196 | 257 | 10 | 7026c1fc33425e5476063d17c79e4b79356a9e01 |
| ToppCell | IPF-Myeloid-Macrophage|IPF / Disease state, Lineage and Cell class | 2.34e-07 | 197 | 257 | 10 | a2ffb33c7cad6be43cbb8ed9a91338923cc07db4 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | ARHGAP15 SLCO2B1 HMOX1 FMN1 ALCAM KCNAB2 TYMP SLC8A1 ARRB2 CTSS | 2.34e-07 | 197 | 257 | 10 | e42910a653a1b5bd90c090e9665a84871ed2873f |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | ARHGAP15 SLCO2B1 HMOX1 FMN1 KCNAB2 TYMP TFRC SLC8A1 ARRB2 CTSS | 2.34e-07 | 197 | 257 | 10 | 3896729740d151f0eb845f1961c7b969bfbdd28d |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | SLCO2B1 HMOX1 FMN1 ALCAM RAPGEF1 TYMP TFRC SLC8A1 ARRB2 CTSS | 2.46e-07 | 198 | 257 | 10 | 33f0a919188a67d2a876b52c61a1cec2c9747969 |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | ARHGAP15 SLCO2B1 KCNAB2 RAPGEF1 TYMP TFRC SLC8A1 ARRB2 ATP2B1 CTSS | 2.46e-07 | 198 | 257 | 10 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 HMOX1 SERPINA1 SLC31A2 TYMP TFRC SLC8A1 ARRB2 CTSS MCEMP1 | 2.70e-07 | 200 | 257 | 10 | d97e9253df98cf6ad3ef4fb28e344ec108d02b1e |
| ToppCell | Lung_Parenchyma-Control-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SLCO2B1 SERPINA1 SLC31A2 KCNAB2 TYMP TFRC SLC8A1 ARRB2 CTSS MCEMP1 | 2.70e-07 | 200 | 257 | 10 | 3a69149055ac8511eb789dbcc89fd17ccfb2ea6b |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.70e-07 | 200 | 257 | 10 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-07 | 200 | 257 | 10 | 77a68e8fd97a3f3467d25032067fd7ad52ab8522 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SLCO2B1 HMOX1 SERPINA1 SLC31A2 TYMP TFRC SLC8A1 ARRB2 CTSS MCEMP1 | 2.70e-07 | 200 | 257 | 10 | d5b26580c84a7c942407786a67b20027986679fc |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 169 | 257 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.67e-07 | 170 | 257 | 9 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-07 | 173 | 257 | 9 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-07 | 173 | 257 | 9 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 8.10e-07 | 174 | 257 | 9 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-07 | 177 | 257 | 9 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 SERPINE2 SYNE2 MKI67 FMO5 SLC31A2 KIF20B ARRB2 MCEMP1 | 9.79e-07 | 178 | 257 | 9 | 15a99080e9f669572ab6d82934f324e6714846c1 |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 SERPINE2 SYNE2 MKI67 FMO5 SLC31A2 KIF20B ARRB2 MCEMP1 | 9.79e-07 | 178 | 257 | 9 | 200308e109abb7e6f8816a6f8cce6d56862d4098 |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-06 | 180 | 257 | 9 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | ARHGAP15 SLCO2B1 SGK1 KCNAB2 RAPGEF1 TFRC SLC8A1 ARRB2 ATP2B1 | 1.07e-06 | 180 | 257 | 9 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 182 | 257 | 9 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-06 | 184 | 257 | 9 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.35e-06 | 185 | 257 | 9 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 186 | 257 | 9 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-06 | 187 | 257 | 9 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.47e-06 | 187 | 257 | 9 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.54e-06 | 188 | 257 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 190 | 257 | 9 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-06 | 191 | 257 | 9 | bd0f8adfb2a508babee73477d0e9300330471e7a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-06 | 191 | 257 | 9 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.76e-06 | 191 | 257 | 9 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 1.76e-06 | 191 | 257 | 9 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 1.83e-06 | 192 | 257 | 9 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.83e-06 | 192 | 257 | 9 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-06 | 193 | 257 | 9 | 8b2f89c3cf137315eed05d9edb5fc6011c5325a8 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.91e-06 | 193 | 257 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 1.91e-06 | 193 | 257 | 9 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.00e-06 | 194 | 257 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 194 | 257 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 2.00e-06 | 194 | 257 | 9 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 194 | 257 | 9 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 2.08e-06 | 195 | 257 | 9 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.08e-06 | 195 | 257 | 9 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 195 | 257 | 9 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-06 | 195 | 257 | 9 | 0ec1b572bbb92b6da3440139366a4c1743b1ad92 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 2.08e-06 | 195 | 257 | 9 | 22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab | |
| ToppCell | IPF-Myeloid|IPF / Disease state, Lineage and Cell class | 2.08e-06 | 195 | 257 | 9 | fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-06 | 195 | 257 | 9 | 9a9e074f7ac04656dccbed2f0df11377e33d3c05 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 2.08e-06 | 195 | 257 | 9 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 195 | 257 | 9 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-06 | 196 | 257 | 9 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-06 | 196 | 257 | 9 | 48f7516129570981846c667a07abe5a9abe62dcd | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.17e-06 | 196 | 257 | 9 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.17e-06 | 196 | 257 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-06 | 196 | 257 | 9 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-06 | 196 | 257 | 9 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.17e-06 | 196 | 257 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-06 | 197 | 257 | 9 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.27e-06 | 197 | 257 | 9 | dc1c55e3aacc9d60d0f111c2f20f150ca296f011 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.27e-06 | 197 | 257 | 9 | 64fdc12e7ffade669cc1de081b10e84a27f0d1b5 | |
| ToppCell | nucseq-Immune|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-06 | 197 | 257 | 9 | b7c2c08af97a896315c105269ffb5295e20b225a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 197 | 257 | 9 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-06 | 197 | 257 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | ARHGAP15 SLCO2B1 KCNAB2 RAPGEF1 TFRC SLC8A1 ARRB2 ATP2B1 CTSS | 2.27e-06 | 197 | 257 | 9 | f18807124b91310fcd84238484a80ecdba684679 |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 2.27e-06 | 197 | 257 | 9 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.36e-06 | 198 | 257 | 9 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SLCO2B1 SERPINA1 SLC31A2 KCNAB2 RAPGEF1 TFRC SLC8A1 CTSS MCEMP1 | 2.36e-06 | 198 | 257 | 9 | ab70bf89690410221ec7aa3149bb50ac34433f99 |
| Drug | ethyl octanoate | 5.58e-07 | 7 | 259 | 4 | CID000007799 | |
| Drug | ethyl decanoate | 1.11e-06 | 8 | 259 | 4 | CID000008048 | |
| Drug | Water Pollutants, Chemical | CTNNAL1 PABPC4 NCL HMOX1 PGK1 NDUFV2 ABCC2 HSD17B3 ALDOB ALDH6A1 FMO5 SGK1 E2F3 GSS TRIM16 TGM2 RUVBL1 PTGR1 EHHADH CDK13 MRPL48 TXNRD3 ATP2B2 | 1.14e-06 | 635 | 259 | 23 | ctd:D014874 |
| Drug | Petroleum | CTNNAL1 PABPC4 NCL HMOX1 PGK1 NDUFV2 ABCC2 ALDOB ALDH6A1 FMO5 TRIM16 RUVBL1 CDK13 MRPL48 TXNRD3 | 1.30e-06 | 290 | 259 | 15 | ctd:D010578 |
| Drug | Thapsigargin | SELENOT TANC2 SPTBN1 PGK1 CHRNA5 NDUFV2 SERPINA1 SERPINE2 P3H1 KLHL13 MKI67 ALCAM TAF1 TIMM44 TAF1L ALDH6A1 ISLR2 MTHFD1L SGK1 POLR2A SMC4 AP3B1 KIF20B POLR3A SLC3A2 TGM2 SLC8A1 H1-2 H1-4 UBA6 TRIQK EXO1 EIF5B MACF1 HADHA CDK2 | 1.82e-06 | 1353 | 259 | 36 | ctd:D019284 |
| Drug | bepridil | RYR2 ITPR1 SCN4A ATP2C2 SCN5A SCN9A SCN10A SLC8A3 ATP2B1 ATP2B2 | 1.85e-06 | 126 | 259 | 10 | CID000002351 |
| Drug | oxybenzone | 1.97e-06 | 52 | 259 | 7 | ctd:C005290 | |
| Drug | Mexiletine | 1.97e-06 | 9 | 259 | 4 | ctd:D008801 | |
| Drug | Phthalic Acids | SELENOT MYH6 CTNNAL1 SPTBN1 HMOX1 ABCB1 GMPS DECR1 SACS FAM20B TAF1 HSD17B3 RC3H2 ASRGL1 SGK1 BAG3 RAPGEF1 DRAM2 SLC3A2 TFRC PTPA USP40 EIF4G2 AACS EPHA7 | 2.29e-06 | 762 | 259 | 25 | ctd:D010795 |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | VPS13C ASH1L RYR2 ITPR1 CASKIN2 ALDH6A1 NLRX1 SMC4 EHHADH CDK13 EIF5B PC | 2.58e-06 | 195 | 259 | 12 | 2311_DN |
| Drug | Antipyrine [60-80-0]; Down 200; 21.2uM; HL60; HG-U133A | MBTPS1 IRF2BP1 MECP2 TIMM44 ALDH6A1 RC3H2 RANBP2 FXR1 H1-2 H1-4 MACF1 CDK2 | 2.72e-06 | 196 | 259 | 12 | 1989_DN |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | IRF2BP1 PIK3CB P3H1 ALCAM TMCO3 ZC3H7B AP3B1 DMC1 EHHADH H1-3 EIF5B MACF1 | 2.87e-06 | 197 | 259 | 12 | 7321_DN |
| Drug | tricyclohexyltin chloride | 3.26e-06 | 10 | 259 | 4 | CID000076539 | |
| Drug | gramicidin s | 3.54e-06 | 37 | 259 | 6 | CID000073357 | |
| Drug | perfluoro-n-undecanoic acid | MYH6 SPAM1 HMOX1 DECR1 SERPINA1 SAMD9L SACS SCN5A ALCAM ABCC2 ALDOB FGFBP1 TCF20 TGM2 SLC8A1 EIF5B HADHA | 4.01e-06 | 402 | 259 | 17 | ctd:C101814 |
| Drug | doxorubicinol | 5.22e-06 | 23 | 259 | 5 | CID000083970 | |
| Drug | Lidocaine | 5.77e-06 | 4 | 259 | 3 | DB00281 | |
| Drug | Magnetite Nanoparticles | ASH1L NCL HMOX1 MECP2 ABCB1 ITPR1 GMPS SERPINA1 SAMD9L SACS ATXN1 FMN1 MKI67 DLAT ALCAM USP1 SERPINA7 RC3H2 SLC31A2 G2E3 JMJD1C KIF20B KIF3A TFRC TRIM16 TGM2 SLC8A1 SLC20A2 H1-2 NT5C2 EXO1 RASSF8 ATP2B1 CTSS | 6.21e-06 | 1310 | 259 | 34 | ctd:D058185 |
| Drug | Succimer | ASH1L NCL HMOX1 MECP2 ABCB1 ITPR1 GMPS SERPINA1 SAMD9L SACS ATXN1 FMN1 MKI67 DLAT ALCAM ABCC2 USP1 SERPINA7 RC3H2 SLC31A2 G2E3 JMJD1C KIF20B TFRC TRIM16 TGM2 SLC8A1 SLC20A2 H1-2 EXO1 RASSF8 ATP2B1 CTSS | 7.62e-06 | 1264 | 259 | 33 | ctd:D004113 |
| Drug | nitroxyl | MORC1 MB PEX12 HMOX1 PGK2 RYR2 DECR1 TAF1 TGM2 MAP2K1 ATP2B1 | 9.40e-06 | 185 | 259 | 11 | CID000000945 |
| Drug | AC1MMLID | 1.03e-05 | 92 | 259 | 8 | CID000013245 | |
| Drug | fluo-3 | 1.11e-05 | 122 | 259 | 9 | CID000104978 | |
| Drug | NSC226080 | MYH6 MBTPS1 RPS6 PSMA7 HMOX1 PSMA8 RYR2 ABCB1 ITPR1 PIK3C2A PIK3CB AKT3 SGK1 TFRC CNNM1 TGM2 PTPA RUVBL1 EIF4G2 EIF5 EIF5B EIF2AK4 MAP2K1 CDK2 | 1.13e-05 | 782 | 259 | 24 | CID000005040 |
| Drug | potassium | MYO1A F5 RYR2 ITPR1 GMPS PIK3C2A SACS PIK3CB SCN4A ATP2C2 SCN5A SCN9A SCN10A DLAT SDS AKT3 SGK1 KCNAB2 SLC3A2 TFRC SLC8A1 SLC8A3 PTPA NT5C2 ATP2B1 ATP2B2 ALPK2 PLCE1 | 1.30e-05 | 1008 | 259 | 28 | CID000000813 |
| Drug | beta-NADP | HMOX1 PGK1 PGK2 NDUFV2 DECR1 DLAT HSD17B3 ALDOA ALDOB ALDH6A1 SDS FMO5 MTHFD1L KCNAB2 PTGR1 LZTS1 TXNRD3 PC | 1.43e-05 | 490 | 259 | 18 | CID000000929 |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; HL60; HG-U133A | LIN7C NCL DHX15 FMR1 ADNP2 GSPT1 SHQ1 TFRC MRPL48 EIF5 EIF5B | 1.47e-05 | 194 | 259 | 11 | 1741_DN |
| Drug | Azathioprine | ABCB1 SERPINA1 SERPINE2 RAD54B MKI67 ABCC2 DNA2 SERPINA7 FMO5 HSDL2 SGK1 ZG16B SMC4 KIF20B SLC3A2 GSS PTGR1 EHHADH SHCBP1 EXO1 MAP2K1 | 1.49e-05 | 639 | 259 | 21 | ctd:D001379 |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | MYH6 IRF2BP1 HMOX1 ITPR1 RUSC2 ZC3H7B SDS CNNM1 TGM2 SLC20A2 H1-4 | 1.54e-05 | 195 | 259 | 11 | 3346_UP |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | HMOX1 PIK3CB RAD54B KIF13B HSDL2 FXR2 DMC1 TGM2 CDK13 UBA6 CDK2 | 1.62e-05 | 196 | 259 | 11 | 7357_DN |
| Drug | 2-butenedioate | HMOX1 DECR1 ATP2C2 ASRGL1 FMR1 TCF20 FXR2 ARG1 FXR1 PC ATP2B1 ATP2B2 | 1.65e-05 | 234 | 259 | 12 | CID000000723 |
| Drug | oxaloacetate | PGK1 PGK2 DECR1 SERPINA1 DLAT ALDOA ALDOB ARG1 CNNM1 AACS PC | 1.78e-05 | 198 | 259 | 11 | CID000000970 |
| Drug | nalidixic acid | ERVK-6 SCN5A ABCC2 FMR1 FXR2 SLC8A1 SLC8A3 FXR1 SLC20A2 H1-2 H1-3 H1-4 PLCE1 | 1.89e-05 | 277 | 259 | 13 | CID000004421 |
| Drug | magnesium | ERVK-6 CPAMD8 MYO1A SPTBN1 PSMA8 PGK1 PGK2 RYR2 ABCB1 GMPS DECR1 PIK3C2A PIK3CB ATP2C2 DLAT KIF13B DNAH3 RANBP2 MTHFD1L DDX52 POLR2A CCT2 GSS DMC1 PTPA DNAH17 NT5C2 EIF5B PC MAP2K1 ATP2B1 ATP2B2 CDK2 | 1.99e-05 | 1325 | 259 | 33 | CID000000888 |
| Drug | AGN 193109 | 2.07e-05 | 30 | 259 | 5 | ctd:C096920 | |
| Drug | Amiodarone | MYH6 ARHGAP15 SLCO2B1 RPS6 SPTBN1 PABPC4 PEX12 HMOX1 PGK2 ABCB1 DECR1 C3orf33 SERPINA1 CASKIN2 SCN4A SCN5A ABCC2 ALDH6A1 TCF20 HSDL2 FXR2 BAG3 SLC3A2 GSS ARG1 SLC8A1 SLC8A3 GTPBP2 EHHADH OR52N2 EIF5 AACS EXO1 PC SERPINA9 | 2.76e-05 | 1469 | 259 | 35 | ctd:D000638 |
| Drug | myrcen-8-ol | 2.84e-05 | 6 | 259 | 3 | CID005319723 | |
| Drug | Co K | 2.84e-05 | 6 | 259 | 3 | CID006852202 | |
| Drug | tiapamil | 2.84e-05 | 6 | 259 | 3 | CID000042106 | |
| Drug | esperamicin A1 | 2.84e-05 | 6 | 259 | 3 | CID006435576 | |
| Drug | APETx1, Anthopleura elegantissima | 2.84e-05 | 6 | 259 | 3 | ctd:C475726 | |
| Drug | sodium | ERVK-6 NCOA6 SLCO2B1 HMOX1 PGK2 RYR2 GMPS SACS ATXN1 SCN4A ATP2C2 SCN5A SCN9A SCN10A ABCC2 ASRGL1 SGK1 KCNAB2 SLC3A2 SLC8A1 SLC8A3 SLC20A2 MAP2K1 ATP2B1 ATP2B2 ALPK2 | 3.11e-05 | 944 | 259 | 26 | CID000000923 |
| Drug | Fura-2AM | 3.28e-05 | 79 | 259 | 7 | CID000105091 | |
| Drug | E1-P | 3.35e-05 | 33 | 259 | 5 | CID000104406 | |
| Drug | TBHQ | 3.52e-05 | 141 | 259 | 9 | CID000016043 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 3.54e-05 | 176 | 259 | 10 | 2666_UP | |
| Drug | N-nitrosomorpholine | NDUFV2 ABCB1 DECR1 SERPINA1 ALDOB ALDH6A1 SERPINA7 USP29 CCT2 GSS ARG1 HADHA PC MAP2K1 | 3.61e-05 | 338 | 259 | 14 | ctd:C002741 |
| Drug | St. Thomas' Hospital cardioplegic solution | 3.72e-05 | 142 | 259 | 9 | ctd:C041711 | |
| Drug | AC1L1A5Z | 4.05e-05 | 111 | 259 | 8 | CID000000850 | |
| Drug | Flavonoids | RPL21 MYH6 MBTPS1 VPS45 RPS6 SPTBN1 RPS13 PEX12 GPHA2 MECP2 CHRNA5 ITPR1 ATP2C2 HSD17B3 ALDOB FGFBP1 SYCP3 ARG1 BPIFA2 ARRB2 RUVBL1 LZTS1 EHHADH SLC20A2 EIF5 CDK5RAP1 HADHA PC MAP2K1 | 4.25e-05 | 1136 | 259 | 29 | ctd:D005419 |
| Drug | motexafin gadolinium | 4.63e-05 | 146 | 259 | 9 | ctd:C437683 | |
| Drug | SC-11927 | 4.92e-05 | 7 | 259 | 3 | CID003034422 | |
| Drug | malonate semialdehyde | 5.54e-05 | 19 | 259 | 4 | CID000000868 | |
| Drug | AC1L2YVP | 5.54e-05 | 19 | 259 | 4 | CID000080135 | |
| Drug | coenzyme 1 | PGK2 RYR2 NDUFV2 ITPR1 GMPS DECR1 DLAT HSD17B3 ALDOA ALDOB ALDH6A1 MTHFD1L PTGR1 EHHADH H1-2 H1-3 H1-4 HADHA PC | 5.75e-05 | 596 | 259 | 19 | CID000000925 |
| Drug | mag-fura-2 | 5.93e-05 | 37 | 259 | 5 | CID000123839 | |
| Drug | MgCl2 | MYH6 SPAM1 MYO1A SPTBN1 GMPS DHX15 DECR1 ATP2C2 PTPA H1-2 H1-3 H1-4 ATP2B1 ATP2B2 | 5.95e-05 | 354 | 259 | 14 | CID000024584 |
| Drug | nsc25485 | ERVK-6 ABCB1 PIK3C2A PIK3CB SCN4A ATP2C2 SCN9A SLC8A1 SLC8A3 TXNRD3 ATP2B1 ATP2B2 PLCE1 | 6.45e-05 | 312 | 259 | 13 | CID000004605 |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.46e-05 | 189 | 259 | 10 | 3788_DN | |
| Drug | arabinosyladenine | NCOA6 MYH6 HMOX1 F5 RYR2 ABCB1 ITPR1 GMPS PIK3C2A PIK3CB ATP2C2 ABCC2 SDS AKAP6 POLR2A TYMP PTPA NT5C2 CDK5RAP1 MAP2K1 ATP2B1 ATP2B2 | 6.55e-05 | 762 | 259 | 22 | CID000000191 |
| Drug | lovastatin acid | 6.87e-05 | 20 | 259 | 4 | CID000064727 | |
| Drug | 3-hydroxy-4-oxobutyl-1-phosphonate | 7.81e-05 | 8 | 259 | 3 | CID003016813 | |
| Drug | glycerol | ERVK-6 NCOA6 SPTBN1 MB HMOX1 PGK1 PGK2 DECR1 PIK3C2A CLK2 DLAT ALDOA ALDOB VTI1B DDX52 NLRX1 POLR2A UBA2 ARG1 DMC1 EIF5 PC CDK2 | 8.12e-05 | 829 | 259 | 23 | CID000000753 |
| Drug | deoxythymidin | GPHA2 PGK2 FMR1 FXR2 TYMP TFRC FXR1 TMEM132D TXNRD3 NT5C2 INO80B CDK2 | 8.23e-05 | 276 | 259 | 12 | CID000001134 |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.39e-05 | 195 | 259 | 10 | 3721_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; HL60; HG-U133A | LIN7C PIK3C2A DNA2 AKT3 JMJD1C KIF20B AACS EIF5B ATP2B1 CTSS | 8.39e-05 | 195 | 259 | 10 | 1370_UP |
| Drug | LY294002; Up 200; 10uM; PC3; HG-U133A | 8.39e-05 | 195 | 259 | 10 | 429_UP | |
| Drug | N-ethylmaleimide | ERVK-6 MYH6 MYO1A VPS45 SPTBN1 ABCB1 ATP2C2 DLAT ABCC2 VTI1B KIF13B KIF3A SLC3A2 GSS TFRC ATP2B1 ATP2B2 | 8.48e-05 | 511 | 259 | 17 | CID000004362 |
| Drug | caffeine | MYH6 GDPD2 RYR2 ITPR1 PIK3C2A ATP2C2 DMD AKAP6 BRSK2 ARG1 PTPA TMEM132D NT5C2 BRSK1 ATP2B1 ATP2B2 CNOT1 PLCE1 | 8.51e-05 | 562 | 259 | 18 | CID000002519 |
| Drug | Antigens, Polyomavirus Transforming | LIN7C SPTBN1 PEX12 ZRANB3 RAD54B TAF1 DNA2 USP1 ASRGL1 TCF20 SMC4 G2E3 CCT2 JMJD1C GTPBP2 ARRB2 TRIQK EXO1 HADHA CDK2 | 8.68e-05 | 668 | 259 | 20 | ctd:D000952 |
| Drug | HFIP | 8.71e-05 | 40 | 259 | 5 | CID000013529 | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A | 8.75e-05 | 196 | 259 | 10 | 2036_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | KLHL9 PIK3CB ZC3H7B DNAH3 DDX52 KIF3A GTPBP2 ARRB2 H1-3 EIF5B | 8.75e-05 | 196 | 259 | 10 | 6924_DN |
| Drug | alpha-ketobutyrate | 8.83e-05 | 64 | 259 | 6 | CID000000058 | |
| Drug | isoflurane | MB HMOX1 MECP2 DECR1 PIK3C2A SCN4A ATP2C2 SCN9A SCN10A DMD ATP2B1 ATP2B2 | 9.12e-05 | 279 | 259 | 12 | CID000003763 |
| Drug | hex-2-ulose | 9.37e-05 | 93 | 259 | 7 | CID000001101 | |
| Drug | amiodarone | 9.40e-05 | 160 | 259 | 9 | CID000002156 | |
| Drug | lidocaine | 9.40e-05 | 160 | 259 | 9 | CID000003676 | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | LIN7C SPTBN1 TMCO3 ALDH6A1 AEN RC3H2 DDX52 KIF3A SLC20A2 H1-3 | 9.52e-05 | 198 | 259 | 10 | 4837_DN |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A | IRF2BP1 SPTBN1 ATXN1 SCN5A TAF1 ABCC2 ALDH6A1 DNAH3 EHHADH RASSF8 | 9.52e-05 | 198 | 259 | 10 | 6238_UP |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; HL60; HT_HG-U133A | SPTBN1 SCN10A PLCL1 ABCC2 ZC3H7B AKT3 CRYBG2 TYMP GSPT1 ARG1 | 9.52e-05 | 198 | 259 | 10 | 3091_DN |
| Drug | geldanamycin | C5orf22 SPTBN1 HMOX1 OSBPL8 DMD AKT3 E2F3 JMJD1C NBAS SLC8A1 CDK13 H1-3 RASSF8 MAP2K1 | 9.78e-05 | 371 | 259 | 14 | ctd:C001277 |
| Drug | 3,5,5-trimethylhexanoylferrocene | 9.83e-05 | 41 | 259 | 5 | ctd:C050224 | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HG-U133A | 1.03e-04 | 200 | 259 | 10 | 1955_DN | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; PC3; HT_HG-U133A | TANC2 VPS13C ASH1L CUL7 KIF13B RC3H2 SLC31A2 EHHADH H1-3 H1-4 | 1.03e-04 | 200 | 259 | 10 | 7151_DN |
| Drug | Aspirin | RPS6 HMOX1 ABCB1 SERPINA1 PIK3C2A CLK2 ALDOA SDS FXR2 POLR2A CAPN2 SMC4 UBA2 TYMP KIF20B KIF3A GTPBP2 EHHADH MAP2K1 CDK2 | 1.06e-04 | 678 | 259 | 20 | ctd:D001241 |
| Drug | Thimerosal | TANC2 LIN7C SPTBN1 LIX1L HMOX1 PGK1 RUSC2 PIK3C2A ATXN1 SYNE2 OSBPL8 TDRD6 ALDOA USP1 ALDH6A1 AKT3 PCLO NLRX1 BAG3 USP29 SYCP3 JMJD1C NBAS SLC8A1 H1-3 H1-4 HADHA RASSF8 PC | 1.10e-04 | 1199 | 259 | 29 | ctd:D013849 |
| Drug | NSC281245 | 1.14e-04 | 96 | 259 | 7 | CID000002854 | |
| Drug | Co-O | 1.16e-04 | 9 | 259 | 3 | CID009547993 | |
| Drug | phenethyl acetate | 1.16e-04 | 9 | 259 | 3 | CID000007654 | |
| Drug | R 8231 | 1.16e-04 | 9 | 259 | 3 | CID003084926 | |
| Drug | divicine | 1.22e-04 | 23 | 259 | 4 | CID000091606 | |
| Drug | AC1MNMWT | 1.22e-04 | 23 | 259 | 4 | CID003330240 | |
| Drug | Spkk | 1.24e-04 | 43 | 259 | 5 | CID000129363 | |
| Drug | strontium | 1.24e-04 | 68 | 259 | 6 | CID000104798 | |
| Drug | Zinc Acetate | 1.24e-04 | 166 | 259 | 9 | ctd:D019345 | |
| Drug | Flecainide | 1.29e-04 | 2 | 259 | 2 | DB01195 | |
| Drug | benzoylaconine | 1.29e-04 | 2 | 259 | 2 | ctd:C047307 | |
| Drug | enkephalin-Leu, Ala(2)-melphalan methyl ester- | 1.29e-04 | 2 | 259 | 2 | ctd:C040240 | |
| Drug | Hexylcaine | 1.29e-04 | 2 | 259 | 2 | DB00473 | |
| Drug | Ranolazine | 1.29e-04 | 2 | 259 | 2 | DB00243 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.04e-08 | 10 | 251 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.04e-08 | 10 | 251 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.23e-08 | 12 | 251 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | fragile X syndrome (implicated_via_orthology) | 6.08e-07 | 3 | 251 | 3 | DOID:14261 (implicated_via_orthology) | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 6.08e-07 | 3 | 251 | 3 | DOID:7474 (implicated_via_orthology) | |
| Disease | Global developmental delay | 2.20e-06 | 133 | 251 | 9 | C0557874 | |
| Disease | Malignant neoplasm of breast | NCOA6 SLCO2B1 RPS6 HMOX1 ABCB1 NAA25 SERPINE2 PIK3CB SYNE2 MKI67 UTP20 HERC2 DMD ALDOA AKAP6 TFRC TGM2 SLC8A3 FXR1 TRAPPC12 H1-2 EIF5 EXO1 MACF1 GEN1 | 5.88e-06 | 1074 | 251 | 25 | C0006142 |
| Disease | Intellectual Disability | TANC2 ASH1L NSUN2 MECP2 SACS SCN8A TAF1 AKAP6 FMR1 TCF20 BRSK2 E2F3 GTPBP2 NT5C2 MACF1 | 7.68e-06 | 447 | 251 | 15 | C3714756 |
| Disease | glucagon measurement, glucose tolerance test | 1.19e-05 | 6 | 251 | 3 | EFO_0004307, EFO_0008463 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.19e-05 | 6 | 251 | 3 | DOID:0050429 (implicated_via_orthology) | |
| Disease | electrocardiography | MYH6 SPTBN1 SCN5A SCN10A PLCL1 TMCO3 SGK1 BAG3 E2F3 JMJD1C GSS SLC8A1 USP40 CNOT1 PLCE1 EPHA7 | 1.42e-05 | 530 | 251 | 16 | EFO_0004327 |
| Disease | Myocardial Ischemia | 2.14e-05 | 176 | 251 | 9 | C0151744 | |
| Disease | Grand Mal Status Epilepticus | 2.31e-05 | 67 | 251 | 6 | C0311335 | |
| Disease | Petit mal status | 2.31e-05 | 67 | 251 | 6 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.31e-05 | 67 | 251 | 6 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 2.31e-05 | 67 | 251 | 6 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.31e-05 | 67 | 251 | 6 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.31e-05 | 67 | 251 | 6 | C0751523 | |
| Disease | Status Epilepticus | 2.51e-05 | 68 | 251 | 6 | C0038220 | |
| Disease | Leigh syndrome | 3.30e-05 | 8 | 251 | 3 | cv:C0023264 | |
| Disease | Epilepsy | 4.22e-05 | 109 | 251 | 7 | C0014544 | |
| Disease | inflammatory biomarker measurement | 6.60e-05 | 26 | 251 | 4 | EFO_0004872 | |
| Disease | epilepsy (implicated_via_orthology) | 8.20e-05 | 163 | 251 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | PR interval | SPTBN1 RYR2 CASKIN2 SYNE2 SCN5A SCN10A AKAP6 KIF13B CRYBG2 CCDC7 TGM2 SLC8A1 MACF1 CNOT1 | 9.80e-05 | 495 | 251 | 14 | EFO_0004462 |
| Disease | Colorectal Carcinoma | CPAMD8 ABCA13 F5 ABCB1 SACS MKI67 ABCC2 DMD AKAP6 DNAH3 MTHFD1L TYMP TFRC TGM2 H1-4 EXO1 EPHA7 | 1.20e-04 | 702 | 251 | 17 | C0009402 |
| Disease | Neurodevelopmental Disorders | 1.47e-04 | 93 | 251 | 6 | C1535926 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 1.63e-04 | 13 | 251 | 3 | C0750905 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 1.63e-04 | 13 | 251 | 3 | C0002514 | |
| Disease | Postherpetic neuralgia | 2.15e-04 | 3 | 251 | 2 | C0032768 | |
| Disease | Child Development Disorders, Pervasive | 2.15e-04 | 3 | 251 | 2 | C0008074 | |
| Disease | Primary Erythermalgia | 2.15e-04 | 3 | 251 | 2 | C0014805 | |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 2.15e-04 | 3 | 251 | 2 | EFO_0803063 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 2.15e-04 | 3 | 251 | 2 | C0349788 | |
| Disease | Hair Diseases | 2.15e-04 | 3 | 251 | 2 | C0018500 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.15e-04 | 3 | 251 | 2 | C1833661 | |
| Disease | B Virus Infection | 2.15e-04 | 3 | 251 | 2 | C0037140 | |
| Disease | Sick sinus syndrome | 2.15e-04 | 3 | 251 | 2 | cv:C0037052 | |
| Disease | Herpesviridae Infections | 2.15e-04 | 3 | 251 | 2 | C0019372 | |
| Disease | Pervasive Development Disorder | 2.15e-04 | 3 | 251 | 2 | C0524528 | |
| Disease | silicosis (is_marker_for) | 2.15e-04 | 3 | 251 | 2 | DOID:10325 (is_marker_for) | |
| Disease | Familial sick sinus syndrome | 2.15e-04 | 3 | 251 | 2 | cv:C0340491 | |
| Disease | alpha fetoprotein measurement | 2.18e-04 | 100 | 251 | 6 | EFO_0010583 | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.18e-04 | 100 | 251 | 6 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.43e-04 | 36 | 251 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | P wave duration | 2.57e-04 | 15 | 251 | 3 | EFO_0005094 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 2.71e-04 | 194 | 251 | 8 | EFO_0004265, EFO_0007908 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.75e-04 | 147 | 251 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 3.14e-04 | 16 | 251 | 3 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.31e-04 | 108 | 251 | 6 | DOID:684 (biomarker_via_orthology) | |
| Disease | familial atrial fibrillation | 3.94e-04 | 156 | 251 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.94e-04 | 156 | 251 | 7 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 3.94e-04 | 156 | 251 | 7 | C0235480 | |
| Disease | pulmonary venoocclusive disease (is_marker_for) | 4.28e-04 | 4 | 251 | 2 | DOID:5453 (is_marker_for) | |
| Disease | Brugada ECG Pattern | 4.28e-04 | 4 | 251 | 2 | C1721096 | |
| Disease | neutrophil-activating peptide 2 measurement | 4.28e-04 | 4 | 251 | 2 | EFO_0020606 | |
| Disease | Atrial Fibrillation | 4.59e-04 | 160 | 251 | 7 | C0004238 | |
| Disease | Familial dilated cardiomyopathy | 5.31e-04 | 44 | 251 | 4 | C0340427 | |
| Disease | Anxiety Disorders | 5.31e-04 | 44 | 251 | 4 | C0003469 | |
| Disease | Anxiety States, Neurotic | 5.31e-04 | 44 | 251 | 4 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 5.31e-04 | 44 | 251 | 4 | C1279420 | |
| Disease | Seizures | 5.89e-04 | 218 | 251 | 8 | C0036572 | |
| Disease | sick sinus syndrome (is_implicated_in) | 7.09e-04 | 5 | 251 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Iron Metabolism Disorders | 7.09e-04 | 5 | 251 | 2 | C0012715 | |
| Disease | Adverse reaction to drug | 7.65e-04 | 84 | 251 | 5 | C0041755 | |
| Disease | Drug toxicity | 7.65e-04 | 84 | 251 | 5 | C0013221 | |
| Disease | lung adenocarcinoma (is_marker_for) | 8.07e-04 | 85 | 251 | 5 | DOID:3910 (is_marker_for) | |
| Disease | Cardiomyopathies | 8.84e-04 | 130 | 251 | 6 | C0878544 | |
| Disease | calcium measurement | NCOA6 SPTBN1 ITPR1 SERPINA1 CASKIN2 SYNE2 SGK1 NLRX1 USP40 MACF1 EIF2AK4 ATP2B1 CTSS PLCE1 | 1.06e-03 | 628 | 251 | 14 | EFO_0004838 |
| Disease | portal hypertension (is_marker_for) | 1.06e-03 | 6 | 251 | 2 | DOID:10762 (is_marker_for) | |
| Disease | intercellular adhesion molecule 2 measurement | 1.06e-03 | 6 | 251 | 2 | EFO_0008163 | |
| Disease | Sick Sinus Syndrome | 1.06e-03 | 6 | 251 | 2 | C0037052 | |
| Disease | lipopolysaccharide-binding protein measurement | 1.06e-03 | 6 | 251 | 2 | EFO_0021894 | |
| Disease | Metastatic melanoma | 1.16e-03 | 54 | 251 | 4 | C0278883 | |
| Disease | Small cell carcinoma of lung | 1.16e-03 | 54 | 251 | 4 | C0149925 | |
| Disease | Major Depressive Disorder | 1.19e-03 | 243 | 251 | 8 | C1269683 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.24e-03 | 55 | 251 | 4 | C0079744 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.25e-03 | 139 | 251 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | atrial fibrillation | MYH6 ATXN1 SYNE2 SCN5A SCN10A HERC1 AKAP6 POLR2A JMJD1C CCDC7 | 1.38e-03 | 371 | 251 | 10 | EFO_0000275 |
| Disease | electrocardiography, PR interval | 1.47e-03 | 7 | 251 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Immune System Diseases | 1.47e-03 | 7 | 251 | 2 | C0021053 | |
| Disease | Congenital Pain Insensitivity | 1.47e-03 | 7 | 251 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.47e-03 | 7 | 251 | 2 | C0020075 | |
| Disease | pulmonary venoocclusive disease (biomarker_via_orthology) | 1.47e-03 | 7 | 251 | 2 | DOID:5453 (biomarker_via_orthology) | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 1.69e-03 | 200 | 251 | 7 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.69e-03 | 257 | 251 | 8 | DOID:10652 (is_marker_for) | |
| Disease | Generalized seizures | 1.75e-03 | 101 | 251 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.75e-03 | 101 | 251 | 5 | C0234535 | |
| Disease | Non-epileptic convulsion | 1.75e-03 | 101 | 251 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.75e-03 | 101 | 251 | 5 | C0751123 | |
| Disease | Single Seizure | 1.75e-03 | 101 | 251 | 5 | C0751110 | |
| Disease | Visual seizure | 1.75e-03 | 101 | 251 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.75e-03 | 101 | 251 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 1.75e-03 | 101 | 251 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.75e-03 | 101 | 251 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.75e-03 | 101 | 251 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.75e-03 | 101 | 251 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.75e-03 | 101 | 251 | 5 | C0422852 | |
| Disease | pancreatic cancer (is_marker_for) | 1.75e-03 | 101 | 251 | 5 | DOID:1793 (is_marker_for) | |
| Disease | Convulsive Seizures | 1.75e-03 | 101 | 251 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.75e-03 | 101 | 251 | 5 | C0751496 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKAIVKKELLSVVAG | 56 | Q9NWW9 | |
| ILKLLKGKVVVGHAL | 181 | Q8WTP8 | |
| VTEKGGLVEIINKKI | 256 | Q8IVW6 | |
| ETGKLLAVRELVKKG | 396 | Q9Y2R4 | |
| LGTVVGLVNKDLGKK | 361 | Q9NR48 | |
| ATLKGLVQKGVKVDL | 121 | Q8N129 | |
| TVLKHLKGVNGKDII | 1091 | Q96M83 | |
| EEVVGLLKKLGIKLQ | 1296 | Q9P2K8 | |
| VLRQVDTKTGKLKIG | 301 | P49902 | |
| KPLKLVLKVGGNEVT | 21 | Q9NPI1 | |
| NGKKVEVAVKQIIAG | 631 | Q86V21 | |
| GHLAEGVKKKILSRV | 1721 | Q86TB3 | |
| GKLFRNILKEKGIVV | 91 | P05062 | |
| NILKEKGIVVGIKLD | 96 | P05062 | |
| KSRVKGLGGLIVVSK | 256 | Q7L266 | |
| GGARVALKIIKNVEK | 186 | P49760 | |
| EKGTQGKIVDLVKEL | 186 | P01009 | |
| QVIKSKGGVVGIKVD | 96 | P04075 | |
| RVILKEGGGIKKLVD | 751 | Q8NEN0 | |
| LKVGAKLLFREGVTK | 566 | Q9BX10 | |
| KLGLKSLVSKGTLVQ | 81 | P16403 | |
| AQVLLVEGKKKVKNG | 16 | Q14512 | |
| HLITLGKEFQKLVKG | 1546 | Q86UQ4 | |
| ITEVGEALKTVLGKK | 1631 | P11532 | |
| ASIIVGDKLLKQKVA | 176 | Q6P1W5 | |
| KGSIIQLANGELKKV | 576 | P54253 | |
| GINVADIKKLKSVGI | 31 | Q14565 | |
| NLGSVVLQLKKLGID | 506 | O43143 | |
| LKGLVSIKDKSQQVI | 316 | Q5RIA9 | |
| LEKSGVNLDGKKILV | 211 | Q6UB35 | |
| NLIVDKATKKAVIVG | 551 | Q14004 | |
| LLSQGGGKIKVEILK | 516 | Q7L311 | |
| GGKIKVEILKILSNF | 521 | Q7L311 | |
| IVKEGANKEVLGILV | 306 | P32121 | |
| VLQGKLTKLAVQIGK | 361 | P20020 | |
| LQGKLTKLAVQIGKA | 386 | Q01814 | |
| LKIIKALQESGAIVA | 656 | O75185 | |
| GKASKQAGALKLVQI | 721 | Q8WXS8 | |
| LKLLGKGTFGKVILV | 151 | Q9Y243 | |
| RKKVKGILVDIGLDS | 16 | Q6IQ32 | |
| AGKVAEVKKNGRISL | 81 | P05089 | |
| VIEKLLKDKSTLVAG | 191 | O00203 | |
| KIKGQGLAKVSILGE | 416 | Q6UXK2 | |
| KKAGRIPEQILGKVS | 156 | Q02750 | |
| ILGGAKVADKIQLIK | 211 | P07205 | |
| RALETVKKVGKVGAN | 516 | Q9HBD1 | |
| VKGKIGKVKGEIDIQ | 291 | Q8NHQ8 | |
| VLIVKGKSFILKNLE | 146 | Q9Y620 | |
| IGNVKILRHKTSGKI | 1216 | P49792 | |
| KISKVIVVGDLSVGK | 51 | Q9BZG1 | |
| KIIKLLDGKRSQTVG | 1046 | Q68DA7 | |
| VTVFKALKLGQEGKV | 516 | Q32P28 | |
| VVIFLGVKLLSKKIG | 321 | Q8NHS3 | |
| LIKALSGGKNTKIIT | 6 | Q6ZNQ3 | |
| EVKILKGLNLKVQSG | 406 | P08183 | |
| EKVGSQLKLKSLLGA | 381 | Q86VD1 | |
| QLKLKSLLGAGVVGI | 386 | Q86VD1 | |
| VLGEKKKEGVILTNE | 706 | Q08J23 | |
| KVVLRIKAEGAVAKA | 226 | Q8NGH8 | |
| LKEIAKLITLEQGKT | 116 | Q02252 | |
| KEGASILLDGRKIKV | 376 | Q02252 | |
| DAKLGGVIKEKLNLS | 91 | Q9Y2X3 | |
| ISGKIIFVGRAQKKV | 256 | Q13310 | |
| LQEIGITKLGHQKKL | 581 | Q8WXD9 | |
| KGIQLGKEEVKLSLF | 686 | O00370 | |
| AVELLKAAQGKVKLV | 156 | Q9NUP9 | |
| SLKDVKDVGILQVKV | 501 | Q6DN12 | |
| KDVGILQVKVLKAAD | 506 | Q6DN12 | |
| EILGLKAQLKDTRGK | 411 | Q9Y250 | |
| GLGKAVVVKTLEQLA | 41 | Q9P2W1 | |
| SIVKNLKDTLGIGKV | 66 | P16333 | |
| AILKKIDVLNLSIGG | 296 | Q14703 | |
| VIGKNGKVIQEIVDK | 306 | P51116 | |
| KVLGSIAGKLEKGTI | 451 | Q14643 | |
| INESIKVGIGEKKKV | 361 | Q9UBC5 | |
| KLLEGLQGKKVIDVA | 701 | O95714 | |
| VIGKNGKVIQEIVDK | 296 | P51114 | |
| KLQGVIKSLEKDIQG | 926 | Q96MR6 | |
| IAKGNGILSKAGILK | 2351 | Q15652 | |
| LGKVELKSHKGSIIV | 301 | Q8N0U4 | |
| QKIDVLCGIGIKKVA | 4231 | Q15751 | |
| LEKTLGKGQTGLVKL | 21 | Q8IWQ3 | |
| LKGLVSIKDKSQQVI | 316 | Q8IUF1 | |
| LKGLVSIKDKSQQVI | 316 | Q9BRT8 | |
| NLSKKIKKIGVVVGN | 461 | Q08426 | |
| VKKAKKETGNGIILE | 2301 | Q9Y6V0 | |
| AKKLAVEKGIDLTQV | 361 | P10515 | |
| LLKQTKLVQLLGGVA | 1046 | O00443 | |
| LKLEDTEKKIQVGLG | 1331 | Q14999 | |
| NVIIKLNKAGLVLGI | 86 | Q6UX65 | |
| IIGVNLATKKKEGTL | 1716 | Q96Q89 | |
| TGGQTLVAKKAVVIK | 656 | Q9ULH7 | |
| HGVNKVGLKKIIDFI | 96 | Q9P2J3 | |
| KEKKDILVLAAGQLG | 316 | Q8IVB5 | |
| EKAIKKFGGIDILVN | 86 | Q6YN16 | |
| NGVGKILKKINKAIV | 86 | P07093 | |
| VKKRGKTGLETAVLL | 516 | Q9HCC8 | |
| VKGQKLIKKEFIETG | 946 | Q92887 | |
| EALKGKKFIVVCGNI | 326 | A8MYU2 | |
| KASLGKVGVKEELLA | 1026 | P46013 | |
| KVGVKEELLAVGKFT | 1031 | P46013 | |
| ILGGAKVADKIQLIN | 211 | P00558 | |
| IVLGLRKTTLQKVGK | 506 | Q86UT6 | |
| LILKTVLGIASKKEQ | 221 | Q8NGJ6 | |
| GVKTKQIQEGVIKFL | 296 | Q8NGI0 | |
| KLSALEKKVIVGGVD | 471 | Q9Y496 | |
| EKKVIVGGVDLLAKA | 476 | Q9Y496 | |
| GKRDVAVAIKTLKVG | 656 | Q15375 | |
| LNVGVESKLILKGVI | 101 | P78344 | |
| VLLRTGKLAEAKNKG | 1506 | A2RRP1 | |
| VKNGDVTGVQKLVAK | 11 | Q8WXE0 | |
| DEGKTIAIGKVLKLV | 481 | P15170 | |
| AAGKAEVVLGNIIKK | 91 | Q13303 | |
| VVTGGIIDLKRGKKV | 2411 | Q9UPN3 | |
| LTGLKVFGNEIKLEK | 366 | P19338 | |
| LKIKLGGQVLGTKSV | 71 | Q9C086 | |
| LGAILKIQTKEGRIK | 221 | Q6IF42 | |
| ISGKLKLGKEVLATL | 621 | Q9BZF1 | |
| GKGKVDKIGQILLTK | 1816 | Q14686 | |
| KLFVGVGISRIAKVK | 511 | Q9NQV7 | |
| KQKGILLTGSKTEVL | 711 | Q460N5 | |
| IIGAVLKIKTASGRK | 221 | Q8NGY6 | |
| TLEIGKQLIKAQKGA | 176 | Q16698 | |
| IIKNIIKSKIDIKGG | 221 | Q9H1X3 | |
| ILLKRGGVKVSTKNL | 21 | P87889 | |
| ILLKRGGVKVSTKNL | 21 | Q9YNA8 | |
| ILLKRGGVKVSTKNL | 21 | P62683 | |
| ILLKRGGVKVSTKNL | 21 | P63145 | |
| ILLKRGGVKVSTKNL | 21 | Q7LDI9 | |
| ILLKRGGVKVSTKNL | 21 | P63130 | |
| ILLKRGGVKVSTKNL | 21 | P62685 | |
| ILLKRGGVKVSTKNL | 21 | P63126 | |
| VSTLLIELGFQIKKK | 346 | Q7L622 | |
| ILLKRGGVKVSTKNL | 21 | P62684 | |
| KIKIKFGLAISQLVD | 71 | P30532 | |
| GKSVIAKGLLNKIQE | 2101 | Q9C0G6 | |
| LIAKVEGKGNGIKTV | 21 | P55010 | |
| VIGKNGKLIQEIVDK | 296 | Q06787 | |
| ALKKLGIQVKVINAA | 286 | P49915 | |
| KLHGVSKVGLRKIID | 136 | Q9P2N7 | |
| TVDNTLKGILEKLKV | 46 | Q96DR5 | |
| KISGLKDQTVIVVKA | 306 | O00716 | |
| VVLKALKLTGVEGNL | 416 | Q9UBT7 | |
| LKDVEALGKKLGFTI | 3886 | Q9UFH2 | |
| EDLKKIILQVGVATK | 2471 | Q8TD57 | |
| ISGLKKVKVQLQCVG | 91 | Q96T91 | |
| NRIISGLVKVKGNVK | 291 | P49326 | |
| EGIKVGKAKLLNQVL | 41 | O15432 | |
| SQGAILDKGTIKLKV | 76 | Q8IZJ3 | |
| GEILEILKKGKAFVL | 236 | Q49AR2 | |
| EGLKGEQVKLTEALK | 1081 | Q8N1P7 | |
| LKGLVSIKDKSQQVI | 316 | Q5JTY5 | |
| LKGLVSIKDKSQQVI | 316 | Q4V339 | |
| AGAEKNGLVKIKVAE | 136 | P08195 | |
| LEKTLGKGQTGLVKL | 36 | Q8TDC3 | |
| LLKAELTALKKGEGI | 201 | Q6P1S2 | |
| LGEGKVKAIGQSKVK | 581 | Q6ZN28 | |
| LKEGKTLGAIQIIIG | 66 | Q9BY19 | |
| LAGIKNIDTKVQKIL | 161 | Q8IX19 | |
| IAQVSVDKGLKTILK | 376 | P40939 | |
| VAVGLKQGKVIIVVK | 526 | P40939 | |
| GVGKEQALKLIQILK | 216 | Q17RS7 | |
| KLGLKSLVSKGTLVQ | 81 | P10412 | |
| LSGGQVLKKIAQKAL | 141 | P09601 | |
| GALEAQLKLKTGKLV | 146 | P25774 | |
| GKDFLVETIKLGKLL | 196 | P38567 | |
| ARNKLTGEVVALKKI | 21 | P24941 | |
| VLSVLSKTKEAGKIL | 166 | P48637 | |
| IKLGLKSLVSKGTLV | 81 | P16402 | |
| GVLKVEAILEKVQGL | 421 | O95817 | |
| KIIQKALQKGSLLGC | 226 | P17655 | |
| GLKGKIDVTVGVKIH | 271 | P51530 | |
| IKEKLAGLEIGILVN | 116 | P37058 | |
| KALGVKTVGAQALKL | 221 | P20132 | |
| KITGKLQKEGALSRV | 241 | Q08357 | |
| ADIVQKLGGFVLKKL | 841 | Q9NZJ4 | |
| KLGGFVLKKLDASIQ | 846 | Q9NZJ4 | |
| VTLLEAKGKVKDIAI | 311 | P34925 | |
| GSLVEGAKKIKVAEL | 4316 | Q92736 | |
| GLKKRESLTLIVEGK | 401 | Q13740 | |
| GEIATILAGDIKVKK | 566 | Q8IU81 | |
| SVVGQIAKLKGCKVV | 156 | Q14914 | |
| GVQVKRVLEKSPGKL | 206 | P51608 | |
| DVQLAIRKVLGKKGS | 316 | Q8NGX6 | |
| EKLLGKKLTIFIIGG | 296 | Q8NH83 | |
| QEVAVKEQLTGKGKL | 1361 | Q9NQT8 | |
| ISIDLLQKKGLVKAV | 986 | Q8N2Y8 | |
| KGLLLKTIKGTAVVD | 286 | Q5T160 | |
| EILGKFVGKDQVTKL | 1966 | O75691 | |
| VFKLVLIGLIIVGKD | 91 | P62341 | |
| QLKTGIVEKVKGSIT | 716 | Q68CJ6 | |
| LSVLNLVIVKKGEKD | 106 | P62753 | |
| LKTLILGKAVNAKIE | 396 | O60522 | |
| LKTIVGALIQSVKKL | 236 | P35499 | |
| ILKAFGLKGIISKTE | 821 | Q4G0N8 | |
| AVLNKLKTAIGAVEK | 66 | Q6UWJ1 | |
| IGGLEDVKLKLKQSI | 466 | Q9BVQ7 | |
| GVGVDINKALLAKRK | 76 | Q8IZU3 | |
| KSKRKSILAVGVGNV | 781 | Q8N3T6 | |
| GQLKVAKDVEKLIGQ | 731 | Q8WXH0 | |
| TLRAKVKKGVNIIGV | 321 | Q14C87 | |
| VVKGKLKLCSISGLI | 41 | A6NKL6 | |
| DLLKIKKITAIITQG | 2126 | P12259 | |
| KGAGKFILKLKEQVQ | 2226 | Q9P212 | |
| KESEGLKLVKLLIGN | 391 | Q8IVG5 | |
| KVEGTKIVFGKQLIE | 1336 | Q8IZX4 | |
| IKVEGTKIVLGKQLI | 1316 | P21675 | |
| VKILGKDLEKTLAGL | 931 | O60841 | |
| LKVIGKGSFGKVLLA | 101 | O00141 | |
| GIEKGALSQLKKLLF | 111 | O60938 | |
| IAKAKGLAILSVIKA | 41 | Q96HL8 | |
| KTLQEKGLIKDQIFG | 266 | Q53QZ3 | |
| AFNGTVKKCGLLKII | 161 | O14802 | |
| QIIASILVGKDEKIK | 566 | O14802 | |
| LKTIVGALIQSVKKL | 236 | Q14524 | |
| LKTIVGALIQSVKKL | 231 | Q15858 | |
| DTIKILQLGKSAVLK | 346 | Q6PI26 | |
| KKGKVEVRAINLGTD | 71 | Q96GC5 | |
| KGSGNLEAIHIIKKL | 191 | P78371 | |
| NTSVVVTLLKKGAKI | 1211 | Q9HCD6 | |
| GLIVLEGLKILSGKI | 396 | Q9UBT2 | |
| SVLGGVLKTKQQLKT | 581 | Q8NCN4 | |
| GQIKKKRLSELGITQ | 626 | Q8NEM2 | |
| KLDSKIGVLIGKGLH | 121 | P42338 | |
| FVKAKILSREGGKVI | 46 | P13533 | |
| KINSALKKAVGGVAL | 231 | O00623 | |
| KGILHKEKLEQGTLA | 311 | Q9H930 | |
| LKEIKILNIFGVIKG | 381 | P02786 | |
| LKGKQLLREGKVSEA | 101 | Q9UQ84 | |
| KKTQGKVVDIIQGLD | 181 | Q86WD7 | |
| ILLKRGGVKVSTKNL | 21 | P63128 | |
| KALAVEGKRIGKVLD | 281 | Q01082 | |
| LLSKVEALKKGGVLL | 1016 | Q13023 | |
| FVLLLQGKVEVEVGK | 671 | Q9NRU3 | |
| SKVLKLSKVQEVIFG | 116 | A5YKK6 | |
| KVLGLQGLKEVTLLG | 301 | Q96SZ6 | |
| DKLKAVKGFRNVIIG | 671 | P21980 | |
| KLKVGKTVTARVIGG | 1081 | Q14690 | |
| IAKNLVLAGIKAVTI | 76 | A0AVT1 | |
| ITVLKGQGDLLKNAK | 1031 | Q15111 | |
| VGLLLVKSVQVKLGD | 81 | Q96DA0 | |
| GLNVLVTISGKKNKL | 1096 | Q9UKE5 | |
| TTVKGVIKAVLDGVK | 186 | Q13905 | |
| VEKVTQKLDGLQGKI | 606 | Q8WVT3 | |
| ILRGVKKEDKTLAVG | 586 | O94956 | |
| FILTLNEGVKGKKLT | 51 | Q15257 | |
| GLKVIVGALIHSVKK | 231 | Q9Y5Y9 | |
| VTGNKILRILKSKGL | 66 | P62277 | |
| DLGKQIKLKEVEGTL | 6 | O00338 | |
| EGVKELSKKLVIVNG | 1011 | P24928 | |
| TQLKALLILEGGQKV | 106 | O75063 | |
| TKGKVVGLIQDLKPN | 181 | P05543 | |
| VGTELKLKKELTGLN | 506 | Q6Q0C0 | |
| IKRELLGNVKKVISA | 346 | Q9HBJ7 | |
| AVGIVVNKQVKGKIL | 71 | P46778 | |
| RGKVLDAIIQEKKSG | 596 | Q9NTJ3 | |
| GLKTIVGALIQSVKK | 236 | Q9UQD0 | |
| VAITKQFLKGLKGVE | 446 | Q9NRW7 | |
| KVDGKLSFKVGCIQI | 1691 | Q709C8 | |
| KGRGLKLEAIVQKIT | 1346 | Q9UGU0 | |
| QGKGIFITRTVKEIK | 181 | Q8N841 | |
| HVIIGLKTAKGTKQL | 156 | Q9Y265 | |
| GATVLTALGGILKKK | 66 | P02144 | |
| KKKVASALGIGIAIG | 221 | Q6P7N7 | |
| EVLRKKLGELTGTVK | 116 | O43615 | |
| TRKIGLEKIGVKINE | 441 | Q86VQ6 | |
| LEKIGVKINEKSGKI | 446 | Q86VQ6 | |
| VGLKDKLSGIRKVIT | 301 | O95361 | |
| NIVVLGVEKKSVAKL | 41 | Q8TAA3 | |
| IKLAIKALLEVVQSG | 196 | Q8TAA3 | |
| QGIKFVKRLGKLLSE | 726 | Q9P2L0 | |
| VVLGVEKKSVAKLQD | 41 | O14818 | |
| AKKTAIGIKEVGLVL | 41 | Q629K1 | |
| VDQLGQKLLKKIGIS | 361 | Q9NVE5 | |
| RLLGTAGTEEKKKLI | 31 | Q9UEU0 | |
| IDIKVVAGAKVAKGQ | 1121 | P11498 | |
| KKLVEGLSALVVDVK | 221 | P19971 | |
| KVLNKKNVEAIGLLG | 656 | O94782 | |
| SVIKNEKVNGGKKLL | 196 | Q2M3W8 | |
| KVKNVGGHVRLITKE | 846 | Q5FWF4 | |
| GVKRGSLTIAKLLKE | 531 | Q9UGR2 | |
| GLKDKLSGIRKVITE | 86 | Q309B1 | |
| VDKLIKKTNLALVVG | 726 | P32418 | |
| DKLIKKTNLALVVGT | 681 | P57103 | |
| CAKVLKAIGLQRTGK | 46 | Q14CX7 | |
| DSILEAIQKKLGIKV | 146 | P19404 |